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ABSTRACT
To ascertain the current provision of pharmaceutical services in Independent Hospitals 
(IHs), data were collected using three surveys. First, a postal questionnaire obtained 
information from the persons in charge of pharmaceutical services provision at 192 
(75%) of the 257 IHs in the UK. Second, 138 senior pharmacists involved in the 
inspection of IHs on behalf of Health Authorities/Health Boards in the UK were 
surveyed by postal questionnaire. Their responses covered 228 (89%) of the EHs. 
Third, a number of interviews were undertaken with senior pharmacists involved in 
the inspection of EHs.
Six different service-provider models were identified, four involving pharmacists and 
the other two not. Pharmacists were responsible for providing pharmaceutical services 
in 189 of the independent hospitals which ranged from small hospitals with less than 
40 beds to larger hospitals having up to 390 beds and up to 7 operating theatres. Based 
on the responses provided by pharmacists involved in inspection, there were 
significant differences in the perceived quality of 9 of 13 service criteria between 
hospitals with and without a pharmacist. In contrast, no significant differences were 
found for any service criteria when the perceived quality was based on self-assessment 
by the service provider.
The inspecting pharmacists’ assessments of perceived service quality showed that for 
most service criteria, two service provider models -  involving a directly-employed 
pharmacist or a pharmacist contracted from a NHS hospital -  were ranked on average 
as either best or second best. The ranks obtained from self-assessments were rarely in 
accordance with those of the inspecting pharmacists’ assessment.
Assessments of quality by pharmacists involved in service provision were more likely 
to be in accordance with those of the inspecting pharmacists. Non-pharmacist 
providers were more likely to over-estimate the quality of their services.
The results indicate that there are advantages in employing a pharmacist to provide 
pharmaceutical services in IHs and provide evidence that the judgement of non­
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The National Health Service (NHS) in the United Kingdom has been complemented 
by an Independent Health Sector. The independent sector has complemented the 
(NHS) not only in areas such as elective surgery, but also in areas where NHS 
coverage is limited 1 The advantages brought by the independent sector are:
• an increase in the range of options available to patients and their GPs.
• contributions to the cost-effective treatment of NHS patients, increasing the options 
available to NHS management as well as to individual patients.
• responding flexibly and rapidly to patients needs.
The independent sector has demonstrated its confidence in the future of private 
healthcare through a steady expansion of facilities .
1.1. Legislation.
1.1.1. Definition.
Under the Registered Homes Act 1984 , independent hospitals were assumed to be a 
type of Registered Home. Part II of this Act makes the following statement:
"(a) Any premises used, or intended to be used, for 
the reception of, and the provision of nursing 
for, persons suffering from any sickness, injury 
or infirmity,
(b) Any premises used, or intended to be used, for 
the reception of pregnant women, or o f women 
immediately after childbirth.
(c)Any premises not falling within either of the 
preceding paragraphs which are used, or 
intended to be used, for the provision of all or 
any of the following services, namely:
(i) the carrying out of surgical procedures 
under anaesthesia;




(iv) haemodialysis or peritoneal dialysis;
(v) treatment by specially controlled techniques.
The 1984 Act itself does not use the term "acute independent hospital" nor define it. 
Thus such establishments are considered as a type of nursing homes. Therefore, the 
above definition does not include premises which fall into the following categories set 
out in section 21(3) (a), (f) and (g) of the Registered Homes Act 1984 3:
"any hospital or other premises maintained or 
controlled by a government department or local 
authority or any other authority or body instituted 
by special Act of Parliament or incorporated by 
Royal Charter;
unless they are used, or intended to be used, for the
provision of treatment by specially controlled
techniques and are not excepted by regulations
under paragraph (g) below;
any premises used, or intended to be used, wholly
or mainly as a private dwelling; or
any other premises exceptedfrom that definition by
regulations made by the Secretary o f State".
1.1.2. Registration.
Under the Registered Homes Act 1984 section 23 (1)3, it is an offence not to register 
a nursing home with the Local Health Authority:
"Any person who carries on a nursing home 
without being registered under this part of this Act 
in respect o f that home shall be guilty o f an 
offence".
Therefore, the person to be registered can be an individual or a corporate body. This 
person will be responsible for ensuring that the services to be provided are adequate 
before the registration of the facility.
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Under the same Act, section 25 (1) (a) 3, the Secretary of State can refuse registration 
applications:
"that the applicant, or any person employed or 
proposed to be employed by the applicant at the 
home, is not a fit person (whether by reason o f age 
or otherwise) to carry on or be employed at a home 
of such a description as that named in the 
application".
Therefore, the fit person-in-charge to carry on or be employed at an independent 
hospital is one of the important aspects of the registration process.
1.2. Development of independent hospitals.
Independent hospitals should, however, possess either acute medical and surgical 
facilities, including an operating theatre, or acute psychiatric facilities .
As a result of the rapid growth of healthcare in the UK over the last 10 years or so, 
there has been a gradual increase in the number of acute independent hospitals. 
According to the Independent Hospital Association 2, as at January 1995, there were 
227 acute independent hospitals in the UK, with a total of 11,681 beds. Table 1.1 
shows the changes year by year in the number of acute independent hospitals and 
beds.
This expansion in the private health sector is expected to continue to grow in the 
coming years following the introduction of the Government White Paper "Working 
for patients 1 " , and the introduction of the "purchaser/provider split" which has 
allowed the independent hospitals to sell their services to Health Authorities and also 
to General Medical Practitioners (GPs). GPs and their patients are currently able to 
use NHS funds to pay for treatment in the private sector under certain conditions, if 
this offers better quality or better value for money than buying NHS services. 
Similarly, Health Authorities carrying out their new role as purchasers rather than as 
providers of care will buy in services from the private sector if it offers a better deal 
than is available from NHS hospitals.
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Table 1,1. Changes in the number of IHs and beds since 1980:

















(Source: Independent Hospital Association: Acute Hospital Survey, 1996) .
As can be seen from Table 1.1, there was a rapid increase in the number of 
independent hospitals between years 1980 and 1984 followed by a more gradual 
increase.
Following the White Paper "Working for patients1 " , it seems that the Government at 
that time welcomed the increase in the independent sector, not only because it was 
able to relieve pressure on the NHS but also because it provided opportunities for the 
NHS and independent sectors to learn from each other, to support each other and to 
buy from each other. This has also led to clearer performance criteria, improved 
productivity, innovative ideas and techniques, and better management. As part of the 
Government’s drive to reduce hospital waiting lists, many Health Authorities entered 
into short-term contracts with private hospitals specifically to treat waiting list cases.
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A study of patients who chose private healthcare for treatment4 showed that 61.5% of 
the respondents stated that the most common reason for using private healthcare for 
treatment was to avoid NHS waiting lists although they did not necessarily know how 
long that wait would have been. In addition, that study showed that the majority of the 
patients who decided to use private healthcare for treatment had decided to use private 
healthcare before consulting their GPs, and this was because they had private health 
insurance cover and they wanted to use it.
Independent hospitals in the past were primarily owned and operated by religious or 
charitable institutions. Nowadays, commercial "for profit" organisations have begun 
to invest in private healthcare in the UK. Table 1.2 shows the ownership of the private 
healthcare hospitals in the 1980s and 1990s.
Table 1.2. Independent hospitals ownership in the 1980s and 1990s.
Category No. of hospitals in 
the 1980s





Charitable (single) 24 20
Charitable Groups 33 47
Charitable TOTAL 89 84
FOR-
PROFIT
American Groups 3 1
British Groups 5 81
European Groups 0 31
Independent 57 30
For-profit TOTAL 65 143
TOTAL 154 227
(Source: Independent Hospital Association; Acute Hospitals Survey 1996)5.
As can be seen from Table 1.2, the "for-profit" section of the independent sector has 
overtaken the charitable section in terms of the number of establishments; this may be 
due to the religious and charitable institutions lacking the incentive schemes and 
marketing skills, at least in the past.
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1.3. The new structure of the NHS.
In 1991, the Government introduced a programme of reform in the National Health 
Service6 . The reform aimed to improve services to patients by devolving 
responsibility to local level. As a result, the responsibility for patient services rested 
with individual GPs, with District Health Authorities (DHAs) and Family Health 
Services Authorities (FHSAs), and with NHS Trusts. The elements of the reforms 
were:
• the establishment of NHS Trusts, such that, by April 1994, more than 90% of NHS 
services would be managed by some 440 Trusts;
• the introduction of GP Fund-holders. These GPs, would have the funding to 
purchase hospital services and other treatment for their patients;
• the development of the purchasing function so that DHAs were responsible for 
purchasing the most appropriate services from a range of providers;
• the encouragement of closer working relationships between DHAs and FHSAs to 
ensure a better balance between hospital and community health services and 
primary care services.
Therefore, the resulting structure was as follows:
• 190 District Health Authorities (DHAs);
• 8 Special Health Authorities (SHAs) which managed London’s postgraduate 
teaching hospitals;
• 90 Family Health Services Authorities (FHSAs) which administered the general 
practitioners services (doctors, dentists, opticians and pharmacists);
• 14 Regional Health Authorities (RHAs); and
• the NHS Management Executive (NHS-ME) within the Department of Health.
In May 1993, the Secretary of State for Health set up a review of the structure, 
functions and manpower required to:
• ensure that the Government’s reforms of the NHS are fully effected;
• ensure effective oversight of both purchasers and providers;
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• ensure that the Secretary of State is able to discharge her statutory responsibilities 
for the NHS; and to
• ensure that the proportion of NHS expenditure devoted to direct patient care is 
maximised.
The 1991 structure of the NHS is shown in Figure 1.1.













Family Health Services 
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In the light of the review, the Secretary of State made a subsequent decision that:
"The effectiveness o f the NHS in delivering 
services to patients would be improved by 
streamlining the central management structure 
and consolidating joint working between DHAs 
and FHSAs6''.
This meant:
• creating a clear identity for the NHS Management Executive, within the 
Department of Health;
• abolishing the 14 RHAs and reorganising the NHSME to include 8 Regional 
Offices, to replace the RHAs and the existing NHSME Outposts;
• enabling DHAs and FHSAs to merge to create stronger local purchasers.
Figure 1.2. shows the new structure of the NHS which resulted from that further
reorganisation.






P U R C H A SE R S P R O V ID E R S
t S S . j ,
Department o f  Health
Secretary o f  State
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Moreover, NHS Hospital Trusts were given a range of power and freedom, designed 
to stimulate greater enterprise and commitment, which was intended in turn to 
improve services for patients. This freedom gave the NHS Hospital Trusts a power to 
employ whatever and however many staff they consider necessary. The Trusts also 
employ their own consultants. Those consultants may also work for other NHS 
hospitals or in the private sector. The main source of revenue for those Trusts is from 
contracts with Health Authorities for the provision of services to their residents; and 
those services include pharmaceutical services. Other contracts and revenue come 
from GP practices with their own NHS budgets, private patients or their insurance 
companies, contracts with private hospitals for the provision of some services (e.g. 
pharmaceutical services) and, perhaps, other NHS Hospital Trusts.
1.4. Pharmacists and the Pharmaceutical Services.
The role of the pharmacist in offering pharmaceutical services is to provide 
pharmaceutical care to patients1. As an appendix to the Code of Ethics, section 2.5 of 
the Medicines, Ethics and Practice guide published by the Royal Pharmaceutical 
Society of Great Britain (RPSGB) 7, there is a "Statement of Principles and Standards 
of Good Practice for Hospital Pharmacy". This section stated that:
"pharmaceutical care has been defined as "the 
responsible provision of drug therapy for the 
purpose of achieving definite outcomes which 
improve the patient’s quality o f life", These 
outcomes may include the cure of disease, 
elimination of symptoms or prevention of a disease 
or symptoms".
It was also stated that:
"Z/i achieving these outcomes, the pharmacist is 
professionally and legally responsible directly to 




The Nuffield Report emphasised the pharmacist’s role in making a significant 
contribution to the cost effective use of medicines and to the care of individual 
patients.
Pharmaceutical services are primarily concerned with patients and their treatment with 
medicines. Pharmacists are responsible for ensuring that the law related to medicines 
is implemented and the Department of Health Guidelines are followed. The practice of 
pharmacy in Great Britain is governed by the Code of Ethics of the Royal 
Pharmaceutical Society of Great Britain (RPSGB)7. As an appendix to the Code of 
Ethics, section 2.5 of the Medicines, Ethics and Practice guide published by the Royal 
Pharmaceutical Society of Great Britain (RPSGB) 7, there is a "Statement of 
Principles and Standards of Good Practice for Hospital Pharmacy". This section lists 
the following requirements which underlie the professional responsibilities of the 
pharmacist when offering pharmaceutical care in hospitals and elsewhere1.
• Pharmacists are professionally, ethically and legally responsible directly to the 
patient for the quality of care they provide;
• the pharmacist has a duty of care to the patient to ensure that the medicines they 
receive are safe, effective and represent an effective use of scarce NHS resources;
• The pharmaceutical care provided should be commensurate with and responsive to 
the needs of the patient;
• pharmaceutical care is provided through interaction of the entire pharmacy team 
and its integration with other healthcare professionals in the treatment of patients;
• the patient’s rights to privacy, independence, confidentiality and dignity should be 
maintained at all times;
• patients and where appropriate their carers should be empowered to make informed 
choices about their care and participate in the planning of that care;
• pharmaceutical care should be of optimum quality and regularly monitored to 
ensure maintenance of that quality;
• standards should recognise the professional independence of the pharmacy 
practitioner;




1.5. Standards of good practice for hospital pharmacy.
Obligation 1.14 to principle one of the Code of Ethics of the RPSGB requires that:
"A pharmacist must conform to the obligation in 
the standards of Good Professional Practice and 
with other guidelines appropriate to the relevant 
field o f work".
Such standards are applicable to all aspects of pharmacy practice and relate to the 
following matters, as summarised by Dale and Appelbe in the textbook "Pharmacy 
Law and Ethics" 9 :
fP  Standards for premises - appearance, safety, environment, condition, 
tidiness, size and hygiene.
(2) Standards for dispensary design and equipment - suitability, work surfaces, 
shelves, flooring and water-supply.
(3) Standards for procurement and source o f  materials - sources of supply, 
safe systems of work and requirements for medical gases.
(4) Standards for manufacturing and quality assurance - good manufacturing 
practice, quality assurance, quality control, batch numbers and equipment.
(5) Standards for dispensing procedures - supervision, safety, dispensing 
containers, reuse of medicines, labels and storage.
(6) Standards for professional indemnity - personal and establishment 
insurance.
(7) Standards for education, training and development - training and 
continuing education.
(8) Standards for relationships with patients and public.
(9) Standards for relationship with other health professionals.
(10) Standards for administration and management.
1.6. Standards of pharmaceutical services in independent hospitals.
Pharmaceutical services are primarily concerned with patients and their treatment with 
medicines. Within independent hospitals, the services standards should be no less 
rigorous than those in the NHS. Any publications which are primarily directed to NHS 
hospitals should be considered equally relevant to the independent sector.
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There is no statutory requirement for independent hospitals in the UK to establish a 
pharmacy department, because private hospitals are covered by Nursing Home 
regulations. Therefore, in the past prior to the purchaser/provider split, the District 
Pharmaceutical Officer (DPhO) was responsible for ensuring that the appropriate 
pharmaceutical care was available and that the service was adequately monitored.
1.6.1. NAHAT Guidelines for Acute Independent H ospitals10.
The National Association of Health Authorities and Trusts (NAHAT) came into begin 
in 1990, formed from a merger of the National Association of Health Authorities and 
the society of Family Practitioner Committees. The association’s primary role is to 
express the collective views of its membership on important national issues affecting 
the NHS. One of its aims was to foster co-operation and communication between 
NHS authorities, government departments, local authorities and other organisations 
concerned with health matters. This Association has published advice and model 
guidelines, which interpret the Registered Homes Act 1984. The guidance provided 
for independent hospitals is similar to that for Nursing Homes and does not provide a 
distinction between acute independent hospitals and nursing homes. However, these 
guidelines have no specific statutory force but comprise recommendations which are 
implicit in the statutory requirements.
The 1993 NAHAT guidelines 10 recommended that:
"Whenever possible, a pharmaceutical service 
should be established in an acute independent 
hospital with appropriate out o f hours cover".
More specifically, the guidelines recommended that:
1) In hospitals with fewer than 40 beds and without an operating theatre-
pharmaceutical advice only is needed.
2) In hospitals with fewer than 40 beds with an operating theatre-
services of a pharmaceutical department are needed.
3) In hospitals with more than 40 beds and without an operating theatre-
services of a pharmaceutical department are needed.
4) In hospitals with more than 40 beds and with an operating theatre-
services of a pharmaceutical department are needed.
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Few studies have examined the provision of pharmaceutical services in independent 
hospitals. A study was undertaken by Rees et al 11 with the aim of surveying the 
provision of pharmaceutical services in IHs throughout Great Britain from the point of 
view of the person responsible for the provision of pharmaceutical services within the 
hospital. The study obtained information on 112 IHs. Of those, a pharmacist was 
employed by 51% (57) of the hospitals. Fifty one of the hospitals surveyed with 1, 2 or 
even 3 operating theatres did not employ a pharmacist, and a number of those 
hospitals had up to 74 beds. The study also showed that of the 55 hospitals without a 
pharmacy, the matron or the senior nurse was considered directly responsible for 
pharmaceutical services in 71% of these hospitals. Also, there were no regular visits 
by a pharmacist in 42% of the hospitals in the survey which did not employ a 
pharmacist. In those cases where there were visits, more than half of the hospitals 
were visited by a community pharmacist.
I ^
Another study was undertaken by Rees et al with the aim of assessing the 
pharmaceutical services within IHs as perceived by pharmacists involved in their 
inspection. The study surveyed 61 Senior Pharmacists involved in inspection of 
independent hospitals in England. Of the 70 independent hospitals covered by the 
survey, the inspectors confirmed that 38 obtained a full pharmaceutical service 
provided by a pharmacist either employed by the IH or contracted to the EH by an 
NHS hospital or community pharmacist. The study provided details on 54 hospitals 
and showed that 23 of them had over 40 beds, or included one or more operating 
theatres, but did not employ a pharmacist. From a view point of the standards of 
pharmaceutical services within EHs, that study concluded that the standard of services 
was lower in IHs where no pharmacist was present.
A comparison of small independent hospitals with small NHS hospitals was
11undertaken by Anderson .The study was carried out to assess compliance with 
NAHAT guidelines with regard to the establishment of a pharmacy department within 
both public and private sectors. In that study, information was gathered from the 
owner or manager of the hospital.
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The survey results showed that out of 92 hospitals (43 of them were acute independent 
hospitals and 49 were NHS hospitals), no hospital with 40 or more beds but no 
operating theatre had its own pharmacy, contrary to the NAHAT recommendations. 
The results of Anderson’s study also showed that, of the hospitals with fewer than 40 
beds and having 1 or more operating theatres, only three out of 23 in the private sector 
and none of the 10 in the public sector had their own pharmacy department. Even 
slightly larger hospitals with 40 or more beds together with one or more operating 
theatres rarely had a pharmacy department; only two out of 12 private hospitals and 
two out of 14 public ones had a pharmacy. The finding of that study confirmed that . 
there was poor compliance with the NAHAT recommendations on pharmaceutical 
services not only in acute private hospitals but also in NHS hospitals of equivalent 
size.
1.6.1.1. Hospitals without a pharmacy.
NAHAT recommended that hospitals which do not establish a pharmacy department 
should obtain on-going advice from a pharmacist with experience of the type of 
service provided by the unit to ensure that appropriate arrangements are made for 
pharmaceutical services, including out of hours arrangements 10.
1.6.1.1.1. The role o f the Community Pharmacist in providing pharmaceutical 
services to registered homes.
The community pharmacist (CP) can play a crucial role in providing pharmaceutical 
services in establishments such as Residential Homes, Nursing Homes as well as acute 
independent hospitals. He/she can provide an important involvement in many aspects of 
pharmaceutical care such as: the provision of a clinical pharmacy service, reviewing 
patient medication records, etc. Several studies have been undertaken to investigate the 
importance and usefulness of CPs in providing services to such establishments that have 
no pharmacy. The previous study undertaken by Rees et al 11 confirmed that a local 
community pharmacy was solely responsible for the supply of medicines to 18% of the 
55 independent hospitals without a pharmacy and at least a further 46% sourced from a 
local pharmacy in conjunction with a NHS hospital pharmacy or wholesaler. Also the 
second survey undertaken by Rees et al 12 indicated that 25% of the IHs with no 
pharmacist present, received a regular visit from a community pharmacist.
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A study by Duggan et al 14 was run with the objective of appraising the introduction of 
locally agreed contracts between Residential Homes (RHs) and the CP. The study was 
undertaken in 13 RHs and the results showed that homes which had a negotiated 
contractual agreement with a local CP for providing pharmaceutical services had a 
greater pharmacy input and service provision than those without such a contract. For 
example, 58% of homes with a contract received more than a basic dispensing service 
while only 8% of non-contractual homes received such a service. Also, 33% of 
contracted homes received home visits and consultation while none of the non­
contracted homes received such visits. The findings of that study indicated that there is a 
great need for pharmaceutical input to all levels of care for RHs. The work suggested a 
need for development and rationalisation of the relevant contracts and increased 
pharmacy input into all homes.
The advisory role of the CP in registered homes has also been investigated by a survey 
undertaken to observe the areas where RHs would welcome advice from pharmacists 
and to identify areas where advice may be beneficial15. In that study, 30 establishments 
were surveyed. Observations obtained from that study showed that only 5 of those 
establishments received visits from a pharmacist to advise on medical matters such as 
safe-keeping and correct administration of medicines. From the above survey, all 
respondents felt that there was most need for pharmacists input in advising on different 
aspects of drug utilisation and administration.
1.6.1.2. Hospitals with a pharmacy.
The 1993 NAHAT guidelines recommended that when a pharmaceutical department is 
established in an independent hospital, there should be a pharmacist in charge and that 
the pharmacist should have had previous hospital experience. This pharmacist should be 
responsible for preparation, purchasing, quality , storage, dispensing and distribution of 
all medicines and pharmaceutical supplies, as well as for ward-based pharmacy services. 
The pharmacist should also advise on drug therapy, dosage, patient counselling and 
discharge medicines. Pharmacists should also be involved in the provision of such 
services as Total Parenteral Nutrition (TPN), Intravenous additives (TV-additives), 
Cytotoxic preparation and reconstitution 10.
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1.6.2. Community Services Pharmacists (CSP) Guidelines for Acute IHs 16. 
Formerly, a CSP was a pharmacist, employed by a District Health Authority (DHA) 
who, on behalf of the DPhO, ensured that when a community service required a 
pharmaceutical in-put, a satisfactory service was received. Since NHS reorganisation, 
some CSPs are employed by Health Authorities and others are employed by Trusts.
The CSPs have published guidelines in 1992 16 which are similar to the NAHAT 
guidelines but more detailed 'with regard to pharmaceutical services provision. A 
number of additional recommendations are included on subjects such as the following: 
the supply of medicines in cases of emergency, storage of patients’ own medicines, 
self-administration of medicines by patients, administration of medicines and record 
keeping.
1.6.3. Association o f  Private Hospital Pharmacists (APHP) Guidelines17.
The Association of Private Hospital Pharmacists was set up in 1982 to bring together 
pharmacists working in this area of practice and to ensure that legislation and
1 *7professional practices are appropriate for small independent hospitals. This group 
has played a very important role in matters affecting pharmacy in the private hospitals. 
The group have issued their own guidelines on the pharmacy services that should be 
provided in acute independent hospitals. The aim of these guidelines was to set out the 
minimum standards for the provision of a pharmacy service in acute independent 
hospitals with at least one operating theatre. The requirements of the APHP guidelines 
are similar to those of the NAHAT and CSP guidelines but some additional guidance 
is provided with regard to areas such as the necessity to maximise liaison with other 
health personnel and with those involved in inspection and registration of independent 
hospitals. Special mention is also made of the need to offer clinical services and the 
advantages of good record keeping.
1 ftSavage reported a number of comments by pharmacists engaged in IHs when asked 
their opinions about the provision of pharmacy service in independent hospitals.
One respondent stated:
"The hospital managers do not see the need when 




"In independent hospitals, pharmacists will be 
directly responsible to a hospital manager, who 
may not have a medical background. All they see is 
that pharmacists are expensive regardless o f what 
pharmacists have to offer".
However, Mrs. K. Fullerton (Pharmacy Manager at the Princess Margaret Hospital, 
Windsor, and the chairperson of APHP in 1993) said 19:
"After the recommendations had been published 
by NAHA in 1983 for Nursing Homes with more 
than 40 beds and an operating theatre to establish 
a pharmacy service - this led to an increased 
awareness by Private Healthcare Managers o f the 
minimum standards for a pharmacy service'
1.7. Pharmaceutical services provision in independent hospitals in the UK.
The pharmaceutical services provision does not only include the provision of 
medicines, but also associated advice to fellow professionals and counselling of the 
patients. Any patient on medication is likely to need more care, and this should be 
reflected in the arrangements made for their pharmaceutical care. The arrangements in 
acute independent hospitals should parallel those in acute NHS hospitals, so most of 
the procedures and other publications written about use of medicines within NHS 
hospitals would have applications in the independent hospitals.
The provision of pharmaceutical services in independent hospitals can be grouped 
under the following topics:
1.7.1. Procurement o f  medicines.
The NAHAT 1993 guidelines 10 recommend that:
"Where a pharmacist is employed by an 
independent hospital, medicines should be obtained 




There are various categories of medicines:
• Prescription Only Medicines. Pharmacy medicines and General Sales List 
medicines. These can be purchased by an IH from a manufacturer, wholesaler, 
community pharmacy, or a District Managed Unit (DMU) or a Trust Hospital.
• Controlled Drugs. For these kinds of medicines, an independent hospital can hold 
these drugs if the hospital is: A} run by a charity or B} possesses a Home office 
Licence. Both Schedule II and ID Controlled Drugs can be ordered by an 
independent hospital from a wholesaler or a community pharmacy using a single 
order.
Where no pharmacist is employed, the 1993 NAHAT guidelines 10 recommend that:
"supplies may be purchased through a community 
or hospital pharmacy",
It was also recommended in NAHAT guidelines that: independent hospitals with no 
pharmacist employed, supplies of medicines should be obtained from a community 
pharmacy. A signed order form is required to obtain medicines from a pharmaceutical 
supplier. Therefore, the NAHAT and CSP guidelines recommend that a signed order 
should be issued by the person in charge, that is either by a Medical Practitioner or a 
first level registered nurse.
Some medicines may be obtained for in-patients from a community pharmacist by 
means of a private prescription signed by a medical practitioner. All medicines 
obtained in this way are the property of the person for whom they are prescribed.
1.7.2. Storage o f  medicines.
The 1993 NAHAT guidelines 10 recommend that:
"All medicines should be stored under the control 
of a pharmacist, or, if  there is no pharmaceutical 
department, under the control of the person-in- 
charge within the hospital",
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These guidelines also recommend a separate lockable facility should be provided for 
the storage of:
• Controlled Drugs,
• medicines for external use,
• medicines for internal use,
• disinfectants and antiseptics,
• diagnostic reagents,
• medicines requiring refrigeration,
• large volume intravenous infusion fluids,
• flammable substances.
Controlled Drugs should be stored in a locked safe, cabinet or room which is so 
constructed as to prevent unauthorised access to the drugs. Controlled Drugs must not 
be stored in a medicines trolley. However, a medicines trolley can be used for storage 
of other medicines; this must be securely fastened to the wall when not in use.
1.7.3. Stock Control and Records Keeping.
The pharmacist (if present), in consultation with medical and nursing staff should 
determine the range and quantity of medicines to be stocked.
The APHP guidelines 17 state that:
"A pharmacist must have responsibility for good 
pharmaceutical stock control throughout the 
hospital".
Regular checks of pharmaceutical stock should be made to ensure that:
• there is adequate stock rotation,
• appropriate stock levels are maintained,
• expired stock is identified, and
• the pharmacist (if present) initiates more stringent controls of ward stock in the 
case of items that are liable to misuse.
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A record should be kept of receipts, issues, administration and disposal of all 
medicines to ensure that reconciliation can take place and such records should be 
available for members of Health Authority inspection teams on request. Within the 
hospital, a medication chart should be kept for each patient.
The NAHAT guidelines 10 mention several details which should be included in a 
medication record. These are:
i) the name, home address and date of birth of the patient;
ii) registration number and ward where appropriate;
iii) the name of the medicine;
iv) the dose;
v) the route of administration;
vi) the frequency and time for administering each dose;
vii) the date of prescribing;
viii) any known drug hypersensitivity-in red;
ix) any special requirements.
In independent hospitals with no pharmacy which are supplied by a community 
pharmacy, the CP should maintain records of medicines supplied.
7.7.4. Disposal o f  Medicines.
1.7.4.1. Disposal o f  unwanted medicines.
All medicines must be withdrawn from stock and should be disposed of when:
a) they have reached or passed the expiry date;
b) they become unfit for use e.g. due to deterioration or contamination.
If a pharmacist is available within the hospital, he/she will then dispose of these in 
accordance with locally agreed procedures. Hazardous substances such as cytotoxics, 
should be disposed of as recommended by the Health and Safety Executive 10.
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The NAHAT guidelines recommend that for a hospital which has no pharmacy 
department, the destruction of small quantities of medicines may take place at ward or 
departmental level by a first-level registered nurse, in the presence of an appropriate 
witness e.g. a doctor, a pharmacist or another first-level registered nurse. The 
destruction should be recorded and the record signed by both persons. If the required 
destruction facilities are not available or there is no proper person available, the CSP 
guidelines recommend that the hospital should consult their supplying pharmacist for 
advice on safe disposal.
1.7.4.2. Disposal o f medicines brousht into the hospital by a patient. 
The NAHAT and CSP guidelines state that medicines brought into the hospital by 
individual patients are their property and should be sent out with the patient on 
discharge. These medicines should be kept separate from other drugs on the ward and 
held in a safe place until discharge and should not be used for other patients. If it is 
inappropriate for them to be retained (e.g. the labelling is unclear or instructions for 
use have been changed) the medicines should be destroyed with the consent of the 
patient or a relative.
1.7.4.3. Disposal o f Controlled Druss.
Independent hospitals authorised to hold stocks of Controlled Drugs may destroy any 
such Controlled Drugs in the presence of an authorised person i.e. a police officer, an 
inspector of the Home Office Drugs Branch, an inspector of the Royal Pharmaceutical 
Society of Great Britain or, in some cases, the Senior Administrative Officer 
employed by the independent hospital.
Such drugs awaiting destruction by an authorised person should be stored separately 
in the Controlled Drugs cupboard. A record of items awaiting destruction should be 
kept, for example in a separate section of the pharmacy register (if there is one).
1.7.5. Sterile preparations.
The preparation of sterile products e.g. Total Parenteral Nutrition (TPN) or making 
IV-additions or reconstitution of cytotoxic drugs -  is a procedure associated with 
potential risks due to the route of administration and/or the nature of the constituents.
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1.7.5.1. Intravenous Additives (JV-additives).
As the use of intravenous therapy has become increasingly common place, the 
availability of a Centralised Intravenous Additive Service (CIVAS) has been well 
received by the medical and nursing staff in hospitals. As a result of this, hospital 
pharmacists have begun to evaluate critically the quality aspects of the ward-based
preparation of injections, and to examine the economics and desirability of preparing
0(\intravenous doses within pharmacy. Cousins suggested that it would seem
inevitable that a full CIV AS provision would be considered one of the essential
hospital pharmacy services to be provided to any hospital in the 1990s. But the
changes in the management arrangements within the NHS has had a very profound
effect on the way clinical services are delivered within acute hospitals. With the
advent of the internal NHS market, requiring hospitals to contract for business, NHS
Hospital Trusts, Clinical Directorates, patient focused care, internal contracts between
Clinical Directorates and service departments like pharmacy, have all produced
different sets of requirements for hospital pharmacy services.20 The Breckenridge 
0 1report made a number of recommendations regarding the prescribing, preparation 
and administration of intravenous drug therapy. Training of nursing staff for their role 
in intravenous therapy was recognised as inadequate. Regarding the role of the 
pharmacist, the report recommended that pharmacists should advise on 
pharmaceutical aspects of intravenous therapy. The report also recommended to 
“ carefully examine the possibilities of providing a dispensing service for the 
necessary drug-infusion mixtures, which would enable these to be aseptically prepared 
in the pharmacy” because this should be carried out in appropriate environmental 
conditions under the direct control of a pharmacist.
Due to intravenous therapy being used more frequently, this has led to rapid 
development of CIV AS. The National CIV AS Group of hospital pharmacists has 
undertaken a survey of senior hospital pharmacists to determine the extent of 
pharmacy-based CIV AS operations in the UK 23. The results showed that, out of 173 
responses, 71 were operating CIV AS, with a further 36 intending to start within 2 
years. The results also showed that these units were preparing up to 100,000 doses per 
annum. Some units without preparation facilities were buying-in ready-to-use 
intravenous products, mainly from other, larger, hospital units.
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In contrast, CIV AS was becoming a recognised element of the overall pharmacy 
service. Also the centralising CIV AS within a pharmacy could be of benefit to doctors 
and nursing staff in the context of workload as well as the actual improvements in 
quality.
Several reports have been published of investigations into the problems associated 
with intravenous admixture preparation on the ward, and the advantages of setting up 
a pharmacy-based service. These problems include:
1. Occurrences of instability and incompatibility caused by lack of knowledge among 
ward staff of the potential problems of inappropriate combinations of drug and 
diluent.
2. Errors in the selection of drug, diluent, or dose, often exacerbated by frequent 
interruptions of the nurse performing the preparation.
3. Doses being given as boluses at too fast a rate, due to lack of knowledge, and 
pressure on time.
4. Cases of phlebitis, possibly caused by excessive speed of administration, 
inadequate dilution, or contamination of the infusion.
5. Doses being given more than an hour later than the prescribed time, or being 
missed altogether.21
Hospital pharmacists have traditionally been involved with the training of nurses and, 
more recently, of medical students and junior doctors in the IV-administration of 
drugs.22 At Bristol Medical School, drug administration is taught by clinical 
pharmacists, who combine a practical hands-on teaching session with theory for final- 
year medical students. Also the Northern Devon Healthcare Trust includes a session 
on IV drug-therapy during pre-registration house-officer induction days, which is 




Awareness has heightened of the potential danger of occupational exposure to 
cytotoxic drugs. Safe measures for handling and preparation can achieve a reduction 
in exposure levels. The 1994 guidance published by the Department of Health on 
aseptic dispensing recognises the need for good practice standards.24 Moreover, in a 
survey of more than 4,000 health workers in the USA, it was found that approximately 
one third of the pharmacists involved in the preparation of cytotoxic drugs regularly 
did so without using a vertical laminar flow cabinet and this level of protection among 
nurses were found to be even lower.25 Great care is needed when prescribing and 
preparing cytotoxic drugs as damage to normal tissue can occur, which may be 
irreversible. The British National Formulary 26 (BNF) lists 6 guidelines for the safe 
handling of cytotoxic drugs. These guidelines are:
1. trained personnel should reconstitute cytotoxics;
2. cytotoxic reconstitution should be carried out in designated areas;
3. protective clothing (including gloves) should be worn;
4. the eyes should be protected, and means of first aid should be specified;
5. pregnant staff should not handle cytotoxics;
6. adequate care should be taken in the disposal of waste material, including syringes, 
containers, and absorbent material.
A study by Wastnage 27 has shown how the cancer-care pharmacist can play a crucial 
role within cancer services by his/her:
• active involvement within the multidisciplinary team;
• promoting safe, effective and economic prescribing;
• enhancing patient care through adherence to policies/protocol;
• reducing health and safety risks to staff and patients.
The author stated that, with the increasing incidence of cancer and the developing role 
of chemotherapy, the implications for pharmaceutical services are enormous. 
Specialised pharmaceutical support services and advice will be required by cancer 
centres, units and primary care teams.
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1.7.5.3. Total Parenteral Nutrition (TPN).
Nutrition is a speciality where the pharmacist’s clinical knowledge, formulation 
expertise and communication skills can all contribute to optimum patient care and 
value for money. In 1992, the Kings Fund report 28 recommended a multidisciplinary 
team approach to nutritional care in hospitals. That report proposed that such 
multidisciplinary teams should include a senior clinician, a clinical nurse specialist, a 
dietician and a pharmacist.
An NHS Executive Letter issued in December, 1996 29 required hospitals to conduct 
internal audits to check whether aseptic dispensing carried out in unlicensed units 
complies with standards published by the NHS. The Executive Letter was issued 
because of concern raised by the death of two children at the Royal Manchester 
Children’s Hospital, in April 1994. The letter also stated that the Medicines Control 
Agency (MCA) is taking forward a prosecution as a result of that incident which, it is 
alleged, was due to contaminated Total Parenteral Nutrition (TPN) fluids prepared in 
the pharmacy department. The letter said that the MCA had surveyed a 10% sample of 
such units (i.e. 26 units) and concluded that standards and guidelines were not being 
consistently met. The report by the MCA was worrying in that, in over 60% of cases, 
there were significant failings and the units concerned would have had difficulties 
fulfilling the required standards if they had wished to become licensed. Only one-in- 
six of the units surveyed had standards comparable to those of licensed units. It is of 
concern however, that the MCA’s survey did not include an assessment of the 
corresponding aseptic procedures carried out elsewhere in hospitals, that is outside 
such aseptic dispensing units.
The pharmacist’s potential contribution in nutrition 28 can be outlined as:
• purchasing and provision of central feeds and parenteral nutrition solutions;
• advising on, and provision of, stable parenteral nutrition formulations;
• advising on all problems arising from concurrent drug and intravenous therapy in 




•  monitoring patients receiving parenteral nutritional support with particular 
reference to biochemistry, signs of infection, fluid balance and blood glucose levels 
and determining changes necessary to the parenteral nutrition regimen;
• ensuring provision of protocols for doctors and nurses caring for patients receiving 
intravenous feeding;
• determining adequate procedures are in place for dealing with requests for 
parenteral nutrition, both during and outside normal working hours;
• educating colleagues and members of other disciplines in the pharmaceutical 
aspects of parenteral nutrition;
• contributing to TPN audits, and
• providing suitable advice and information to patients and their relatives regarding 
intravenous feeding.
1.7.6. Other important issues relating to pharmaceutical services.
1.7.6.1. Hospital Formularies.
The use of formularies has been advocated as a means of promoting rational and cost- 
effective prescribing in specific institutions or in specific circumstances. However, it 
seems important that the pharmaceutical profession should effectively promote 
whatever services are deemed to be strategically important, including formularies.
Some Health Authorities have their own formularies based on their specific 
requirements. However, in independent hospitals, medical practitioners often prefer to 
order drugs for their private practice through the pharmacy, without relying on a 
specific formulary, as indicated in the following statements by independent hospital 
pharmacists:
Mrs. Gill Burton (pharmacy manager at Parkside Hospital, Wimbledon, London) has 
said 18:
"Sometimes, consultants prefer to use the drugs 
they are familiar with, and with many different 




Mrs. K. Fullerton (pharmacy manager at Princess Margaret Hospital, Windsor) 19 has 
said:
"The various consultants who use the hospital will 
not necessarily have their NHS contracts with the 
same Health Authority which means that their 
drug requirements will differ as they are used to 
prescribing from differentformularies
A survey was undertaken in Northern Ireland with the aim of evaluating the views of 
GPs on pharmacist’s involvement in formulary development . The GPs viewed the 
pharmacist’s role in formulary development as being useful in several respects: 
improving prescribing and providing cost advice; closer working relationships; 
discussing treatment options, and; a reduction in the doctor’s workload.
L 7.6.2. The use o f  Branded or Generic pharmaceutical products.
The BNF 26 states that:
" Where non-proprietary (Generic) titles are given, 
they should be used in prescribing. This will enable 
any suitable product to be dispensed, thereby 
saving delay to the patient and sometimes expense 
to the health service
Clearly the latter reference in this case is specifically to the NHS.
It is also emphasised in the BNF26, however, that:
"The only exception is where the bioavailability 
problems are so important that the patient should 
always receive the same brand; in such cases, the 




The perception of bioequivalence in the context of generic prescribing was recently 
addressed by a clinical pharmacologist and a pharmacist. The medical view of generic
' l  1
prescribing was presented by Professor Michael Rawlins ; who said:
"There were four main reasons why generic 
prescribing was desirable. Firstly, it was 
educational, secondly, generic prescribing ensured 
that patients did not inadvertently receive two 
products containing the same ingredient, thirdly, 
generic prescribing was a reminder of the 
therapeutic class of drug and finally, the real 
advantage was that it was less expensive
A pharmacist’s viewpoint was presented by Dr. Robert Calvert31 when he said:
"The regulatory authorities should tackle the issue 
of bioequivalence of modified release products or 
the financial benefits o f approved name prescribing 
would fall off In addition, the approved name 
prescribing coupled with pharmacist product 
selection had saved public money and reduced 
inventories
7.7.6.3. Antibiotic Policy.
Many Health Authorities place limits on the antibiotics that may be used in their 
hospitals, to achieve reasonable economy consistent with adequate cover, and to 
reduce the development of resistant organisms. An authority may indicate the range of 
products permissible for general use, and permit treatment with other products only on 
the advice of the microbiologist or physician responsible for the control of infectious 
diseases. Many considerations are listed in the BNF with regard to the use of 
antibiotics for the treatment of infections, such as: culture sample and sensitivity tests, 
dose, route of administration and the duration of therapy.
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1.7.6.4. Product Recall Parallel Imported and Counterfeit Medicines. 
Principal one of the Code of Ethics of the RPSGB 7 states that:
"A pharmacist's prime concern must be for the 
welfare of both the patient and other members of  
the public
In the context of this ethical principle, the CSP guidelines 16 emphasise that:
"The Department of Health expects District Health 
Authorities to circulate appropriate defect notices 
in respect of medicines to all registered Nursing 
Homes and acute independent hospitals
The Pharmaceutical Inspecting Officer and the independent hospital pharmacist, 
where employed, should advise on an appropriate and suitable procedure for the 
circulation of hazard notifications and drug alerts. The Pharmaceutical Inspecting 
Officer and the independent hospital pharmacist, where employed, need to ensure that 
the person-in-charge is aware of procedures to be followed in the event of a hazard 
notification or drug alerts.
It is also stated in the CSP guidelines 16 that:
"There should be an established procedure for the 
reporting of hazards occurring within the hospital 
and the person-in-charge should be encouraged to 
report any hazards to their own pharmacist where 
employed or to their Community pharmacist or 
supplier
The guidance on obligations relating to Principal One of the RPSGB’s Code of Ethics 
7 makes reference to parallel imported and counterfeit medicines:
"A medicinal product for which a United Kingdom 
product licence has been granted must have the 
licence number on each pack. This will be either a 
PL or a PL(PI) number, A pharmacist should 
decline to accept from a supplier medicinal 
products that are not so labelled
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"Unless a prescription bears the British approved 
(generic) name of the medicinal product ordered, a 
pharmacist may not dispense a PL(PI) medicine if  
the name o f that medicine is different from the 
name appearing on the prescription. The name 
used on the pharmacy dispensing label must be the 
name that is given on the prescription
"Counterfeiting in relation to medicinal products 
includes the deliberate and fraudulent mislabelling 
with respect to the identity and/or source o f the 
medicinal products
On this basis, a pharmacist must report to the RPSGB any instance where he suspects 
that he has been offered or has been supplied with counterfeit medicines. He also must 
isolate and withhold from sale or supply any such medicinal products7.
So, a pharmacist must, in this respect, inform appropriate bodies of the hazards which 
come to his/her attention, particularly about suspected defective or counterfeit 
medicines. Also procedures must be in place to ensure that all batch numbers and 
expiry dates of notified products are checked throughout the hospital and all recalled 
items are withdrawn.
1.7.7. Ward and Clinical Pharmacy Services.
Prior to 1986, the majority of pharmacists in hospitals were engaged in the traditional 
pharmaceutical activities of dispensing of medicines and manufacturing of 
pharmaceuticals. The starting point for the increasing development of "Ward 
Pharmacy" and "Clinical Pharmacy" was a growing awareness of the high incidence 
of medication errors at ward level . The provision of pharmaceutical services, at ward 
level, covers functions such as: drug supply, stock control, prescription monitoring, 
and providing pharmaceutical advice to doctors, nurses, and patients.
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The role of the pharmacist has been taken further in participation in decisions on 
treatment and greater contact with individual patients. This role allows the pharmacist 
to make his/her professional input before the prescription is written to help ensure that 
the treatment is correct, efficient and active. His/her contacts with individual patients 
should include counselling, at various times including at the time of discharge, about 
the taking of medicines.
The clinical pharmacist, in a hospital, does not make decisions concerned with 
diagnosis. The doctor will determine the type of drug therapy, but increasingly the 
pharmacist can help particularise the medication to be used and contribute to the 
choice of drug regime especially when more than one condition is being treated in the 
same patient.
Therefore, the clinical pharmacist must be in a position to supply the physician with 
evaluated information on pharmaceutical and therapeutic aspects of drug use as well 
as on the changing awareness of the toxic profile of drugs. He also can help decide 
which dosage form or formulation of an active principle should be used and the best 
route of administration of a medicine; he may be expected to undertake the 
responsibility for deciding the formulation as well as the dosage calculation of a 
medicine. The formulation may for example be critical to the patient’s willingness and 
ability to comply with a prescribed medication regimen.
Further considerations apply in relation to the participation of the clinical pharmacist 
in therapeutic drug monitoring. He/she has a contribution to make in the interpretation 
of assays for drugs in body fluids through a knowledge of pharmacokinetics. In some 
hospitals, with large individual departments in such specialities as paediatrics, 
psychiatry, or oncology, the ward or clinical pharmacists have become pharmaceutical 
specialists within these same fields 8. Prescription monitoring is also one of the ward 
pharmacist’s duties. This can be achieved by using all the information available, 
including that obtained within the patient’s notes, obtained on ward rounds, or could 
be by direct communication with the patient, or the prescriber. Potential medicine- 
related problems should be discussed with the clinician, and suitable advice relating to 
alternative treatment should be offered.
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The in-patient prescribing monitoring allows the ward/clinical pharmacist to use 
his/her knowledge to identify significant drug/drug interactions, drug/food interaction, 
drug/laboratory test interference and drug/disease incompatibilities.
The American Society of Health System Pharmacists (ASHSP) advises that 
ward/clinical pharmacists have a "responsibility and professional obligation to report 
any suspected adverse drug reactions (ADR)" 32. Ward pharmacists are ideally placed 
to identify and report on ADRs and this may be achieved using a number of methods; 
for example, interaction with the ward staff and patients may lead to the identification 
of certain clues that may suggest the occurrence of an ADR.
A number of studies have been undertaken to evaluate the usefulness of clinical 
pharmacy services in Residential and Nursing Homes.
Patient Medication Records (PMRs) and their usefulness was evaluated in Nursing 
Homes as distinct from acute hospitals. A survey was undertaken with the aim of 
investigating the benefits gained by patients, the pharmacist and the care staff from the 
use of PMRs. That survey was conducted over a period of 1 year; with 3 homes 
providing a total capacity of 94 beds being involved. The survey results showed that 
out of 2074 prescriptions dispensed, intervention was necessary in 115 cases. Several 
interventions were detected in these cases. For example, 59 cases had a wrong dose 
and/or strength of medication, 24 cases had duplication or over-ordering of 
medication, 6 cases had the wrong drug prescribed and 4 cases had serious drug- 
interactions. It was concluded that had the pharmacist not intervened, the patient 
would have received incomplete/incorrect medication as well as 
inappropriate/ineffective treatment. That survey emphasised the importance in such 
circumstances of using the expertise of the CP in reviewing PMRs.
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Another survey was carried out to measure the benefit of a pharmacist-again, in this 
case, a CP-undertaking medication reviews in a nursing home.34 The study was carried 
out in 21 Nursing Homes with a total of 312 residents, over a period of six months. It 
was found that 116 prescriptions contained unnecessary medication, with possible side- 
effects in 6 cases. Ten cases involved serious drug interactions and a correction of the 
dosage form was needed in 38 prescriptions. That study showed clearly that the 
pharmacist could play an important role in improving quality of life as well as achieving 
cost savings through his contribution to revision of the prescription. The provision of 
clinical pharmacy services has also been investigated in residential homes. A study was 
undertaken to determine the potential benefits of providing a clinical pharmacy service 
for elderly people in a residential home . That study focused on providing a clinical 
pharmacy service in residential homes similar to that delivered by pharmacists in 
hospitals. The study was undertaken in nine residential homes with 160 residents. This 
sample was divided into two similar groups (test and control groups). The medication 
received by patients in the test group was reviewed by a pharmacist and treatment 
modifications were suggested to the GP. Medication for the control group patients was 
documented without pharmacist intervention. Thirty five treatment modifications were 
suggested by the pharmacist, and the relevant patient’s GP agreed to take the suggested 
action in 11 cases. In that study, the interventions were scored independently by a panel 
of experienced medical practitioners and pharmacists and several were considered to be 
beneficial or even life-saving. The study showed that there were potential benefits in 
providing clinical pharmacy services to Residential Homes and suggested that essential 
liaison between GPs and pharmacists would be of great benefit to patients in such 
establishments. It can be said, based on the above-mentioned two studies, that the 
pharmacist’s role is very important in providing clinical pharmacy services to Nursing 
and Residential Homes, where the use of medicines is quite limited. Therefore, his/her 
role in independent hospitals is likely to be much more important and essential due to 
the more extensive use of medicines as well as the need for more complete patient care 




In addition to developments in the provision of ward and clinical pharmacy services in 
recent years, another important development in a specialist activity has taken place in 
the provision of drug information. This has always been a traditional role of the
pharmacist, but the increasing complexity of the work has led to its development as a
separate speciality. Most large NHS hospitals have a drug information centre whose 
function is to act, not merely as a reference library, but as a source of up-to-date and
o
evaluated information about particular drugs and their properties . This service is 
available to GPs and community pharmacists as well as to hospital staff. The nature of 
information provided may consist of answering specific queries or providing more 
widely disseminated articles on specific topics. These may include information on 
new drugs and on the choice of drugs for particular disease states, or provision of data 
sheets on drug interactions, drug effects on biochemical values, drug overdose etc.
As an Appendix to the Code of Ethics, the RPSGB specifies "Standards of Good 
Professional Practice 7 ". Section 9 of that Appendix, Guidance is provided on 
"Standards for relationships with other health care professionals" and part of that 
refers as follows to Drug Information in the Hospital Service:
"Drug information is a clinically oriented service 
providing a focus for the accumulation, 
organisation, evaluation and dissemination of 
information pertaining to all aspects o f medicine
use. The service should be provided to pharmacists 
and other health care professionals working in the 
hospital Medical practitioners should be 
encouraged to make use of this service. Inquiries 
from the general public may be answered provided 
that the wishes o f the patient fs medical practitioner 
or pharmacist are not compromised. The service 
should be organised to permit the prompt 
answering of inquiries from health care 
professionals and, where appropriate, the public on 
all matters relating to the use of medicines
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17The APHP guidelines recommend the availability of the latest editions of certain 
reference books in the independent hospital drug information centre such as: 
Martindale, the British National Formulary (BNF), RPSGB’s Medicines, Ethics and 
Practice Guide, ABPI Data Sheet Compendium etc.
1.7.9. Training and Continuing Education.
a
As stated in the Nuffield Report on Pharmacy , any profession, the members of which 
base their professional service on knowledge which is continually expanding and 
changing, must embrace the philosophy that continuing education is an integral part of 
professional practice 8. So the purposes of continuing education are to enable the 
pharmacist to keep him/herself up-to-date in developing knowledge and changes in 
practice and to supplement the initial training of the pharmacist.
In section seven of the Standards of Good Professional Practice appended to the 
RPSGB Code of Ethics, there is a requirement relating to "Competency'' . It states:
"Pharmacists and support staff must receive 
continuing education and training to enable them 
to provide competently the professional services 
being offered
So all pharmacy staff should be kept abreast of current developments in pharmacy, 
and given specialist training where relevant. Continuing education will enable the 
pharmacist to be in a position to be actively involved in providing training for other 
members of staff including clinicians, nurses and other healthcare professionals in all 
areas relating to the safe and effective use of medicines.
1.7.10. Liaison with other healthcare staff.
Principle nine of the Code of Ethics of the RPSGB 7 states that:
"A pharmacist must at all times endeavour to co­
operate with professional colleagues and members 




An important vehicle for co-operation between different professions in many hospitals
e
is provided by the hospital drug and therapeutics committee . Such committees 
provide a forum for doctors, pharmacists and, in some cases, nurses to discuss ways of 
improving the efficiency and effectiveness of their use of drugs.
Further possibilities for inter-professional co-operation lie in the reporting of 
suspected adverse drug reactions (ADRs). The pharmacist’s contribution lies, not 
necessarily in the diagnosis of the adverse reactions, but in identifying possible 
causes, including those which might be related to the formulation and its components. 
Drug information pharmacists may be good candidates to co-ordinate schemes as they 
will have experience in ADRs from their daily activities in dealing with drug-related 
queries and have experience of, and access to, numerous literature sources .
1.8. Inspection of Independent Hospitals.
1.8.1. Responsibility for Inspection.
Under s. 17 of the National Health Service Act 1977 36, and the Registered Homes Act 
1984 3, the Secretary of State for Health delegated responsibility for registration and 
inspection of Nursing Homes (and hence Independent Hospitals) to District Health 
Authorities (DHAs). Initially, most authorities passed on this requirement, as related 
to pharmaceutical aspects, to their District Pharmaceutical Officer (DPhO), who 
ensured that registration was appropriate in that regard and, when inspecting, that 
there was total compliance with the Act.
Statutory Instrument (SI) No.1578,1984 (regulation 10 (1))37 states that:
"iSubject to the following provisions of this 
regulation any person authorised, on producing (if 
asked to do so) a duly authenticated document 
showing that he is so authorised, may enter and 
inspect any premises which are used, or which he 
reasonably believes to be used, as a nursing home, 
and in the course o f such inspection may require 
the production of records".
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Following registration, visits for the purpose of inspection must take place as 
frequently as necessary, but not less than twice a year, (SI No. 1578, 1984 Regulation 
11).
1.8.2. Frequency o f  inspection.
Both the CSP and the NAHAT guidelines provide advice and guidance concerning 
inspection of independent hospitals and of nursing homes in general.
It is stated in the CSP guidelines 16 that:
"The Registering Authority is responsible for  
carrying out a statutory minimum of two 
inspections per year by an experienced and 
qualified pharmacist Where no pharmacist is 
employed by the hospital, it is recommended that 
the inspection should be more frequent 
A previous study of pharmaceutical services in IHs in 1991 11 showed no significant 
difference, at the 95% confidence level, between the number of inspections carried out 
at independent hospitals with and without a pharmacist. A further study of 
pharmaceutical services in IHs reported on assessments provided by pharmacists 
involved in the inspection of the hospitals 12 . That work showed that most of the 
inspectors (72%) considered that all IHs should employ the services of a pharmacist. 
Despite this view, only 37.2% of the respondents considered that more frequent 
inspection of an IH was necessary where no pharmacist was present. The two surveys 
11,12 concluded that there was poor compliance with the NAHAT recommendations on 
pharmaceutical services in acute IHs.
1.8.3. Inspection team.
It is important that inspectors have been carefully selected and that their background, 
training and skills are relevant to the inspection of acute units. The accountability of 
inspectors is to the registering authority 10. The NAHAT guidelines advise that there 
should be an adequate separation of duties to ensure that no conflict of interest arises 
with any duties they may undertake in a DHA or NHS Trust provider un it10.
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The independent hospitals inspection teams could :
i) District Health Authority (DHA) employees, one of whom should preferably be 
exclusively employed on these duties;
ii) people-self-employed and contracted to the DHA;
iii) external contractors;
iv) people-contracted from other HAs;
v) people-seconded from an NHS Trust with safeguards against any conflict of 
interest;
vi) part of the joint Health Authority/Local Authority "arms length" inspection team- 
but specialists and with experience of acute hospital inspection and with an 
accountability to the DHA.
Therefore, Nursing Home Registration and Inspection Teams will either contract with, 
or directly employ, suitably experienced pharmacists to undertake inspection. The 
pharmacists concerned are individually authorised to enter Registered Nursing Homes 
and may be empowered to make unannounced visits as well as visits out of hours for 
example by a minute of the Health Authority or Health Board, as reported in a paper 
by Taylor et a l 38. The inspecting pharmacist’s prime function is to ensure that any 
registered home meets that authority’s standards for the care and control of medicines, 
and they can demand to be shown all medication within the home 38. If observed 
standards fall below the desired level, the inspecting pharmacist may recommend that 
the inspection team takes formal action against the home, especially if there is 
evidence that patient safety is at risk.
The inspecting team often consists of a pharmacist, a nurse, a registration officer, a 
medical practitioner and various other specialists. The inspecting pharmacist is 
empowered to inspect all aspects of pharmaceutical service within the hospital, this 








f) Occupational Health Department
g) Outpatient Department
h) Intensive Care Unit (ICU)
i) any other specialist departments where medicines are stored 
j) Any area where patients’ own medicines are stored
k) The medical gases store.
1.8.4.The advisory functions o f  the inspector.
Currently, one of the inspecting pharmacist’s duties are to give independent advice to 
Nursing Homes which were no pharmacist on-site, relating to different pharmaceutical 
aspects. Some of these Nursing Homes, which include acute independent hospitals, 
already receive visits from a pharmacist, possibly a community pharmacist. So, it is 
important for that particular pharmacist to establish a link with the inspecting 
pharmacist before and after official visits are made. If problems arise, matters can be 
discussed between the professionals concerned with the aim of achieving better 
understanding. Moreover, for independent hospitals with a pharmacist on-site, such 
links may be even stronger. In 1990, Kirby (principal pharmacist, Riverside Health 
Authority) said:
"proper channels o f communication had to be kept 
open between the inspecting health authority 
pharmacist and the private hospital's chief 
pharmacist For example, there was little point in 
drug recall notices being sent to the person in 
charge of a private hospital rather than the 
pharmacist",39
1.8.5. Checklists o f  inspection.
Both the NAHAT and CSP guidelines contain checklists for use during inspections. 
The lists include sections on the following aspects:
i) Supply of medicines e.g. whether the supply is from a wholesaler, a community 
pharmacy, a GP dispensing practice etc.
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ii) Inspection of the pharmacy e.g. with regard to temperature recommendations, 
distribution records, storage of medicines for external use separately from internal 
medicines etc.
iii) Inspection of wards and departments e.g. medicines records (records of receipt of 
prescribed medicines, records of purchased medicines, records of medicines 
brought in by patients).
iv) Storage e.g. cupboards, trolley, refrigerator, etc.
v) Administration e.g. is the administration directly from pharmacist’s container or 
from a monitored dose package, are limited life medicines dated when opened, etc.
vi) Recording e.g. medicines records approved by Health Authority, medicines records 
signed by prescriber, directions accurately transcribed, clear directions for "p.r.n." 
medicines (i.e. medicines to be taken when required), etc.
vii) Destruction e.g. disposal records, returned medicines, medicines outside expiry 
date, etc.
viii) Emergency medicines e.g. resuscitation medicines, anaphylactic-shock packs 
(availability of adrenaline), etc.
ix) Medical gases e.g. records of maintenance, storage, test, etc.
x) Self-administration "  self-medication" e.g. a written policy for self-administration, 
monitoring of self-administration by patients, etc.
xi) Other written polices e.g. for medicines brought-in by patients, ordering of 
medicines, destruction of medicines, administration of medicines etc.
xii) Information sources e.g. BNF, MIMS, advice from the supplying pharmacist, 
NHS hospital drug information, etc.
1.8.6. Conflict o f interest with resard to inspection.
As mentioned before in section 1.6.3, the NAHAT guidelines recommend that there
should be an adequate separation of duties to ensure that no conflict of interest arises
with any duties the inspector may undertake in a DHA or NHS Trust provider unit.
The CSP guidelines also draw attention to a conflict of interest in the inspection role: 
"If pharmaceutical services are provided from the 
department in which the pharmaceutical inspecting 
officer is employed, there is a possibility o f a 
financial conflict of interest".16
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The CSP guidelines 16 recommend that, in such a case, a pharmaceutical officer from 
a different Health Authority or Trust is asked to carry out the inspection role. The 
results of a previous study 12 showed that 39.5% of the inspecting pharmacists 
considered that there was no conflict of interest despite the possibility referred to by 
the CSP guidelines.
In contrast, as mentioned above in section 1.4.1, few studies have considered the 
range and quality of pharmaceutical services provided in acute independent hospitals 
11,12’13. In addition, these studies have provided only limited information in this 
context.
11 10The results of the two previous surveys undertaken by Rees et al ’ , suggested that 
there is a variation between the pharmaceutical services provided in independent 
hospitals with a pharmacist and those without. Also, there are differences between 
hospitals, in term of the range of services that are provided. Furthermore, those studies 
suggested the possible need for specific legislation to distinguish acute independent 
hospitals from nursing homes.
1.9. Aims and objectives.
The overall aim of the study was to ascertain the range and quality of pharmaceutical 
service provision in acute independent hospitals in the UK. Specific objectives 
included the following:-
• to extend the previous two studies by Rees et a l11>12;
• to obtain an up-to-date assessment of the pharmaceutical services provided in 
independent hospitals;
• to identify how those services are provided;
• to analyse the current situation in independent hospitals throughout the UK, with 
regard to the involvement of pharmacists in the provision of care;
• to obtain an assessment of the quality of the pharmaceutical services available
a) from the perspective of the person responsible for providing the 
pharmaceutical services in independent hospitals, and
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b) from the independent perspective of Senior Pharmacists involved in the 
statutory inspection of IHs on behalf of Health Authorities/Health Boards in 
the UK;
• to examine the emphasis placed on various service criteria by inspecting 
pharmacists;
• to examine relations between the range and quality of pharmaceutical services 
available and the presence or absence of a pharmacist in the hospital, and






In order to obtain information on the pharmaceutical services within independent 
hospitals throughout the UK, it was decided that the most appropriate method for 
targeting as many of the relevant institutions as possible, was by means of 
questionnaires.
The questionnaire method was chosen a) because of the considerable number of 
independent hospitals spread throughout the UK, and b) to minimise the cost of the 
survey.
2.1. Questionnaire 1. -  Pharmaceutical services provision in independent 
hospitals.
2.1.1. Choice of method.
The purpose of the questionnaire was: to profile the range and extent of 
pharmaceutical services provided in independent hospitals; to determine the means 
whereby the hospitals obtained pharmaceutical services, that is to identify the source 
of the services and the nature of the services provider; and to assess the quality of the 
pharmaceutical services within these establishments.
2.1.2. Equipment and instruments used.
Questionnaire forms were produced using Microsoft Word for Windows V.6 and V.7. 
SPSS for Windows V.6.2. (Statistical Package for Social Sciences) was used to record 
results from the returned questionnaires and for statistical analysis of the data. 
Advantage was taken of a Free-post licence arrangement to allow respondents to 
return their completed questionnaires.
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2.1,3. Design of questionnaire.
It was intended that the final questionnaire would be distributed to all independent 
hospitals providing a variety of different services. Therefore, it was necessary to 
design a suitable, detailed questionnaire that could easily be completed by the person 
responsible for the provision of pharmaceutical services within each independent 
hospital; this person might be a pharmacist or a non-pharmacist. Therefore, it was 
essential for the questionnaire to be designed in such a way that it could easily be 
completed by all types of service providers, whether they were pharmacists or non­
pharmacists.
2.1.3.1. Question wording.
The questionnaire included many types of question which needed to be worded clearly 
and in an unambiguous way. The questions required various types of responses, such 
as ticks, scales, closed and open-ended questions, and in many cases a space was 
provided for any further comments. An effort was made to make the questions as short 
and as simple as possible. Loaded questions, double-barrelled questions and negative 
phrases needed to be avoided.
2.1.3.2. Questionnaire structure.
The survey questionnaire (appendix I) was developed by listing a number of types of 
questions which addressed how the pharmaceutical services might be provided in the 
independent hospitals. Therefore, the questionnaire was divided into the following 
parts:
Part 1. General questions
Part 2. Questions to a pharmacist
Part 3. Questions to a non-pharmacist
Part 4. Questions to both pharmacists and non-pharmacists.
Because the decision was made to restrict this study to acute independent hospitals, it 
was therefore necessary to include some early questions which would serve to identify 
those establishments that are traditionally considered as "Nursing Homes", so that 
they could be excluded from the analysis. Therefore, the first part of the questionnaire 
(questions 1 to 8) included questions to achieve this.
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When designing a questionnaire, it is important to start off with questions that are easy 
to answer and are not perceived as a threat to the respondent; therefore, the early 
questions that are asked need to be about facts rather than about opinions or beliefs. 
So, the first question asked if the establishment is an independent hospital; the person 
responsible for providing pharmaceutical services within the independent hospital was 
required to complete this first section of the questionnaire. This first part included 
information about the name and address of the hospital, the year it first opened, 
hospital ownership, number of beds and operating theatres, support and specialised 
services available, and the availability of a Resident Medical Officer (RMO). The 
independent hospital ownership question provided options of whether the hospital is 
owned by a private individual, limited company, charity or other owners. The support 
services question gave the respondents a number of different services which might be 
available in the independent hospital such as: Pharmacy department, X-ray, 
Physiotherapy and Pathology or any other support services. The specialised services 
question also listed a number of possible services available within the hospital such 
as: Acute Psychiatric, In-vitro fertilisation, Cardiology, Paediatrics. A space was 
provided for respondents to add other specialised services which were available but 
not listed in the questionnaire. The services provided by the Resident Medical Officer 
were also asked; that question asked whether the services provided by the RMO 
covered only the day or night, or both day and night.
The second part of the questionnaire was directed to those independent hospitals with 
a pharmacist responsible for the provision of pharmaceutical services (questions 9 to 
14). The first section in this part asked whether the pharmacist was employed directly 
by the hospital or contracted to provide the pharmaceutical services or by any other 
form of agreement. This question was intended to ascertain the way in which the 
pharmaceutical services were being provided within the hospital, that is, whether the 
services were provided by an in-house pharmacist or, for example, contracted from an 
NHS hospital pharmacy or from a community pharmacy. The next question asked 
about the identity of the pharmacist with principal responsibility for pharmaceutical 
services within the hospital (i.e. the name, qualifications and job title), and to whom 




The next section was designed to obtain information about how many hours were 
spent by the pharmacist in providing pharmaceutical services within the hospital and 
how pharmaceutical services were provided outside the pharmacist’s hours of service 
(i.e. out-of-hours services). One option given in this question was to indicate the 
provision of "out-of-hours services" by an "on call" pharmacist who could be 
contacted either by telephone or pager.
The next question sought information with regard to the number of pharmacy staff 
employed in the pharmacy department and a space was provided to indicate the 
approximate full-time-equivalents (FTEs) for the total numbers of pharmacists and 
pharmacy technicians respectively. The last question in this part referred to the 
Association of Private Hospital Pharmacists (APHP) and their activities. A question 
was asked whether the respondent was a member of this association and whether 
he/she attended the association’s meetings. In order to obtain some idea about the 
possible reasons for pharmacists working in the independent sector attending or not 
attending such meetings, several options were given to the respondents to describe 
their situation, such as: lack of time, lack of resources, lack of interest in the meeting 
programme, travel distances involved, a preference for other meetings, or no comment 
at all. A space was provided for the respondents to mention other possible reasons.
Part 3 of the questionnaire was designed to be completed by any other person, that is, 
other than a pharmacist, responsible for the provision of pharmaceutical services 
within an independent hospital (questions 15 to 19). The first question in this part 
asked about the identity of the person responsible for the provision of pharmaceutical 
services within the hospital with his/her qualifications and job title, and to whom this 
person reports managerially.
It was thought that hospitals without an employed or contracted pharmacist might, 
nevertheless, receive visits from pharmacists or other persons for the provision of 




Therefore, a series of questions were asked to cover the situation where the person 
responsible for the pharmaceutical services within a hospital was not a pharmacist. 
These questions were intended to ascertain who provided the pharmaceutical services 
on a regular basis to those hospitals. The questionnaire provided several options to 
indicate the nature of any person who might visit the hospital to provide advice 
(whether it was a community pharmacist, an NHS hospital pharmacist, a group 
pharmacy advisor or any other pharmacist). The question also asked about the 
minimum and maximum number of visits per week and the average total number of 
hours spent by such an adviser for the provision of pharmaceutical advice and to 
address any other pharmaceutical issues.
The provision of "out of hours" services was also investigated in hospitals without a 
pharmacist. A question was asked whether the pharmacist, referred to in the previous 
question (i.e. the visiting pharmacist), provided an "on call" advisory service. And if 
there was no visiting pharmacist, a question was asked about who could be contacted 
with regard to a problem or a query concerning the medication for a particular patient.
The last question in this part was concerned with the provision of clinical pharmacy 
services within a hospital which has no pharmacist. A question was asked about who 
is the person available to advise nursing and medical staff on a "day-to-day" basis on 
drugs and medicines (i.e. concerning drug interactions, dosages, side effects, 
alternative products, cost-effectiveness, etc.).
Part four of the questionnaire was designed to be completed by all respondents, 
pharmacists and non-pharmacists, and covered further matters related to 
pharmaceutical services provision.
According to NAHAT guidelines, when a pharmacist is employed by an acute 
independent hospital, medicines should be obtained by that pharmacist. Where there is 
no pharmacist employed, medicines should be obtained by the person in charge. So, it 
was recognised that hospitals might normally obtain medicines from different sources 
(suppliers). Therefore, the first two questions (questions 20 and 21) in this part of the 
questionnaire asked about who normally provided the pharmaceutical supplies to the 
hospital and who were the suppliers in an emergency situation, respectively.
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The respondents were asked to list the names of the hospital’s main suppliers. 5 
possible suppliers were provided for the respondents to choose from, such as: local 
pharmacy, local NHS hospital pharmacy, pharmaceutical wholesaler, pharmaceutical 
manufacturer and health centre. Space was provided to allow the respondents to list 
other sources of pharmaceutical supplies. In an emergency situation, if a medicine was 
not available in the hospital, the respondents were asked to mention the sources used 
in such a case. Four possible options of suppliers in cases of emergency were provided 
in the questionnaire, such as: local pharmacy, local NHS hospital pharmacy, other 
private hospital and pharmaceutical wholesaler. Space was also provided to allow the 
respondents to list other pharmaceutical suppliers in cases of emergency.
Many hospitals have a defined policy for the patients’ take-home medications (TTOs), 
meaning "to take out". Respondents were asked to point out how patients were issued 
with TTOs during the day, night and at weekends (question 22). The respondents were 
also asked whether the supply of TTO medicines is limited and who usually advises 
the patient, at the time of discharge, concerning their use of TTO medication if it 
needs to be issued to a particular patient.
The availability of an out-patient department in a hospital usually means that out­
patient prescriptions need to be dispensed. A question was therefore asked (question 
23) to find out if there was an out-patient clinic and, if so, the average number of such 
prescriptions issued or dispensed per month.
With regard to the Schedule 2 Controlled Drugs (CDs), an acute independent hospital 
may hold these drugs as stock if: 1) the hospital is a registered charity or maintained 
by public authority or 2) the hospital possesses individual Home Office Licences to 
hold stocks of the relevant drugs. If the hospital pharmacy is registered with the Royal 
Pharmaceutical Society of Great Britain (RPSGB), the pharmacy then does not need a 
licence to hold stocks of CDs. In those circumstances, the procurement of these drugs 
can be obtained or ordered from several sources provided that the order is signed by a 
pharmacist (if available) or by the person in charge within the hospital.
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On this basis, a question was asked (question 24) about who is the person named on 
the Home Office Licence for Schedule 2 Controlled Drugs (name and job title). If the 
hospital does not need to have such a licence, a space was provided to mention why 
(e.g. charity). The next question (question 25) asked whether the hospital pharmacy 
department is registered with RPSGB and, if the hospital pharmacy is not registered 
with the RPSGB, respondents were asked to give the reasons for that.
The limitation of medicines was also investigated (questions 26 to 30 and 32). This 
series of questions started with one about whether the hospital uses any kind of 
formulary. The origin of the formulary, if in use, was asked as a continuation of the 
previous question. Several possible origins of formularies were provided such as: 
Local Health Authority, other Health Authorities, the respondent hospital, another 
hospital, group or company formulary. A space was provided to mention other sources 
of formularies.
Many Health Authorities place limitations on the use of antibiotics, to achieve 
reasonable economy in treatment consistent with adequate cover, and to reduce the 
development of resistant organisms. An authority may indicate a range of drugs for 
general use, and permit treatment with other drugs only on the advice of the 
microbiologist or physician responsible for the control of infectious diseases . On 
that basis, a question was asked (question 27) about the availability of a policy on the 
prescribing of antibiotics. The respondents were also asked to indicate the procedures 
adopted when an antibiotic is prescribed.
When generic names for medicines exist it is common practice in NHS hospitals for 
those to be used when prescribing medicines. This enables any suitable product to be 
dispensed, thereby saving delay to the patient and sometimes reducing expense to the 
NHS. An exception is where the bioavailability problems are so important that the
")£kpatient should always receive the same brand . The next questions (question 28 to 
30) asked about the use of generic and brand-name products. As a continuation to this 
question, another question (29) asked the respondent to indicate how they decided 
which generic products to use if generic pharmaceutical products were in use. 
Question (30) asked about the use of parallel-imported medicines and the procedures 
adopted to avoid counterfeit and/or substandard products if they are in use.
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Question (32) dealt with medicines warnings and product recall notices. The 
respondents were asked if their hospital receives notices issued by the Department of 
Health or by pharmaceutical manufacturers concerning product recalls and medicines 
warnings. If the hospital does receive such notices the respondents were asked to 
indicate the origin of the notifications and who is the person that co-ordinates action 
in the hospital in response to these notices.
Question (31) asked the respondent to state how the hospital calculates the cost of 
medicines administered to individual patients and whether information regarding the 
costs of medicines is used for any additional cost analysis. On the other hand, if the 
hospital does not calculate the cost of medicines, the respondents were asked to 
outline how medicines are charged to patients in that hospital.
The next part of the questionnaire asked about official inspections of the 
pharmaceutical facilities carried out during the past 12 months. Given a list of 
possible types of inspections provided in the questionnaire, the respondent was asked 
to state who undertakes the official inspection of their hospital and to give the total 
number of each type of inspection visit during the last 12 months (question 33). The 
list of possible inspectors that usually undertake official inspections of independent 
hospitals included: District Pharmaceutical Officer (DPhO) or their equivalent Senior 
Pharmacy Manager (SPM), a Community Services Pharmacist (CSP), Royal 
Pharmaceutical Society Inspector and Home Office Inspector. A space was provided 
for the respondent to indicate other inspectors or official bodies that carry out an 
official inspection of the pharmaceutical facilities in that independent hospital.
The next question also dealt with inspection (question 34). The respondents were 
asked to indicate in what way they perceived the inspection carried out by either the 
DPhO or the CSP, for example whether they saw the inspection as advisory, or as an 
enforcement of Health Authority standards or in some other way.
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With regard to training and continuing education, the respondent was asked to 
mention if they undertake any training or continuing education. The respondents were 
also asked to state the approximate number of hours of training or continuing 
education undertaken, in several subject areas. The topics included pharmacy 
practice/clinical pharmacy, management, financial management, safety, legislation and 
any other topics the respondent wished to add.
The respondent’s perception was also sought with regard to the provision of 
pharmaceutical services in their hospital (question 36). The respondents were asked to 
select 5 key qualities of person(s) responsible for pharmaceutical services within the 
hospital. A scale of 1 (least important) to 5 (most important) was provided in the 
questionnaire for the respondents to rank various personal competencies. 8 such 
competencies were specified for the respondents to choose from and space was 
provided to mention others. The 8 competencies were as follows: purchasing skills, 
knowledge of clinical uses of drugs and medicines, networks of pharmaceutical 
contacts, ability to interact with other people, knowledge of safe handling of 
parenteral/cytotoxic drugs etc., knowledge of pharmaceutical legislation, accurate and 
efficient dispensing and good organisational skills.
The need for staff liaison (i.e. effective communication between the person in charge 
of the pharmaceutical services and the other members of staff within the hospital) 
would seem likely to be very important for the benefit of patients. A question was 
asked (question 37) about whether there was frequent contact between the person 
providing pharmaceutical services and individual medical consultants in the hospital 
and, if so, the approximate amount of contact either weekly or monthly. Also the 
respondents were asked to mention the kinds of topics that were usually discussed 
during such communication (i.e. whether these topics usually dealt with drug 
expenditure, drug therapy or other topics).
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Question 38 addressed the current pharmaceutical services available within the 
independent hospital. This question was carefully designed and worded in order to 
obtain a clear picture about the current situation of pharmaceutical services within the 
establishment. The question was structured as 4 columns. 12 pharmaceutical service 
criteria were specified in column 1. These services were: stock control of 
drugs/medicines; expiry date checks; ward visits to advise patients; patient medication 
chart review; reconstitution of IV preparations; cytotoxic reconstitution; specialised 
production of medicines for the hospital; labelling of medicines; secure storage of 
medicines; environmental control of storage conditions; disposal of medicines; and 
drug information. A space was provided to mention other services which might be 
available within the hospital but which were not specified in the questionnaire. The 
second column was designed for the respondent to indicate which of the 
pharmaceutical service criteria are available within the hospital. The respondents were 
asked to indicate in the third column the provider(s) of each service criterion available 
in the hospital. To facilitate this, the questionnaire provided 6 possible providers of 
the pharmaceutical services and opportunity was also provided for the respondent to 
indicate other provider(s). The 6 providers mentioned in the questionnaire were: an in 
house pharmacist; a community pharmacist; a NHS hospital pharmacist; group 
pharmaceutical advisor; a technician; and a wholesaler. Each of those providers was 
assigned an abbreviation code to be entered as a response instead of writing the whole 
name of the provider; also, more than one provider could be chosen in this column. 
The respondents were then asked to give in the last column their perceived assessment 
of the quality of each of the services available. A scale of 1: very poor; 2: poor; 3: 
satisfactory; 4: good; 5: very good was provided in the questionnaire for the 
respondents to chose from.
At the end of the questionnaire, several questions were addressed to the respondents 
with regard to the provision of pharmaceutical services within their hospital. The first 
question in this section asked the respondent to list any aspects of the pharmaceutical 
services in their hospital that they considered could be significantly improved. The 
next question asked the respondents to give details about any aspects of 
pharmaceutical legislation that create particular difficulties in independent hospitals.
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Another question enquired whether there are any specific reasons why those providing 
pharmaceutical services might find the opportunities available in an independent 
hospital more attractive than in an NHS hospital. The final question in this section 
asked the respondents to mention any disadvantages associated with the provision of 
pharmaceutical services in an independent hospital. Assurance were given to the 
respondents that no specific information from the survey would be attributed to an 
individual or a hospital, nor would such information be disclosed to a third party. Also 
the respondents were asked to indicate whether they or their hospitals would wish to 
be acknowledged in any future report.
2.1.4. Pre-testins of the questionnaire.
The final stage of design was to pre-test the questionnaire. The questionnaire was 
critically examined by a number of university academic staff, by a part-time university 
staff member with hospital experience and by an independent hospital pharmacist. 
Each person was invited to criticise any aspect of the questionnaire, including 
question wording; question order; missing questions; inappropriate questions, and any 
other aspects they considered to be unsatisfactory or felt might be not useful. At that 
stage, the questionnaire was judged by the respondents to be easy to follow and the 
questions were considered to be valid.
2.1.5. Further vre-test.
The further pre-test in April 1994 aimed to ensure that the questionnaire could be 
correctly understood and that the questions would provide valid responses. The 
proposed questionnaire was sent with a covering letter to 8 pharmacy managers 
working for private companies operating independent hospitals in the UK. This 
sample group included both male and female pharmacists and was selected to obtain 
how opinion on the questionnaire from hospitals varying in size and ownership. 
Sample recipients were selected from hospitals owned by different companies, e.g. 




The covering letter contained a brief description of the nature of the study and asked 
the recipients to comment on the content of the questionnaire and to give their critical 
opinion on unnecessary questions or any additional information that they felt might be 
appropriate to gather. A copy of the piloted questionnaire and the covering letter can 
be found in Appendix I.
Responses were received from 5 pharmacists (63% response) and their critical 
comments were used to refine the questionnaire.
2.1.5.1. Alterations made to the questionnaire as a result o f  the 
further pre-test
•  A question about specialised services in independent hospitals, such as in-vitro 
fertilisation, was deleted and a question about oncology was added.
• The question about the provision of out-of-hours pharmaceutical services was 
amended and expanded to cover other possible options for providing services 
outside pharmacy hours. Therefore, 2 options were added to this question. The first 
one is an authorised person having access to the pharmacy (if so, whom) and the 
second is an authorised person having access to an emergency cupboard (if so, 
whom).
• The question about generic and brand-name products was relocated in the 
questionnaire to be in sequence with other relevant questions.
• The question which described the pharmaceutical services provision and its quality 
was re-written. In the provider column, the "Group Pharmaceutical Advisor" was 
deleted and replaced with "Nurse".
• Finally, a definition of an independent hospital was added to the first page of the 
final copy of the questionnaire as recommended by one of the respondents.
The definition of an independent hospital was obtained from the NAHAT guidelines 
and were included in the questionnaire as:
"An Acute Independent Hospital includes any premises which are used for the 
provision o f  acute psychiatric services and/or any o f  the following services: the 
carrying out o f  surgical procedures under anaesthesia; the termination o f  




2.1,6. The National Survey.
With the aim of increasing the response rate to the questionnaire, it was decided that, 
whenever possible, the questionnaire should be addressed personally to the person in 
charge of the pharmaceutical services within an independent hospital. It was realised 
that there might be a tendency for persons including hospital directors who were non­
pharmacists to show less interest in the survey. In addition, a personalised letter might 
encourage the recipients to recognise that their opinions were important and therefore 
increase the likelihood of them completing and returning the questionnaire.
On that basis, 20 letters were sent out in March 1994 to the Head Offices of the major 
UK hospital-group owners using the Directory of Independent Hospitals as the source 
of addresses 2. The letter contained a brief indication of the nature of the survey and 
requested the recipient to provide the names of the pharmacy managers working for 
that hospital group. In addition, another letter was sent out to the Association of 
Private Hospital Pharmacists (APHP) requesting a list of names of pharmacists 
responsible for providing services at independent hospitals. Also personal contacts 
with various colleagues were used to obtain as many names as possible of persons 
responsible for pharmaceutical services in the independent hospitals. A copy of the 
letter which was sent to the UK hospitals-group owners and APHP can be found in 
Appendix II.
Responses were obtained from 12 of the hospital groups (60%). Some of the 
responses were returned with a list of the pharmacy managers while other responses 
stated that the hospitals operated by that particular group did not have a pharmacy 
department. The response received from APHP provided the names of pharmacy 
managers working in the private hospital sector.
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The revised questionnaire was sent out to addresses derived from a combination of 
several reference sources 2,40,41>42. The 283 establishments in England, Scotland, 
Wales and Northern Ireland, listed in these reference sources were described as Acute 
Independent Hospitals. The mailing took place in June 1994 together with a covering 
letter and a Free-post envelope to facilitate the return of the questionnaire. The 
covering letter included a brief description of the study and a request to complete the 
enclosed questionnaire. Assurances were given to respondents that any information 
supplied would be treated in strict confidence and would not be disclosed to a third 
party. A copy of the final, revised questionnaire and the covering letter can be found 
in Appendix EH. A reminder letter was sent out to those who did not replied. A copy of 
a reminder letter can be found in Appendix VI.
2.2. Questionnaire 2 -  Assessment of pharmaceutical services in independent 
hospitals as perceived by pharmacists involved in their statutory inspections.
Based on the results obtained from the service providers by Rees et al 11 which had 
indicated that services provided by a pharmacist were no better than those provided by 
a non-pharmacist, when assessed by service providers. On that basis, the decision was 
made to design a questionnaire, which would be sent out to Senior Pharmacists 
involved in the statutory inspection of independent hospitals throughout the UK in 
order to obtain an independent opinion of the quality of the pharmaceutical services 
provided within independent hospitals. It was resolved that the questionnaire should 
be as similar as possible to that questionnaire which had been sent out to the persons 
responsible for pharmaceutical services provision within each independent hospital. 
Rees, Rendle et a l12 had taken a similar decision earlier in 1992 as they found that the 
standard of pharmaceutical services in independent hospitals without a pharmacist 
was judged to be lower than hospitals with a pharmacist contrary to the finding 
obtained from the service providers study n .
2.2.1. Choice of method.
The purpose of the questionnaire was: a) to determine the current situation regarding 
pharmaceutical services in independent hospitals and b) to assess the quality of 
pharmaceutical services within these establishments as perceived by the pharmacists 
involved in their inspections.
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2.2.2, Equipment and instruments used.
Questionnaire forms were produced using Microsoft Word for Windows V.6 and V.7. 
SPSS for Windows V.6.2. (Statistical Package for Social Sciences) was used to record 
the results from returned questionnaires and for statistical analysis of the data. 
Advantage was taken of a Free-post licence arrangement to allow respondents to 
return their completed questionnaires.
2.2.3, Design o f questionnaire.
It was not possible to include in the questionnaire all the possible pharmaceutical 
services being provided within independent hospitals together with questions 
concerning their quality, because 1) the questionnaire would have been unreasonably 
long and 2) the Senior Pharmacists would probably have had difficulty finding time to 
respond and 3) some of the services might not be relevant to, or directly related to the 
inspection procedures. On that basis, it was decided to limit the questions to allow a 
valid comparison between the responses obtained from the person providing 
pharmaceutical services in independent hospitals (Questionnaire 1) and the 
pharmacists undertaking the statutory inspection of those hospitals (Questionnaire 2).
2.2.3.1. Question wording.
As in the other questionnaire, this questionnaire included many types of questions 
each of which needed to be worded clearly and in an unambiguous way. Also an effort 
was made to make the questions as short as possible. Attention was directed at 
avoiding loaded questions, double-barrelled questions and negative phrases.
2.2.3.2. Questionnaire structure.
The survey questionnaire (Appendix IV) was developed by first listing a number of 
types of questions relevant to the pharmaceutical services provided in independent 
hospitals and the quality of those services as might be perceived by a Senior 
Pharmacist inspecting those services. The questionnaire was commenced with a 
question addressing whether the recipient was the relevant person to complete the 
questionnaire. Therefore, the first question asked whether the respondent was 
involved in the inspection of pharmaceutical services provision in independent 
hospitals. If he/she was the relevant person, they could continue completing the 
questionnaire. Otherwise the questionnaire should be returned uncompleted.
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Usually the inspection is undertaken either by a District Pharmaceutical Officer 
(DPhO)or other Senior Pharmacy Manager (SPM), or by a Community Services 
Pharmacist (CSP). Therefore, in order to identify who undertakes the inspections, the 
next question asked for details of the inspector’s job title(s). A space was provided for 
the inspector’s employer to be named. The next 2 questions asked about the number of 
independent hospitals in the inspector’s area of responsibility and whether these 
hospitals have been previously inspected at some time.
The inspector’s perception with regard to inspection was also sought. Question 5 
asked the inspector whether they regard inspection as an advisory exercise, an 
enforcement of standards, an administrative necessity or in some other way.
The NAHAT guidelines 10 recommended a set number of pharmaceutical inspections 
per year for independent hospitals and this depends on the size of the hospital, the 
number of operating theatres and the availability of a pharmacist within the hospital. 
Questions 6 and 7 in the questionnaire asked the inspector whether some of the 
independent hospitals in his/her area of responsibility had been inspected less 
frequently than recommended by the NAHAT guidelines and, if so, the reasons for 
that. 5 different possible reasons were provided in this question to allow the 
respondents to choose from the following: confidence in the services provided by the 
pharmacist; confidence in the pharmaceutical services provided by others; lack of staff 
for inspections; lack of time for inspection; other higher priority commitments within 
the NHS. A space was provided for respondents to list any other reason(s) that they 
might consider to be relevant.
It was estimated that in each District, there could be up to six independent hospitals or 
possibly, though rarely, more than six. In order to obtain a clear picture of the 
pharmaceutical services in each independent hospital in each district, question 8 called 
for information about how the pharmaceutical services were provided in each 
independent hospital and how the inspectors would describe these services, for 
example, whether the service provided was considered to be comprehensive or partial.
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Six different possible providers of pharmaceutical services were listed in the 
questionnaire: a pharmacist(s) employed directly by the hospital; a pharmacist(s) 
contracted from an NHS hospital; a community pharmacist(s); an independent (self 
employed) pharmacist(s); non-pharmacist(s), and a pharmacist(s) involved only in 
supply. The respondents were also asked to state who provided the services in the case 
of a non-pharmacist (e.g. nurse, wholesaler, etc.). And, if the hospital had a 
pharmacist involved only in the supply of medicines, the respondents were asked to 
state who that pharmacist was (e.g. a community pharmacist , a NHS hospital 
pharmacist, etc.).
Question 9 asked the respondents to state how many hours of pharmaceutical services 
usually were provided per week at each of the specific independent hospitals. The 
number of hours provision of pharmaceutical services were specified with 6 categories 
to allow the respondents to choose from:
• no hours;
• less than 5 hours per week;
• from 5 to less than 15 hours per week;
• from 15 to less than 30 hours per week;
• from 30 to less than 40 hours per week,
• 40 hours per week or more.
A series of questions asked for the perception of the inspecting pharmacist with regard
to the need for a pharmacist to be based in an independent hospital. Questions 10, 11
and 12 asked whether all independent hospitals should employ the services of a 
pharmacist and the criteria the inspector would use to determine whether an 
independent hospital required a pharmacist.
The inspectors were also asked how any requirements to employ the services of a 
pharmacist might be enabled, for example, whether by legislation, or a requirement of 
the inspecting Health Authority or by any other means. Question 13 was in the form of 
a scenario. The question asked the respondents, if a hospital has no pharmacist 
present, whether there are any reasons for inspecting that hospital more or less 
frequently than a hospital which has no pharmacist present.
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The inspectors were asked, in questions 14 and 15, to state their views of the NAHAT 
guidelines relating to pharmaceutical services. Question 14 asked whether the 
inspectors considered the NAHAT guidelines on inspection to be appropriate, and a 
space was provided for comments in case any of these guidelines was not considered 
to be appropriate. Question 15 asked whether the inspector considered these 
guidelines should be closely adhered to.
Each Health Authority may have its own documented procedure(s) for the inspection 
of the pharmaceutical services; therefore, question 16 asked whether the inspector’s 
Health Authority had such procedures. And a request was included to provide a copy 
of those procedures. In cases where the Health Authority does not have a documented 
procedure for the inspection of pharmaceutical services in independent hospitals, the 
respondents were asked about the basis on which standards for inspection were set.
It was assumed that, following inspection of an independent hospital, a progress report 
would be submitted by the pharmaceutical inspector to the hospital concerned and that 
this report would then be forwarded to the person in charge of pharmaceutical services 
within the hospital. Such a report would be expected to include the current 
pharmaceutical status of the hospital, whether or not action was required, and the 
recommendations of the inspector with regard to any services that the hospital needed 
to improve. Furthermore, in the event of quality deficiencies being reported by the 
inspector, a follow-up inspection visit would be expected. In an effort to find out if 
this was the case, 2 questions were asked (questions 17 and 18). Respondents were 
asked to state whether such a report was received following an inspection visit and 
whether there was a follow-up visit when quality deficiencies had been identified.
Question 19 was designed carefully in order to obtain, from the inspectors, 
information about the pharmaceutical services provided in the independent hospitals 




This question was divided into 2 sections. The first section asked the respondent for 
some detail of the hospitals inspected, such as hospital bed number, the number of 
operating theatres available in the hospital (if any), and the number of inspection visits 
during the past 12 months. The second section of this question specified 12 criteria 
related to pharmaceutical service provision that might be offered within the 
independent hospitals. These pharmaceutical service criteria were:
• procurement of medicines
• secure storage of medicines
• comprehensive labelling of dispensed medicines
• qualifications and training of staff
• stock control and record keeping
• environmental storage conditions of medicines
• monitoring intervention of in-patient drug therapy
• disposal of medicines
• procedures involving intravenous additives (IV-additives)
• procedures involving cytotoxics reconstitution
• procedures involving Total Parenteral Nutrition (TPN)
• drug information
This second section of question 19 consisted of two parts. The first part asked the 
inspector to indicate the extent to which they place emphasis on each of these 12 
service criteria when inspecting independent hospitals; three possible levels of 
emphasis were given in the questionnaire: unimportant, quite important, very 
important. One aim of this part of the question was to determine whether there were 
any differences in emphasis between the independent hospitals with a pharmacist and 
those without. The second part of this section asked the inspector to give their 
assessment of the quality of each service criterion, for each of the independent 
hospitals they had inspected; five possible levels of assessment were offered in the 
questionnaire: very good, good, satisfactory, poor, very poor. One aim of this part of 
this question was to determine whether there were any differences in quality between 
individual hospitals and, if so, what factors were associated with those differences, 




A pharmacist who inspected the pharmaceutical services was considered to be an 
appropriate person to ask about the current pharmaceutical services status within 
independent hospitals. On that basis, 2 further questions were asked (questions 20 and 
21). The inspectors were asked about any other criteria which they may use when 
inspecting the quality of pharmaceutical services provision in independent hospitals 
(question 20).
The next question (question 21) asked which of the pharmaceutical services the 
inspector considered could be significantly improved in independent hospitals in their 
District, both in hospitals with a pharmacist present and those without.
The final 2 questions asked about a possible conflict of interest in the inspection role. 
The CSP guidelines state that: if pharmaceutical services are provided from the 
department in which the pharmaceutical inspecting officer is employed, there is a 
possibility of conflict of financial interest. Those guidelines recommend that, in such 
cases, a pharmaceutical officer from a different Health Authority or Trust is asked to 
carry out the inspection role. Based on these guidelines, questions 22 and 23 asked the 
respondents to give their opinion with regard to the possibility of a conflict of interest 
in such cases and, in particular, given the market forces that operate within the NHS.
The questionnaire concluded by assuring the respondent that no specific information 
would be attributed to an individual, to a specific hospital or to a District, nor would 
any such information be disclosed to a third party. The respondents were also asked if 
their contribution could be acknowledged in any future reports or publications. A page 
was provided for any further comments that the respondents might wish to add.
2.2.4. Pre-testins of the questionnaire.
The final stage of the questionnaire design was to pre-test it. The questionnaire was 
critically examined by a number of the university academic staff, by a part-time 
university staff member with hospital experience and by an independent hospital 
pharmacist. Each person was invited to criticise any aspect of the questionnaire, 
including: question wording; question order; missing questions; inappropriate 
questions, and any other aspects they felt might be unsatisfactory or not useful.
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At this stage, the questionnaire was approved by those consulted, but it was decided to 
carry out a further pre-test of the questionnaire.
2.2.5. Further pre-test
In April 1994, the proposed questionnaire was sent for critical comment to 2 groups of 
individuals. The first group consisted of the following: 7 Regional Pharmaceutical 
Officers (RPhOs) in England; the Chief Pharmaceutical Advisor (CPhA) in Wales; the 
Chief Administrative Pharmaceutical Officer (CAPO) in Scotland, and the Director of 
Pharmaceutical Services (DPhS) in Northern Ireland. The second group of individuals 
consisted of the same 8 Pharmacy Managers who had been approached for critical 
comment on the "Questionnaire 1''.
These 2 groups of individuals were asked, in the covering letter sent with the 
questionnaire, to express their views on the content of the questionnaire, and on its 
structure, continuity and ease of completion. In the covering letter that was sent with 
the questionnaire to the group of pharmaceutical officers, a request was also made to 
supply a complete list of the names, job titles and addresses of the Senior Pharmacy 
Managers (SPMs) involved in the statutory inspection of independent hospitals in the 
recipient pharmaceutical officer’s Region. This request was made because in the past, 
the inspection role had been the responsibility of the District Pharmaceutical Officers 
(DPhOs). However, after the latest reorganisation that had taken place within the 
NHS, it was suspected that this may have affected the inspection role as well. A copy 
of the covering letter sent with the draft questionnaire to the group of pharmaceutical 
officers can be found in Appendix IV.
The responses obtained from the group of Officers were: 6 responses from Regional 
Pharmaceutical Officers and 2 other responses from Scotland and Wales. 5 responses 
were obtained from the group of 8 independent hospital pharmacy managers. Both sets 
of responses were used to amend and refine Questionnaire 2.
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2.2.5.1. Alterations made to the questionnaire as a result o f  the further 
pre-testinz.
•  The availability of advice on antibiotic/cross-infection policy was added to the 
question on the emphasis and quality assessment by the inspector relating to 
specified pharmaceutical services provided within a hospital (question 19). So, the 
number of specified pharmaceutical service criteria increased from 12 to 13.
• In Scotland, the term Health District is not used. Therefore, in the questionnaire 
which was sent to the Scottish pharmacists, ail the questions which referred to a 
District were changed to read Health Board (i.e. questions 2,3,12,16, and 22).
• In Scotland, the NAHAT guidelines are not applicable. However, similar 
guidelines for inspection and other aspects of pharmaceutical services in 
independent hospitals did exist. These guidelines have been issued by the Scottish 
Office Home and Health Department.43 The Scottish Chief Administrative 
Pharmaceutical Officers Group (CAPOs) have also issued various guidelines on 
the Registration and Inspection of Nursing Homes and on the Administration and 
Control of Medicine within these establishments 45,46. Therefore, all questions 
referring to NAHAT guidelines were also amended in the questionnaire which 
was sent to the Scottish pharmacists (i.e. questions 6,14, and 15).
• A definition of an Acute Independent Hospital was also added to the first page of 
the questionnaire.
2.2.6. National Survey.
Following the most recent reorganisation that had taken place within the NHS, as 
mentioned in the Introduction, attempts were made to obtain an up-to-date list of the 
Senior Pharmacy Managers involved in the inspection of pharmaceutical services in 
independent hospitals in each of the Districts in England. With that aim, a letter was 
sent out in April 1994 to all Regional Pharmaceutical Officers in the 14 English 
Regions (Note: as explained in section 2.2.5 above, 7 of those Regional 
Pharmaceutical Officers had been involved in the pre-testing of Questionnaire 2). 
Letters requesting the same information were also sent to the Chief Pharmaceutical 
Advisor in Wales, the Chief Administrative Pharmaceutical Officer in Scotland and 
the Director of Pharmaceutical Services in Northern Ireland.
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Responses were obtained from 12 Regions in England, and also from Wales, Scotland 
and Northern Ireland. The Regional Pharmaceutical Officers’ Senior Pharmacy 
Managers Directory, March 1993 47 was used to obtain the names of the person 
responsible for inspection in the 2 English Regions from which no responses had been 
received.
In June 1994, the revised questionnaire (Questionnaire 2) was sent out, together with a 
covering letter and a Free-post envelope, to 230 SPMs in the 219 Health 
Authority/Health Board 'Districts' of the UK. This apparent numerical discrepancy 
(i.e. 230 compared with 219) was because, according to information we had received, 
in 10 of the Districts in England, there was apparently more than one pharmacist 
involved in inspection. The covering letter enclosed with the questionnaire requested 
the addressee, if not involved in inspection, to return the blank questionnaire and to 
provide, if possible, the name and address of the pharmacist to whom it should be 
sent. A copy of the questionnaire used for the national survey and the relevant 
covering letter can be found in Appendix V. Four weeks after the questionnaire first 
posed, a reminder letter was sent out to those who did not replied. A copy of a 
reminder letter can be found in Appendix VI.
2.2.6.1 Problems encountered after receiving responses from some Senior 
Pharmacy Managers who stated that they were not involved in inspection.
After sending out the questionnaire, 52 replies -  equivalent to 23% of the number of 
questionnaires sent out- were received from SPMs in England who stated that they 
were not involved in inspection nor did they know who was responsible for inspection 
in their District. As a result of this, all but one of the Regional Pharmaceutical 
Officers in England were contacted again with a request to supply the names of the 
pharmacists involved in inspection in those Districts where the SPM was unaware 
who was involved in inspection. Prior to that, completed returns for all 'Districts' had 
only been received from East Anglia Regional Health Authority. A copy of the letter 
sent to the 13 Regional Pharmaceutical Officers can be found in Appendix VII. In 
response to those 13 letters, 4 replies were received, each one stating that the names of 
the persons involved in inspection in those Districts were not known.
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Community Services Pharmacists(CSPs) were known to have been involved, either 
solely or jointly, in the inspection of independent hospitals in 44% of the Districts
19surveyed in 1992 . The CSP group was therefore contacted in November 1994, in an 
effort to obtain the information required about SPMs involved in the inspection of 
independent hospitals. Although the CSP group was extremely keen to assist, their 
records, at that time, could not identify which of their members was involved in 
inspection. It was suggested in a response received from the CSP group that the 
difficulties we were encountering in obtaining names may have been due to a lack of 
pharmaceutical involvement in the inspection process in a number of localities. A 
copy of the letter which was sent to the CSP group can be found in Appendix VIII.
In January 1995, a letter was sent to 74 Nursing Homes Registration Officers 
(NHROs). The Health Authorities concerned -  some of them formed by the merger of 
former DHAs as a consequence of continuing NHS reorganisation -  embraced 89 of 
the Districts for which we had still been unable to obtain confirmatory evidence 
regarding the identity of the pharmacist, or other person, involved in the inspection of 
pharmaceutical services at independent hospitals. Replies were received from 64 
(86%) of the NHROs contacted, giving the names of pharmacists involved in 
inspection in 44 of the Districts; 20 of those names were previously unknown to us but 
24 of the names confirmed information we had received from the Regional Officers. A 
copy of the letter which was sent to the NHRO can be found in Appendix IX. That 
information supplied by the NHROs gave a total of 164 'districts' for which the names 
of the pharmacists concerned were now known. Therefore, after 10 months, 75% of 
the relevant pharmacists had been identified. These difficulties were published in an 
abstract and a poster presented at the 1995 British Pharmaceutical Conference held at 
the University of Warwick 48.
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2.3. Interviews with some Senior Pharmacists involved in the statutory inspection 
of independent hospitals.
Following the analysis of data obtained using Questionnaires 1 and 2, it was decided 
that, for the purpose of obtaining additional comments, interviews should be 
conducted with all of the Senior Pharmacy Managers who, according to the survey 
results, were involved in inspection of 3 or more independent hospitals throughout the 
UK.
Full details of the methods used for those interviews and of the results obtained are 
presented in Chapter 5.
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CHAPTER THREE
SURVEY OF PERSONS INVOLVED IN PROVISION OF 
PHARMACEUTICAL SERVICES IN INDEPENDENT HOSPITALS.
3. RESULTS AND DISCUSSION
3.1. General information about the indevendent hospitals>
All the institutions in the UK which, according to available reference sources,2’40'41’42 
were independent hospitals (n=283) were sent a copy of Questionnaire #1. Within a 
period of four weeks, 115 completed questionnaires were returned; that represented a 
response rate, at that stage, of 40%. An additional 12 replies were disregarded as the 
respondents commented that their premises were not independent hospitals, but were 
residential homes, hospices, etc. Those 12 responses led to an effective reduction in 
the sample size from 283 to 271 independent hospitals. Furthermore, 13 of the 
questionnaires were returned uncompleted, from the hospitals concerned, without any 
comments.
After sending a reminder by post to the non-respondents 4 weeks after the 
questionnaire was first distributed in June 1994, a further 24 responses were received. 
The total number of 139 completed questionnaires following the first reminder gave a 
response rate of 51.3% of the total number of independent hospitals. A copy of the 
reminder letter can be found in Appendix VI
This first stage of the survey is shown diagrammatically in Figure 3.1.
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Figure. 3.1.Scheme showing the first stage o f responses to the hospital 
questionnaire, including the postal reminder.
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As a result of this low response rate, the decision was made to use telephone as 
another reminder mechanism to increase the response rate. All the non-respondent 
hospitals, as well as those hospitals which returned the questionnaire uncompleted, 
were contacted by telephone and the person concerned was asked to return the 
completed questionnaire. An offer was made to send another copy of the 
questionnaire, if the previous copy had been mislaid. From this second reminder, 53 
completed questionnaires were received. In addition, this exercise identified another 
13 hospitals which could not be regarded as independent hospitals and 3 hospitals 
which had closed. The telephone reminder also showed that, in 6 of the independent 
hospitals contacted, there was no person responsible for the provision of 
pharmaceutical services at those premises. In a further 5 hospitals, surprisingly, there 
were no medicines held in the hospital. Finally, 11 pharmacists refused to fill in the 
questionnaire because they did not have any interest in such research.
Figure 3.2. illustrates the responses obtained following the telephone reminder.
Responses in the form of completed questionnaire were received on behalf of 192 
independent hospitals throughout the UK which represents a response rate of 75% 
based on the total number of 255 institutions, which were identified as independent 
hospitals. A further 22 institutions (9%) responded in some way without completing a 
questionnaire, leaving only 41 (16%) hospitals for which no response of any form was 
obtained.
Page 70
CHAPTER 3 Service Providers Survey
Figure 3.2. Scheme showing the results o f the telephone reminder for Questionnaire #1
NO RESPONSE UNCOMPLETED
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3.1.1. Ownership o f  independent hospitals.
Questions 1-8 inclusive were answered by all respondents. Of the 192 independent 
hospitals, 7 hospitals (3.6%) were owned by private individuals, 111 (58%) by limited 
companies, 65 (34%) by charitable organisations and 5 (2.6%) were owned by others 
such as: American partners, Arabian Gulf interest, provident associations etc. (Table 
3.1). No information was provided on the ownership of 4 hospitals.
Table 3.1. Ownership o f  the independent hospitals
Ownership Frequency %
Limited Company Jig 111 58
Charity 65 34
Private Individual 7 3.6
Others 5 2.6
TOTAL 188* 100%
* (Note. 4 missing cases were recorded for this question).
Of the 192 questionnaires returned, the responses included 109 (57%) received from 
hospitals representing the following organisations and companies:- 23 (12%) from 
BUPA Hospitals, 19 (10%) from Nuffield Hospitals, 16 (8.3%) from Independent 
British Healthcare (IBH) hospitals, 15 (7.8%) from British Medical Insurance (BMI) 
hospitals, 14 (7.3%) from Compass Healthcare, 7 (3.6%) from Community Hospitals, 
6 (3.1%) from Priory Hospitals Group, 5 (2.6%) from the British Pregnancy Advisory 
Service (BPAS), 4 (2%) from Goldsborough Healthcare (Figure 3.3). Of the 
remaining 83 hospitals, 32 made no mention of an ownership group while the rest (51) 
were privately owned or belonged to various charitable organisations and companies 
such as: Charter Medical Healthcare, Royal Masonic, Marie Stopes International, 
Community Healthcare, Great Northern Healthcare.
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(N.B. The remaining 32 hospitals did not mention their ownership groups).
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3.1.2. Numbers o f beds in independent hospitals.
The figure of 40 beds has been used as a basis for comparison here because that is the 
number used in the NAHAT guidelines to identify independent hospitals which 
NAHAT considers should employ a pharmacist to offer pharmaceutical services. 
Based on the NAHAT guidelines, out of 192 hospitals surveyed, in 189 of the 
hospitals for which detailed figures were provided, one hospital had no beds, some 
had 3 beds, and the maximum number was 420 beds. There were 82 hospitals with 
fewer than 40 beds and 106 hospitals had 40 beds or more (Table 3.2). The mean 
number of beds was 57.
Table 3.2. The number o f beds in the hospitals surveyed:-
Number Frequency %
0to 39 82 43.6
40 4 106 56.4
TOTAL 188* 100%
*(Note: 4 missing replies were recorded for this question).
3.1.3. Numbers o f operating theatres in independent hospitals.
The number of operating theatres also varied between hospitals. Some hospitals had 
no operating theatre whereas the maximum number was 7 (Table 3.3).
Table 3.3. The numbers o f operating theatres in independent hospitals:-
Theatres Frequency %
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T O T A L 189* 100%
*(Note: 3 missing cases were recorded in this question).
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3.1.4. Suvvort services within independent hospitals 
The independent hospitals offered various different support services or activities. 
Question 6 related to the support services provided within the hospital. The 
availability of these services within independent hospitals, according to the responses 
received, is shown in Table 3.4.









3.1.5. Specialised medical services in independent hospitals.
Question 7 related to the specialised services provided within the hospital. Table 3.5 
provides an indication of the range of specialist services offered in different IHs.
Table 3.5. Provision o f specialist medical services within the independent hospitals 
(n=192)
| 'Frequency
Oncology 71 Endoscopy 9
Paediatric 37 Head and back surgery 7
Psychiatric 27 Addiction 5
Cardiology 25 Ophthalmology 1
Gynaecology 23 Renal 1
Orthopaedic 13 Others 14
Page 75
CHAPTER 3 Service Providers Survey
3.1.6. The availability o f a Resident Medical Officer 
The last question in this section of the questionnaire (question 8) was related to the 
availability of a Resident Medical Officer (RMO). Of the 192 independent hospitals 
that responded, 163 hospitals had the services of a RMO, while 26 hospitals did not 
have a RMO. The remaining 3 responses did not report whether there was a RMO or 
not.
Further information was provided in 162 of the 163 responses. In 151 of the 
independent hospitals that employed a RMO, the RMO provided cover for 24 hours 
(day & night). Cover only at night was available in 10 hospitals, whereas 1 hospital 
received the services of a RMO only during the day.
3.2. The provision o f  pharmaceutical services in the independent hospitals
The questionnaire asked whether there was a pharmacist within the hospital, and 
whether that pharmacist was employed directly by the hospital or contracted to work 
in the hospital. From this information and the replies to several other questions within 
the questionnaire, it was possible to identify the model whereby the pharmaceutical 
services were provided within each of the independent hospitals. (Table 3.6).
Table 3.6. The provider o f the pharmaceutical services within the independent 
hospitals.
Provider IHs %
Pharmaeist(s) Employed by the IH 91 47.6
Contract with an NHS Hospital Phannaeist(s) 49 25.7
Contract with a Community Pharmacist(s) 16 8.4
Contract with a Self-employed Pharmacist(s) 8 4.2
Non-Pharmacist(s) 18 9.4
Pharmacists) merely involved in 9 4.7
TOTAL 191* 100%
*(Note: only one missing case was recorded for this question).
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As can be seen from Table 3.6, in 47.6% of the IHs there was a pharmacist employed 
by the hospital. In a further 38.3% of the IHs there was a pharmacist contracted to 
provided pharmaceutical services, with the services being provided either by the a 
NHS hospital pharmacist or by a community pharmacist or by a self-employed, 
independent pharmacist. In 18 hospitals (9.4%) there was no involvement of a 
pharmacist at all while in 9 hospitals a pharmacist was involved but merely acting as a 
supplier. Therefore, some hospitals had a pharmacist but no facility described as a 
pharmacy department as described in Table 3.4.
In an effort to observe the effect of the hospital’s ownership on the different service 
providers, Table 3.6 was cross-tabulated with Tables 3.1 and 3.2. The results are 
shown in Table 3.7.
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Table 3 .7. The effect o f  hospital ownership on the presence o f different service providers in hospitals with less than 40 beds and hospitals 
with 40 beds or more:
f f t : j
PHARMACIST NON-PHARMACIS 
(i.e. others)
Directly NHS CP Self None at all Supply
m m
<40 40+ <40 40+ <40 40+ <40 40+ <40 40+ <40 40+ TOTAL
Private individuals 1 2 1 1 - - - - 1 1 - - 7
Limited company 11 50 18 7 7 4 - 3 5 - 3 - 108
Charity 3 20 12 6 5 - 3 1 6 3 2 3 64
Others 1 2 1 1 - - - - - - - - 5
TOTAL 16 74 32 15 12 4 3 4 12 4 5 3 184
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As can be seen from Table 3.7, the majority of big hospitals (i.e. with 40 beds or 
more) operated by limited companies, tend to employ a pharmacist directly. 
Furthermore, for smaller hospitals (i.e. hospitals having less than 40 beds), the limited 
companies tended to rely on a contract with NHS hospitals or community pharmacies 
for the provision of pharmaceutical service. In general, the majority of hospitals 
without a pharmacist at all were those operated by charitable organisations.
3.3. Nature of the pharmaceutical services provided services within IHs:-
3.3.1. Comprehensive and partial services.
The questionnaire did not specifically ask the respondent to state whether there was 
provision of a "comprehensive" or "partial" pharmaceutical service to the 
independent hospital. Therefore, in order to deduce this from the information that was 
provided, it was necessary to establish certain criteria and to use them as a basis for 
identifying to what extent pharmaceutical services were available within each 
independent hospital. The hospitals were divided into two groups. The first group 
comprised those hospitals which received at least 8 of the defined pharmaceutical 
services referred to in the questionnaire; those IHs were considered to receive a 
"comprehensive" pharmaceutical service. On the other hand, hospitals which 
received less than 8 of the defined pharmaceutical services were considered to receive 
only a "partial" pharmaceutical service.
The following 12 pharmaceutical services were used as a basis for identifying those 
hospitals which received a "comprehensive" or "partial" pharmaceutical service:-
• Stock control of drugs/medicines
• Expiry date checks
• Ward visits to advise patients
• Patient medication chart review
• Reconstitution of IV preparations
• Cytotoxic reconstitution
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• Specialised production of medicines
• Labelling of medicines
• Secure storage of medicines
• Environmental control of storage conditions
• Disposal of medicines
• Drug information.
On that basis, Table 3.8 shows a breakdown of the IHs into those that were judged to 
receive a "comprehensive" and "partial" service, respectively, in relation to the 
different "service provider model" that applied, i.e. the type of person reported to be 
responsible for providing pharmaceutical services.
Table 3.8. The extent o f the services provided related to the person responsible for 
providing those pharmaceutical services to an independent hosvital:-
► e r v *. - iV v i  a e x
Directly Contracted Pharm. Non Pharmacist
- . O X i J V V A v ^ x ! *  ■ Employed NHS CP Self None Pharmacist as TOTAL
Pharm. employed at all a Supplier only
Comprehensive 86 29 6 6 3 0 130
Partial 5 20 10 2 15 9 60
TOTAL 91 49 16 8 18 9 190
(Note:- 2 missing case was recorded in this test).
As can be seen from Table 3.8, pharmacists who were employed directly by the IH 
mainly offered a "comprehensive" service. On the other hand, "partial" 
pharmaceutical services tended to be provided mainly by a contracted pharmacist from 
the NHS or by a community pharmacist or a non-pharmacist.
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A very highly significant result was obtained when the service provider model (i.e. the 
type of person providing the pharmaceutical services) was cross-tabulated with the 
extent of services provided by that person. The Pearson chi-square test leads to the 
conclusion that there is a relationship between the extent of service provision and the 
provider of that service (p= 0.0001, df = 6).
The Kruskal-Wallis One-Way Anova test (corrected for ties) also indicated a 
significant relation between the person providing the pharmaceutical service and the 
extent of the service (p= 0.001, df = 6).
3.3.2. Hours o f  pharmaceutical services provision.
For all hospitals with a pharmacist on site, the respondents were asked to state the 
number of hours per week spent by the pharmacist(s) in providing pharmaceutical 
services (question 12).
In order make the respondent’s task as easy as possible when providing such 
information about the length of time per week spent by the person providing the 
pharmaceutical services within an independent hospital, the numbers of hours were 
divided into 5 groups:-
• Less than 5 hours per week.
• From 5 hours up to less than 15 hours per week.
• From 15 up to less than 30 hours per week.
• From 30 up to less than 40 hours per week.
• 40 hours per week and more.
The number of responses in each group were cross-tabulated against the person 
providing the pharmaceutical services. A very highly significant relation was obtained 
from the Pearson chi-square test (p= 0.0001, df = 16), indicating a statistical 
relationship with the provider model. The Kruskal-Wallis One-Way-Anova (corrected 
for ties) also showed highly significant differences between the groups (p= 0.0001).
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From Table 3.4, 127 of the 192 independent hospitals reported having a pharmacy 
service. As can be seen from Table 3.9, only 112 independent hospitals provided 
details about the hours of service provided by a person based on site and responsible 
for the provision of the pharmaceutical services. When a pharmacist was employed 
directly by the independent hospital or a self-employed pharmacist was contracted to 
provide the service, the time involved was never less than 5 hours per week.
For services of less than 5 hours per week, it was a NHS hospital pharmacist or a 
community pharmacist who provided the service. In all but two cases, for services of 
30 hours or more per week, the hospitals usually employed a pharmacist directly or, 
occasionally, contracted the service provision to a self-employed pharmacist; the 
exceptions were one which had a contract with the NHS and one hospital where the 
services were provided by someone other than a pharmacist.
One community pharmacist provided services of over 15 hours per week to one 
independent hospital, but as in most cases where this service provider model applied, 
no details of hours of service were provided in the questionnaire response.
Of the 91 hospitals which employed a pharmacist directly, nearly 80% of them (72), 
received 40 hours per week or more of pharmaceutical services. In addition, 2 self 
employed pharmacists and 1 NHS hospital pharmacist provided services of 40 hours 
per week or more.
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Table 3.9. Hours o f pharmaceutical services by different service providers
litiSis,H O U R  i
Providers <5 5 -< 1 5 15 <30 30 <40 40+ TOTAL
Employed Directly 0 2 13 4 72 91
NHS Hospital Pharmacist 4 3 2 0 1 10
Community Pharmacist 1 0 1 0 0 2
Self-employed Pharmacist 0 2 3 1 2 8
Only Supplying Pharmacist 0 0 0 0 0 0
Non-Pharmacist 0 0 0 1 0 1
TOTAL 5 7 19 6 75 112
(Note: the total numbers shown here reflect only those respondents who gave the 
exact number of hours per week, and it should be noted that the NHS and community 
pharmacists who gave hours o f service in their NHS hospitals and community 
pharmacies, are excluded from the test and therefore not shown in this Table).
3.3.3. Relating the service provider model to the numbers o f beds.
The hospitals were divided into two groups: those with fewer than 40 beds, and those 
with 40 beds or more. The numbers of hospitals in each of the two groups were cross­
tabulated with the persons providing the pharmaceutical services to the independent 
hospitals. The result are shown in Table 3.10.
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Table 3.10. The Numbers o f Hospitals having (i) 40 beds or more, and (ii) fewer 
than 40 beds, related to the service provider model:-
::: : ::..
'











<40 16 32 12 3 13 6 82 (43.6%)
40+ 74 16 4 4 5 3 106 (56.4%)
TOTAL 90 48 16 7 18 9 188
(N.B. 4 missing cases were recorded in this test).
The pharmacist employed directly was the main provider for larger hospitals having 
40 or more beds. On the other hand, the NHS hospital pharmacist was the main 
provider for small hospitals of less than 40 beds. Surprisingly, 8 hospitals with 40 or 
more beds received their pharmaceutical services either through a non-pharmacist or 
with a pharmacist involved merely as a supplier. (Note: the terms "smaller" and 
" larger " hospitals were used to distinguish between the two types of hospitals on the 
basis of numbers of beds but this does not necessarily mean that they are physically 
different in size).
A very highly significant difference was shown by the Pearson chi-square test (p= 
0.0001, df = 6). This implies that there is a difference in the distribution of service 
provider models between the two groups (i.e. small and large hospitals).
The Kruskal-Wallis One-way-Anova test corrected for ties also showed a very highly 
significant difference (p= 0.0001, df = 6).
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3.3.4. Numbers o f operating theatres.
The number of operating theatres in independent hospitals ranged from none to a 
maximum of 7. The modal value was 2 and the mean value was 1.9.
In order to find out the distribution of the service provider models among hospitals 
with different numbers of operating theatres, the numbers of theatres were cross­
tabulated with the person providing the pharmaceutical services. Table 3.11 shows the 
results.
Table 3.11. The numbers o f hospitals having different numbers o f operating 




















0 7 11 2 4 6 2 32
1 3 14 8 0 9 6 40
2 36 15 2 3 3 1 60
3 28 7 4 1 0 0 40
4 10 0 0 0 0 0 10
5 5 0 0 0 0 0 5
7 2 0 0 0 0 0 2
TOTAL 91 47 16 8 18 9 189
(Note: 3 missing cases were recorded for this test).
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As can be seen from Table 3.11, the NHS hospital pharmacist was the main provider 
of pharmaceutical services for those hospitals with no operating theatre or 1 operating 
theatre. In contrast, the directly-employed pharmacist was the main provider of the 
pharmaceutical services for those hospitals with 2 or more operating theatres. 
Surprisingly, 19 of the hospitals with 1 or 2 operating theatres received their 
pharmaceutical services through a non-pharmacist or with a pharmacist merely acting 
as a supplier. No hospitals with 4 or more operating theatres had a service other than 
one provided by a pharmacist who was employed directly.
A very highly significant difference was obtained from the Pearson chi-square test (p= 
0.0001, df = 36). This means that there is a difference in distribution of the service 
provider model with respect to the number of operating theatres in independent 
hospitals.
The Kruskal-Wallis test also showed very highly significant differences (p= 0.001, df 
= 6), indicating a definite statistical relationship between the number of operating 
theatres and the service provider model.
3.3.5. Comparison o f  the extent o f  services provision {"Comprehensive" or 
"Partial") and the hours o f  services provided per week.
According to the criteria defined previously in section 3.3.1., out of a total of 192 
independent hospitals, 130 (68%) of them received a comprehensive pharmaceutical 
service while 60 hospitals (32%) received only a partial pharmaceutical service. For 2 
of the hospitals, their responses did not allow us to interpret whether the service 
provided was "comprehensive” or "partial" because they did not answer the 
question about the range of pharmaceutical services provided in those hospitals. Also 
large number of respondents did not answer the question about the hours of 
pharmaceutical services provided by person(s) responsible for the provision of 
pharmaceutical service in independent hospital.
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Details available of the extent of pharmaceutical services provision 
("comprehensive" or "partial") and the service provider model were cross-tabulated 
against the available number of hours per week spent by the provider(s). Table 3.12 
illustrates the comparison of the number of hospitals having different hours of 
pharmaceutical services with a comprehensive or partial service and different service 
provider models. Very highly significant differences were obtained from a cross­
tabulation of the "comprehensive" services provided by the service providers with 
the number of hours per week, using the Pearson chi-square test (p= 0.0001, df = 25). 
Also very highly significant differences were obtained for the "partial" services 
provided by the service providers when cross-tabulated with the numbers of hours per 
week using the Pearson chi-square test (p= 0.0001, df = 30). These findings indicate 
that there are differences in distribution between the service provider model, the 
extent of the service provided and the numbers of hours per week spent by the person 
providing pharmaceutical services.
Of the 73 independent hospitals which received a pharmaceutical service for more 
than 40 hours per week, 2 hospitals received only a partial service which was provided 
by a pharmacist employed directly by the hospital. These 2 hospitals had no operating 
theatres but contained, in one case, 150 beds and, in the other, 287 beds assigned to 
rehabilitation and occupational therapy. Another hospital received partial services but 
from a non-pharmacist for between 30 and 39 hours per week; that also had no 
operating theatre but contained 160 beds. Surprisingly, 1 hospital with 96 beds and 4 
operating theatres, which received pharmaceutical services for only 5-15 hours per 
week, was considered to receive a comprehensive pharmaceutical service; that service 
was provided by a pharmacist employed directly by the hospital.
In only 1 hospital, did a NHS hospital pharmacist provide a comprehensive 
pharmaceutical service of more than 40 hours per week. That was the only reported 
involvement of a NHS hospital pharmacist in providing services to an independent 
hospital in excess of 30 hours per week.
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Table 3.12. Comparison o f the hospitals having different hours o f pharmaceutical services. and a comprehensive or partial range o f services, 
with respect to the different service provider models
Provider
Self-employed
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3.3.6. Pharmaceutical supplies.
All the hospitals reported that they relied on more than one source for obtaining their 
pharmaceutical supplies. Tables 3.13 and 3.14 illustrate, respectively, the different 
sources of supply which normally provided pharmaceutical supplies to the hospitals 
and also the main source used in cases of emergency.
As can be seen from Tables 3.13 and 3.14, the directly-employed pharmacists mainly 
relied on wholesalers and manufacturers for the pharmaceutical supplies to their 
hospitals, while the NHS pharmacists mainly obtained their pharmaceutical supplies 
through NHS hospitals. Community pharmacists providing pharmaceutical services 
under contract tended to obtain their pharmaceutical supplies through the community 
pharmacy. Overall, wholesalers, manufacturers and NHS hospitals are the main 
sources of pharmaceutical supplies to independent hospitals.
Table 3.13 shows that 22 hospitals without a pharmacist. Obtained pharmaceutical 
supplies from the pharmaceutical wholesaler or the manufacturer.
Table 3.14 shows that, in cases of emergency, a wider range of sources of supply is 
utilised. In particular, NHS hospitals, community pharmacists and other independent 
hospitals are much more likely to be approached than when supplies are obtained 
routinely. This is particularly true of the directly-employed pharmacists, the self- 
employed pharmacists and the non-pharmacists; all of these three groups are least 
likely to rely on a specific supplier for the provision of pharmaceutical supplies in the 
case of an emergency. The NHS hospital pharmacists, the community pharmacists, 
and the pharmacists who acted only as suppliers, relied frequently on their NHS 
hospital, or on their community pharmacy, for pharmaceutical supplies in an 
emergency. The main sources of pharmaceutical supplies to independent hospitals in 
emergency situations were stated to be NHS hospitals and community pharmacies 
through pharmacists who were directly employed still relied heavily on wholesalers in 
such circumstances.
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Directly Employed 85 18 62 6 7 0 1 0 0 179
NHS Hospital 6 46 2 9 0 0 0 1 1 65
Community Pharmacist 4 4 1 15 0 0 0 0 0 24
Self-employed Pharm. 4 4 4 2 0 0 0 0 0 14
Non-pharmacist 11 7 4 9 0 2 0 0 0 33
Supplying Pharmacist 5 7 2 5 0 0 0 0 0 19
TOTAL 115 86 75 46 7 2 1 1 1 334
(Note:- 6 missing cases were recorded for this test).





Table 3.14. The main source o f pharmaceutical supplies used by IHs in cases o f emergency:-
swarms? r  • -5 . Lie
1
Wholesaler NHS Manufacturer CP Another I.H. G.P. TOTAL
Directly Employed 64 76 2 63 54 0 259
NHS Hospital 4 46 0 16 6 1 73
Community Pharmacist 3 10 0 15 1 0 29
Self-employed Pharm. 3 6 0 5 2 0 16
Non-pharmacist 4 8 0 10 5 2 29
Supplying Pharmacist 1 8 0 5 2 0 16
Other 2 3 0 3 3 0 11
TOTAL 81 157 2 117 73 3 433
(Note: no missing cases were reported in this test).
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3.3.7. Issuing o f patients ’ medication on discharge from hospital.
In an effort to obtain an idea of how supplies of medicines were issued to patients 
immediately prior to their discharge from the hospital, respondents were asked 
(question 22-a) to state how these procedures were carried out in their hospital. Such 
medicines are commonly referred to as "medicines to be taken out" (TTOs). Many 
respondents indicated that more than one approach was employed for issuing TTO 
medicines to patients at the time of discharge. The results are shown in Table 3.15.
Table 3.15. Methods used to provide discharge medication in independent hospitals 
during the day and night:-
during the day during the night
In-house Pharmacist 101 (57.4%) 41 (25.5%)
NHS Hospital Pharmacy 32(18.2%) 26(16.1%)
Ready-Labelled Medicines 23 (13.1%) 55 (34.2%)
Community Pharmacist 22 (12.5%) 26 (16.1%)
Nurse 16(9.1%) 28 (17.4%)
Resident Medical Officer (RMO) 16(9.1%) 49 (30.4%)
Doctors/Consultants 2(1.1%) 7 (4.3%)
Emergency Cupboard 2(1.1%) 5 (3.1%)
Others 2(1.1%) -
TOTAL* 216 237
(Note: 16 missing cases were recorded from the responses for "during the day" and 
31 missing cases for "during the night".
* The total numbers exceed 100% as more than one procedure was reported by many 
hospitals especially for "during the night".
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It was recognised that some hospitals may set a limit on the quantity of each TTO 
medication issued to patients. In an effort to elucidate what limits are applied in 
independent hospitals, the questionnaire asked respondents for details (question 22-b). 
Of the 192 independent hospitals, 175 (91%) provided information. A number (69 = 
39.4%) of the independent hospitals had no limit for issuing TTO medications, but 78 
hospitals (44.6%) had a limit ranging from 5 to 14 days; of those, 46 set a limit of 7 
days. A further 28 (16%) of the hospitals stated that the decision was left to the 
prescribing physician and the pharmacist, (some pharmacists tended to make a 
decision on the basis of the available stock, otherwise no limits were applied). The 
remaining 17 hospitals did not give information and they were excluded from this 
analysis.
The respondents were also asked to state who provides advice to patients regarding 
their TTO medications (question 22-c). The responses indicated that usually more than 
one person was available in the hospital to do this. Mainly the matron or the nurse-in- 
charge had the responsibility to advise patients on their TTO medications; this was the 
case in 152 (48.3%) of the independent hospitals. In addition, in 106 (33.6%) of the 
hospitals, the pharmacist was contacted whenever possible to advise the patients. In 
35 cases (11.1%), the consultant was the person who dealt with advice on the 
medication, and the resident medical officer (RMO) was also involved in offering 
such advice in 22 cases (7%).
3.3.8. Out-vatient prescriptions.
Not all of the independent hospitals had an out-patient department and, in those cases, 
no out-patient prescriptions would be issued. For that reason, the question about how 
many out-patient prescriptions were dispensed per month was not answered by 51 
hospitals (question 23). The responses from the rest of the hospitals indicated that the 
average numbers of such prescriptions per month were as follows: between 2 and 10 
prescriptions for 42 of the hospitals; between 12 and 20 for 20, hospitals; between 24 
and 50, for 26 hospitals; between 60 and 100, for 27 hospitals; between 116 and 200, 
for 12 hospitals, and; between 201 and 1400 prescriptions, for 14 hospitals. Only in 3 
hospitals did the number of out-patient prescriptions exceed 1000 per month.
Page 93
CHAPTER 3 Service Providers Survey
3.3.9. Controlled Druss Licences.
A pharmacy registered with the Royal Pharmaceutical Society may hold stocks of 
Controlled Drugs for dispensing to patients. In those circumstances, no Controlled 
Drugs Licence is required. However, if the hospital needs to hold stocks of Schedule 2 
Controlled Drugs, other than in a registered pharmacy within the hospital, in most 
cases, the hospital requires a Home Office Licence held by a named person; this 
legislative requirement applies to all hospitals with the exception of those owned by 
charitable organisations. A separate licence is required for each Controlled Drug; the 
licence should be held by the person in-charge of the hospital.
The respondents to the questionnaire were asked to state the job title of the person 
who held the Home Office Licence in an effort to identify who had ultimate 
responsibility for Controlled Drugs in the independent hospital concerned (question 
24). Out of 114 hospitals for which responses were received to this question, the 
licence holders were as follows:- in 45 (39.5%) of the hospitals the licence was stated 
to be held in the name of the company which operated the independent hospital; in 30 
(26.4%) hospitals, the licence holder was one of the hospital directors (i.e. hospital 
manager, executive director, medical director); in 25 hospitals (21.9%), it was the 
matron, and; in 14 hospitals (12.3%) it was the pharmacy manager who held the 
licence.
Of the remaining hospitals, 38 hospitals did not hold a Home Office licence because 
they were considered as charitable organisations. In addition, 4 hospitals were not 
using Schedule 2 Controlled Drugs and 3 hospitals obtained their supplies of 
Controlled Drugs (CDs) from an NHS hospital as required -  in the latter situation, the 
CDs were ordered for named patients. A further 33 hospitals did not answer this 
question and, for the analysis, their responses were considered as missing.
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3.3.10. Registration o f the independent hospital pharmacy with the RPSGB.
All the hospitals with a pharmacy department (n=127) were asked (question 25) to 
state whether the pharmacy department was registered as a pharmacy with the Royal 
Pharmaceutical Society of Great Britain (RPSGB). The replies indicated that 55 of the 
hospital pharmacies were registered and 61 were not. The other 11 hospitals which 
had stated that there was a pharmacy department did not answer this question. The 
reasons stated by hospitals which had not registered are cited in Table 3.16.
Table 3.16. Reasons for not having resistered the pharmacy department with the 
RPSGB:-
No benefit or not required
ll |  ’Trexjfflncy£}\;,3 
15 27.3
Planning to register with RPSGB 12 21.8
Limited role (due to small no. of prescriptions) 10 18.2
No proper pharmacy department 7 12.7
No retail function 6 10.9
Hospital policy 3 5.5
No NHS prescriptions 1 1.8
No need (not important) 1 1.8
TOTAL 55 100%
(Note: 6 missing cases were reported for this question).
3.3.11. NAHAT recommendations and the employment o f pharmacists in IHs. 
The NAHAT Guidelines 10 make a certain number of recommendations with regard to 
the employment of pharmacists within independent hospitals. Broadly, these 
guidelines state that:- if  the hospital consists of less than 40 beds, and has no operating 
theatre, pharmaceutical advice regarding the appropriate level of service may be 
required. If the hospital consists of less than 40 beds but has one or more operating 
theatres, the services of a pharmaceutical department are needed, and if  the hospital 
has 40 beds or more, then the services of a pharmaceutical department are needed 
regardless of the number of operating theatres.
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In an effort to obtain a clear idea of the current situation with regard to the 
employment of pharmacists in independent hospitals, the number of operating theatres 
was cross-tabulated with the number of beds and with the service provider model as a 
controlling factor.
From the cross-tabulation of the service provider model for the hospitals having < 40 
beds, a slightly significant difference was obtained using the Pearson chi-square test 
(p= 0.0312, df = 18). A highly significant difference was obtained from the cross­
tabulation of the service provider model for hospitals having 40 beds or more (Pearson 
chi-square, p= 0.0015 and df = 36), which means that there is a difference between the 
service provider model for the hospitals having less than 40 beds compared with that 
for the hospitals having more than 40 beds with different numbers of operating 
theatres in the hospital.
Table 3.17 shows that 4 of the hospitals which, had no operating theatre, but 
nevertheless had more than 40 beds, received their pharmaceutical services through a 
non-pharmacist or had a pharmacist involved merely acting as a supplier. In addition, 
19 hospitals which had one or more operating theatres received their pharmaceutical 
services through a non-pharmacist or with a pharmacist involved only as a supplier. 
Thus, in total, 23 (12%) of the 186 hospitals for which specific information was 
provided would appear to have been failing to comply with the NAHAT guidelines. 
The findings of the previous study in this regard,11 showed that this number was much 
higher 1992; that is to say 51 (45.5%) hospitals, out of a total of 112 which responded 
to that previous survey, were not complying with the NAHAT guideline on 
employment of a pharmacist. This suggests that more hospitals now recognise the 
value of services provided by the pharmacist and have therefore been encouraged to 
employ such services.
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Table 3.17. Overall view o f the distribution o f the independent hospitals having different numbers o f operating theatres and 
different numbers o f beds (<40 & 40+) in relation to the pharmaceutical service provider model:-
0 1 2 3 4 5 7
<40 40+ <40 40+ <40 40+ <40 40+ <40 40+ <40 40+ <40 40+1 Direct|y 1 6 3 0 10 26 2 25 0 10 0 5 0 2
N H S
7 4 13 1 8 7 3 3 0 0 0 0 0 0cp 2 0 8 0 1 1 1 3 0 0 0 0 0 0p$fe|s e , f 1 2 0 0 2 1 0 1 0 0 0 0 0 0
f e H f e f a  SUB-TOTAL 11 12 24 1 21 35 6 32 0 10 0 5 0 2
None at all 4 2 7 2 2 1 0 0 0 0 0 0 0 0
9  Supply only 0 2 6 0 0 1 0 0 0 0 0 0 0 0
mm subtotal 4 4 13 2 2 2 0 0 0 0 0 0 0 0
TOTAL 15 16 37 3 23 37 6 32 0 10 0 5 0 2
(N.B. 6 missing cases were recorded in this test).
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3.4. Service provision by pharmacists and non-pharmacists within IHs:-
The independent hospitals were divided into two groups, in an effort to make 
comparisons between hospitals where the pharmaceutical service provision involved a 
pharmacist and those where it did not. The first group (Group I) included hospitals 
which had a pharmacist employed directly by the hospital, or a pharmacist contracted 
from an NHS hospital, or from a community pharmacy or as a self-employed 
pharmacist. The second group (Group II) included those hospitals where the service 
provision was by non-pharmacists, and where a pharmacist was involved only as a 
supplier. (Table 3.18).
Table 3.18. Hospitals with and without a pharmacist involved in service provision:-
Person Frequency %
Pharmacist (Group I) 165 85.9
Non-Pharmacist (Group II) 27 14.1
TOTAL 192 100%
3.4.1. Pharmaceutical services in hospitals with a pharmacist.
All of the 115 independent hospitals with either a pharmacist employed directly, or a 
pharmacist contracted to provide services in the hospital were asked (question 13) to 
specify the number of pharmacists and the number of other staff in the independent 
hospital pharmacy department (the numbers of staff in an associated NHS hospital 
pharmacy were excluded from this analysis because often there was no specific 
number of pharmacists or other staff allocated to be responsible for the provision of 
pharmaceutical service to the independent hospital). Of those hospitals, 84 (77%) have 
between 1 and 2 pharmacists providing the pharmaceutical services, 20 (18.3%) have 
between 3 and 4 pharmacists and 5 IHs (2.7%) have between 5 and 7 pharmacists. No 
information was supplied on behalf of 6 IHs with regard to the number of pharmacy 
staff within the pharmacy department.
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The minimum full-time-equivalent (FTE) reported in one hospital for the number of 
pharmacists was 0.10 and the maximum FTE was 5.60 with a mean of 1.28. 
Furthermore, 54 (88.6%) of the hospitals had between 1 and 2 pharmacy technicians 
and 7 (11.4%) of the hospitals had between 3 and 4 pharmacy technicians. The 
minimum full-time-equivalent (FTE) for the pharmacy technicians was 0.10 and the 
maximum was 4.0, with a mean of 0.93. In addition, 14 hospitals reported that they 
have other assistant staff and replies from 16 of the hospitals referred to other staff 
including a clerk, bank-staff, locums, etc.
In an effort to obtain information about the identity and credentials of the pharmacists 
providing pharmaceutical services in independent hospitals, the pharmacist, whether 
employed directly or contracted to provide pharmaceutical services from a community 
pharmacy or a self-employed pharmacist, were asked to state their qualifications and 
their job title (question 10). These are presented in Table 3.19.
Table.3.19. Qualifications and job title o f the pharmacists responsible for providing 
pharmaceutical services within IHs:-




2 u a l i f l c c  
M.Pharm.
. .  '■ ■ i t i o n s
Ph.D.
r - ~ * 
Diploma TOTAL
Pharmacy Manager 41 11 1 1 54
Pharmacist 17 2 0 1 20
Principal Pharmacist 11 1 0 0 12
Chief Pharmacist 11 0 0 0 11
Senior Pharmacist 3 0 0 0 3
Clinical Pharmacist 1 0 0 0 1
Superintendent Pharmacist 1 1 0 0 2
Other Title 5 1 0 0 6
TOTAL 90 16 1 2 109
(N.B. 6 missing cases were recorded from this test).
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Again, the NHS pharmacists have been excluded from this set of results because, in 
many cases, more than one NHS hospital pharmacist was involved in providing the 
pharmaceutical services and that made it difficult to characterise the "person(s)" 
providing the pharmaceutical service for a given hospital.
In response to the question concerning to whom the person responsible for providing 
pharmaceutical services reported (question 11), 80 (73.5%) of the respondents stated 
that they reported managerially to the "manager". The manager could be a hospital 
manager, executive manager, clinical manager, commercial manager or a unit 
manager. In 26 (23.8%) of the hospitals, the pharmacist reported to the matron and in 
the rest (2.7%), the reporting line was to some other person. Six respondents did not 
mentioned to whom they reported.
Of the 115 hospital pharmacists, 99 (88%) of them provided on-call services outside 
the pharmacy opening hours (question 12). The majority of the pharmacists (58) could 
be contacted both by telephone and by pager at such times. In other cases, the 
pharmacist could only be contacted by telephone (35 cases) or only by pager (6 cases). 
If the pharmacist could not be contacted for any reason, the alternative possibility for 
the provision of pharmaceutical services outside the pharmacy opening hours was that 
an authorised person(s) had access to the pharmacy. 100 respondents confirmed that 
more than one person had such authority. Table 3.20 illustrates the persons who were 
authorised to gain access to the pharmacy.
Table.3.20. Persons having access to the hospital pharmacy:
Persons Frequency %
Nurses and/or Matrons 69 45.1
Resident Medical Officers (RMO) 69 45.1
Pharmacists & Technicians 7 4.5
Clinical Staff 8 5.3
TOTAL 153* 100%
(Note. 16 missing cases were recorded from this set of data).
* The information was provided for 100 hospitals but in some cases more than one 
person had authority to gain access to the hospital pharmacy department.
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Some hospitals provided an emergency supply cupboard; 28 hospitals have such a 
facility for use if the pharmacist is not available, outside the pharmacy opening hours. 
More than one person had authority to access the emergency cupboard. Table 3.21 
describes those who had such authority.
Table.3.21. Persons havins access to the emergency supply cupboard in the 
hospitals which had such a facilitv:-
Persons 1- | it - S S - s c r - K ^ T s -
Nurses and/or Matrons 25 58.2
Resident Medical Officers (RMO) 11 25.6
Pharmacists & Technicians 4 9.3
Clinical Staff 2 4.6
Hospital Manager 1 2.3
TOTAL 43* 100%
(Note: 4 missing cases were recorded from this set of data).
* The information relates to 24 hospitals but in some cases more than one person had 
authority to gain access to the hospital pharmacy department.
The Association of Private Hospital Pharmacists (APHP) is an association which 
organises meetings and provides a forum and a voice especially for pharmacists 
working in the independent healthcare sector. The aim of the meetings is to discuss 
new topics of mutual interest and other topics related to the work of pharmacist in the 
private sector. Of the 115 pharmacists who were directly-employed or contracted for 
the provision of a pharmaceutical service, 70 (64.2%) stated that they were a member 
of this association; and, of those, 43 attended the association’s meetings and 27 stated 
that they did not (question 14). Various reasons for not attending meetings were given 
(Table 3.22) by 62 respondents, some of whom had stated that they did attend 
meetings and others who said they did not.
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Table.3.22. Reasons for pharmacists not attending theAPHP meetings:-
jy c _ c
fSti M1 ‘ WMMMzt IKS'- t «T 2’s,
Travel Distances Involved 41 38.7
Lack o f  Time 34 32.1
Lack o f  Resources 9 8.5
Preference fo r  other Meetings 9 8.5
No information available 3 4.8
Lack o f interest 2 1.9
Other Reasons 8 7.5
TOTAL 106 100%
(Note: 8 respondents did not indicate any reasons).
3.4.2. Pharmaceutical services provision in hospitals without a pharmacist. 
Certain independent hospitals reported that they received their pharmaceutical services 
through a non-pharmacist. Table 3.23 sets out the qualifications of the non-pharmacist 
responsible in those independent hospitals and the job titles that were cited in the 
survey responses (question 15).
Table.3.23. Qualifications and job titles o f the non-pharmacists reported to be 















* These data relate to 27 IHs, but in some hospitals, more than one person was 
responsible.
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Table 3.23 shows that in most cases, a matron or a nurse was the person with the 
principal responsibility for pharmaceutical services within those independent hospitals 
which had no pharmacist either employed or contracted to provide pharmaceutical 
services on a regular basis.
The majority of the non-pharmacists reported mainly to the manager (question 16); 
that person was either a hospital manager, an executive manager, clinical manager, 
commercial manager or a unit manager. The rest of the respondents reported to the 
nurse manager.
3.4.2.1. Visits by a pharmacist on a resular basis for the provision o f  
pharmaceutical advice or other services. in hospitals with no on-site pharmacist. 
Respondents to the questionnaire who were non-pharmacists were asked whether the 
hospital was visited on a regular basis by a pharmacist providing pharmaceutical 
advice or other services (question 17). This question was included in that section of 
the questionnaire for completion only by those hospitals with no pharmacist employed 
or contracted to work in the hospital. Nevertheless, 80 responses were obtained from 
both types of hospitals, that is to say both from those with a pharmacist contracted 
either from an NHS hospital or a community pharmacy and from those hospitals 
without a pharmacist at all. However, of the 80 responses, 49 (67%) indicated that the 
hospital received a regular visit from one or more of the following persons:-
• a community pharmacist
• a NHS hospital pharmacist
• a group pharmaceutical advisor.
3.4.2.1.1. Visits bv a community pharmacist.
13 hospitals received a regular visit by a community pharmacist. These visits ranged 
in frequency from 1 to 15 visits per week, the mean number of visits per week being 5 
and the mode being 4. The community pharmacists who were involved spent between 
1 and 7.5 hours per week at the hospital; the mean number of hours spent by the 
community pharmacist per week was 5 hours, as was the mode. All of these were 
hospitals where a non-pharmacist was responsible for providing pharmaceutical 
services.
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3.4.2.1.2. Visits bv a NHS hospital pharmacist.
35 hospitals received a regular visit by a NHS hospital pharmacist. These visits ranged 
from 1 to 8 visits per week, the mean number of visits per week being 3.3 and the 
mode being 1. The NHS hospital pharmacists spent from 1 hour per week to a 
maximum of 20 hours per week at the hospitals; the mean number of hours spent by 
the NHS hospital pharmacist per week was 5.6 and the mode was 5. Also all of these 
were hospitals where a non-pharmacist was responsible for providing pharmaceutical 
services.
3.4.2.1.3. Visits bv a Group Pharmaceutical Advisor.
Only 3 hospitals without a pharmacist received a regular visit by a group 
pharmaceutical advisor; in each case, that took place 5 times per week. The group 
pharmaceutical advisor spent in total 10 hours per week at each hospital providing 
pharmaceutical advice and other services.
3.4.2.1.4. Visits bv others.
Other responses to question 17 indicated that 7 hospitals without a pharmacist 
received a regular visit from some other person such as a pharmacist from another 
independent hospital, a wholesaler (for the purpose of supply), etc. These visits ranged 
from 1 to 10 visits per week; the mean number of visits per week being 3.8 and the 
mode being between 1 and 2. These other persons spent between 1 and 7 hours per 
week at the hospital, the mean number of hours being 3.5 hours per week and the 
mode being between 1 and 2 hours.
3.4.2.2. The provision o f  an "On-Call" advisory service bv a visiting 
pharmacist for hospitals without a vharmacist.
Question 18 was designed to be answered by those hospitals with no pharmacist on­
site. Nevertheless, as before, some of the hospitals with a contracted pharmacist also 
answered this question about the provision of an 'on call' advisory service.
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For 58 hospitals where pharmaceutical services were provided by non-pharmacists as 
well as by a contracted pharmacist (either from an NHS hospital or community 
pharmacy), the hospital received a regular visit for the provision of an "on-call" 
advisory service. These visits were provided either by a community pharmacist, a 
NHS hospital pharmacist, a group pharmaceutical advisor or by some other 
"advisor” . In only 48 cases did the visiting person provide an on-call service. If no 
person was available to visit the hospital regularly, and if there was any problem or 
query about medicines in those hospitals which had no pharmacist, one or more of the 
following could be contacted:-
• a NHS pharmacist in the case of 9 independent hospitals,
• a doctor or consultant in 8 hospitals,
• a community pharmacist in 8 hospitals,
• the RMO in 2 cases, and
• some other person in 2 hospitals.
The total exceeds the number of hospitals as many hospitals could contact more than 
one person in this situation.
3.4.2.3. The provision o f  an advisory service on a "dav-to-dav" basis for 
hospitals without a vharmacist.
Of the 80 hospitals where either there was no pharmacist present or the pharmacist 
was contracted from an NHS hospital or a community pharmacy, 69 hospitals 
confirmed that they received advice on a daily basis with regard to the drugs and 
medicines (question 19). In those hospitals without a pharmacist, such advice could be 
provided from one of the following sources:-
• 37 hospitals referred to the local NHS hospital pharmacists,
• 17 hospitals referred to community pharmacists,
• 9 hospitals consulted the prescribing doctor or the consultant for this service,
• 2 hospitals stated that the nurse carried out this function, and
• 4 hospitals indicated that this service is provided via either the group 
pharmaceutical advisor or the wholesaler.
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3.5. Nature o f services provided bv pharmacists and non-pharmacists responsible 
for pharmaceutical services within independent hospitals:-
3.5.1. Comprehensive and Partial Service.
The data for hospitals with and without a pharmacist (i.e. Group I and Group II 
respectively) were analysed to ascertain whether the services provided by these two 
groups of sendee provider had any effect on the range of pharmaceutical services 
available -  that is to say whether a partial or comprehensive service was available. 
Therefore, results in Table 3.18 were cross-tabulated with the type of service available 
in each independent hospital ( i.e. comprehensive or partial). Table 3.24 shows the 
results.
Table 3.24. Nature o f services provided by pharmacists and non-pharmacists
Comprehensive Partial TOTAL




A very highly significant result was obtained using Pearson chi-square test (p= 
0.0001, df = 1) meaning that the two groups are statistically different.
The Mann-Whitney test was also a useful test to apply here, to identify differences 
between the two groups. A very highly significant difference (p= 0.0001) was also 
obtained in that test, indicating a statistical difference between the two groups of 
providers in terms of the extent of service provision.
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3.5.2. Hospital bed numbers and the presence o f a pharmacist.
The numbers of hospitals in each group, that is with or without a pharmacist, were 
cross-tabulated with hospital bed numbers expressed as hospitals with less than 40 
beds and those with 40 beds or more (Table 3.25).
Table 3.25. Service provision bv a pharmacist and a non-pharmacist related to the 
hospital bed number:-
T & * W fftih & r.
g n m a a * Less than 40 Beds 40 Beds or more TOTAL
Pharmacist 63 (39.1%) 98 (60.9%) 161
Non-Pharmacist 19 (70.4%) 8 (29.6%) 27
TOTAL 82 106 188
(Note: 4 missing cases were recorded for this test).
A highly significant difference was obtained using the Pearson chi-square test (p= 
0.0025, df = 1). This means that there is a statistical difference between the hospitals 
with less than 40 beds and those with 40 or more beds when considered in relation to 
the likelihood of pharmaceutical services being provided by a pharmacist or a non­
pharmacist.
The Mann-Whitney test is useful to apply here to confirm the differences between the 
two groups of hospitals. A very highly significant result (p= 0.0001) was obtained 
here, indicating that there is a statistically significant relationship between the two 
factors.
3.5.3. Number o f hospital operating theatres and the presence of a pharmacist. 
The pharmacist and non-pharmacist groups were cross-tabulated with the number of 
operating theatres in an effort to find out the distribution of numbers of operating 
theatres in hospitals with a pharmacist and those without (Table 3.26).
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Table.3.26. Service provision bv a pharmacist and by a non-pharmacist in hospitals 
with different numbers o f oyeratins theatres
^ S i l i - 0 1 2 3 4 5 7 TOTAL
Pharmacist 24 25 56 40 10 5 2 162
Non-Pharmacist 8 15 4 0 0 0 0 27
TOTAL 32 40 60 40 10 5 2 189
(Note: 3 missing cases were recorded in this test).
From the results in Table 3.26, it can be seen that, in general, pharmacists were 
involved in providing pharmaceutical services in hospitals ranging from those with no 
operating theatre to those with seven. On the other hand, although non-pharmacists 
were not involved in hospitals with 3 or more operating theatres, surprisingly, they 
were found responsible for the pharmaceutical services in a number of hospitals with 
1 and 2 operating theatres as well as in several hospitals with no operating theatres.
A very highly significant result (p= 0.00001, df= 6) was obtained from the Pearson 
chi-square test, which means that there is a significant relationship between the 
number of operating theatres and whether a pharmacist or non-pharmacist provides 
the pharmaceutical services in independent hospitals. The Mann-Whitney test was 
also applied here, a very highly significant result (p= 0.0001) being obtained.
At it was mentioned before, NAHAT recommends that hospitals with less than 40 
beds and no operating theatres, pharmaceutical advise is needed. On the other hand, 
hospitals with less than forty beds and with an operating theatre, the service of 
pharmacy department is needed and hospitals with 40 beds or more (regardless the 
existence of operating theatre) the service of pharmacy department is also needed. On 
this basis, pharmacist and non-pharmacist group were cross-tabulated with hospitals 
having less than 40 beds and no operating theatres with those hospitals either having 
less than 40 beds or 40 beds or more but having an operating theatre. Table 3.27 
shows the results.
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Table 3.27. Level o f compliance with NAHAT 2uidelines with resard to the 
employment o f  a pharmacist in independent hospitals.
S i p
< 40 beds 
No operating Theatre
< 40 beds and 40 beds or more 
and 1 ^ operating theatre
TOTAL
Pharmacist 11 148 159
Non-pharmacist 4 23 27
TOTAL 15 171 186
(Note: 6 missing cases were recorded in this test).
As can be seen from Table 3.27, only 4 hospitals with less than 40 beds and with no 
operating theatre did not employ the services of a pharmacist. On the other hand, the 
rest of hospital (23) with either less than 40 beds or 40 beds or more but having 1 or 
more operating theatres did not employ a pharmacist contrary to the NAHAT 
guidelines.
3.6. Policies related to the use o f medicines within IHs.
3.6.1. The Hospital Formulary.
A hospital formulary can be a valuable guide for use by medical practitioners, 
pharmacists, dentists, nurses, and others who are dealing with healthcare provision.
The use of such a formulary especially where no pharmacist is available to give advice 
on medicines, would appear to be essential. Each hospital surveyed was asked about 
the availability o f such a formulary and its origin (question 26). Of the 192 hospitals 
surveyed, 60 hospitals used a formulary and 124 hospitals did not. Eight hospitals did 
not answer this question. Of the 165 hospitals with a pharmacist, only 50 (30%) 
hospitals had a formulary in use while, of the 27 hospitals without a pharmacist, 10 
(37%) of the hospitals had a formulary in use (Table 3.28).
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Table 3.28. The effect o f the presence o f a pharmacist and non-pharmacist on the 
use o f a formulary within IHs.
Formulary Pharmacist (Group I) Non-pharmacist (Group II) TOTAL
Yes 50 10 60
No 111 13 124
T O T A L 161 23 184
(N.B. 8 missing cases were recorded in this test).
Some hospitals produced their own formulary and others relied on the formulary 
issued by a local Health Authority. Of the 60 hospitals with a formulary in use, 57 of 
them stated the origin of the formulary in use. Of those, 31 hospitals (54.4%) used a 
local Health Authority formulary, 12 hospitals (21%) used their own hospital 
formulary, 4 hospitals (7%) used another hospital’s formulary, 2 hospitals (3.5%) used 
a formulary issued by the hospital group or company, and, 8 hospitals used a 
formulary from some other source.
3.6.2. Antibiotic Policy.
According to the British National Formulary (BNF) 26 many Health Authorities now 
restrict the antibiotics that may be used in NHS hospitals in their locality, in order to 
achieve reasonable economy, consistent with adequate treatment cover, and to reduce 
the development of resistant organisms. The Health Authority may indicate a range of 
drugs for general use, and permit treatment with other drugs only on the advice of the 
microbiologist or physician responsible for the control of infectious diseases.
As a result of the common practices whereby certain staff from the NHS hospital may 
also work at independent hospitals, the transfer of drug resistance may be a problem. 
All independent hospitals in the survey were asked if they have a policy for the 
prescribing of antibiotics (question 27). Only 42 (21.9%) of the 192 hospitals have 
such a policy, while the majority of the hospitals 146 (76%) have not. In addition, 4 
hospitals (2.1%) did not give any answer. Of the 165 hospitals with a pharmacist, 35 
hospitals (22%) had an antibiotic policy in use, while of the 27 hospitals without a 
pharmacist, 7 hospitals (26%) had an antibiotic policy in use. Table 3.29 shows the 
results.
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Table 3.29. The effect o f the presence o f a pharmacist and non-pharmacist on the 
existence o f  an antibiotic policy within IHs.
r — -  s
AM bioticpolicy * Pharmacist (Group I) Non-pharmacist (Group II) TOTAL
Yes 35 7 42
No 127 19 146
T O T A L 162 26 188
(N.B. 4 missing cases were recorded in this test).
Of the 42 hospitals with a policy for the prescribing of antibiotics, 37 hospitals gave 
the procedures adopted when an antibiotic is prescribed. The various procedures were 
as follows: 13 hospitals used the NHS written procedure, 21 hospitals stated that there 
was no policy as such but this would depend on the prescriber and the pharmacist as 
well as the pathologist’s decision. Three hospitals referred to other procedures.
3.6.3. Use o f brand-name or generic vharmaceutical products.
Where non-proprietary ('generic') names exist, it is common practice in NHS 
hospitals to use these when a medicine is prescribed. This enables any suitable product 
to be dispensed thereby, according to BNF 26 /'saving delay to the patient and 
sometimes expense to the health service". One exception to the use of generic names 
is where bio-availability problems are known to be so important that the patient 
should always receive the same brand; in such cases, the brand name or the 
manufacturer should be stated. On the basis of such recommendations and concerns, 
the independent hospital survey included a question as to which products were usually 
supplied (question 28).
Out of 192 hospitals, the majority (165=86%) used both brand-name and generic 
products, while 16 (8.3%) of the hospitals used only generic products and 10 (5.2%) 
hospitals used only brand-name products. In addition, at one hospital, the respondent 
(supposedly the person with responsibility for provision o f pharmaceutical services) 
did not know whether brand-name or generic products were being used.
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Whether the hospital was using branded or generic products, the respondents were 
asked to state how they decided which product to use (question 29). Many respondents 
stated that more than one factor was taken into account in reaching such a decision. 
Table 3.30 illustrates the different factors which determine which pharmaceutical 
products are used. As can be seen from Table 3.30, the responses stated different 
factors for procurement of medicines including: preference of the consultant, cost, 
availability. From these responses, it was not possible to ascertain whether the 
respondents felt that the quality of the product was an important factor. Thus, only 11 
responses indicated that the quality of the product is a factor. If the hospital had a 
pharmacist, who was responsible for purchasing medicines, he/she might be expected 
to be more concerned with quality and to be more aware of the potential problems of 
lack of bio-equivalence between generic and brand-named products and between 
different generic manufacturers.
Table 3.30. Factors involved in reaching a decision whether to use brand-name or 
generic pharmaceutical yroducts:-
The price o f the product 63 38.7
NHS pharmacy department experience 31 19.0
The doctor/consultant decision 25 15.3
The group policy 25 15.3
Availability of the product 21 12.9
Pharmacy department decision 18 11.0
The wholesaler’s advice 17 10.4
Company pharmaceutical advisor’s decision 13 8.0
The quality of the product 11 6.7
Community pharmacist’s advice 9 5.5
The preference of the product 7 4.3
Company purchasing pharmacist 5 3.1
TOTAL 245
(Note:- 29 missing cases were recorded for this question).
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As a continuation of this question, a further question was asked about the use of 
parallel-imported medicines (question 30). A large number of hospitals (71.5%) did 
not use such products while 6% of the hospitals stated that they did use parallel- 
imported medicines. In addition, 22.5% of the respondents did not know whether 
these products were used in their hospitals or not. Respondents at those hospitals 
which did not use such products stated that they adopted special procedures to avoid 
counterfeit and/or sub-standard products. They relied on their pharmacy department to 
decide whether or not to use such products, or they consulted the NHS pharmacy 
department for advice. Some hospitals stated that they used these product because it 
was part of their company policy and, finally, the supplier’s experience was being 
used by some hospitals as a source of advice.
3.6.4. Product Recall - Medicines Warnims.
In the event of any product being withdrawn or recalled for some reason, a notification 
of product recall or medicines warning is normally issued from the Department of 
Health and/or by the pharmaceutical manufacturer concerned. In an effort to identify 
whether the hospitals surveyed received such warnings and how they were received, a 
question was asked about these warnings (question 32). Almost all the 192 hospitals 
(189 = 98.4%) stated that they received notices issued by the Department of Health 
and/or by the pharmaceutical manufacturer in this regard. Only 1 hospital, with 20 
beds and where the service provider was a pharmacist employed directly and 
providing a comprehensive service, reported that they did not receive such notices. 
That deficiency is clearly a cause for concern. No answer to this question was given 
by 2 hospitals; one of them has 35 beds and has a pharmacist employed directly 
providing a comprehensive service, and the other has 17 beds and its service provider 
is an NHS hospital pharmacist providing a partial service. The lack of response from 
those two hospitals is also of concern. Of the 189 responses, 182 hospitals indicated 
that they received these notifications from more than one source. Table 3.31 shows the 
different sources from which the hospitals received information.
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Table 3.31. Origins o f information received bv IHs on Product Recalls and 
Medicines Warnines:-
Health Authority/Health Office/Commissioning Agency 89 48.9
NHS Hospital 61 33.5
Corporate Office 38 20.9
District Pharmaceutical Officer (DPhO) 25 13.7
Independent Healthcare Association 21 11.5
Pharmaceutical Manufacturer 6 3.3
This Hospital (i.e. the hospital surveyed) 5 2.7
Medicines Control Agency 5 2.7
National Drug Information Centre 4 2.2
Community Pharmacist 4 2.2
Nursing Home Inspectorate 2 1.1
TOTAL 260
(Note:- 10 missing cases were recorded from this test).
Once a hospital receives such a notice, there should be a person responsible to take 
action in response to the notice. Survey responses showed that responsibility for 
action lay with:- the pharmacy manager in 91 (49%) of the hospitals; the hospital 
Matron or the Nurse director in 58 (31.2%) hospitals; a hospital director (e.g. hospital 
director, executive director, clinical director, operations director) in 24 (13%) of the 
hospitals; a NHS hospital pharmacist in 5 (2.7%) of the hospitals, and; other persons 
in 8 (4.3%) hospitals. In 6 cases the respondent did not mention who co-ordinated 
such action in the hospital.
3.6.5. Costins o f medicines for individual patients.
Most of the 192 hospitals (122 = 63.5%) calculated the cost of medicines administered 
to individual patients, while 61 hospitals (31.8%) reported that they did not. In 
addition, the respondent at 4 (2.1%) hospitals did not know whether such calculations 
are made in their hospital or not, and 5 hospitals did not answer this question 
(question 31).
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Those hospitals which stated that they calculated the cost of medicines (122) were 
also asked to indicate whether these calculations were used for any additional cost 
analyses such as costing of procedures carried out by different consultants. Of those, 
55 (45%) hospitals stated that this was the case and that all the procedures were 
written either in the form of a chart or as a comprehensive report including the 
medicines costs and invoiced to the individual patients. In addition, 4 (3.3%) of the 
hospitals stated that they issued invoices or reports because the patient’s insurance 
company required such a report. Five (4.1%) hospitals reported that private patients 
were only charged specifically for the TTO medicines. Furthermore, 19 (15.6%) 
hospitals stated that they did not add any additional costs (i.e. only the fixed price of 
each item was charged) and, 14 (11.5%) hospitals made a fixed charge for medicines 
for every patient.
Those hospitals that did not calculate the actual cost of medicines for a particular 
patient were asked to state how the medicines administered to individual patients were 
charged to the patients in their hospitals. Nearly half of those hospitals fixed a daily 
rate for any patient (charitable hospitals), some others charged medicines per use, 
some charitable hospitals only charged for high cost medicines, and some hospitals 
issued an invoice for the cost of medicines only. In 5 responses it was stated that the 
patient’s insurance company is responsible for paying the cost of medicines and they 
calculate the cost for this purpose. In addition, 12 hospitals reported that they made no 
charge for medicines at all.
3.7. Inspections of the Independent Hospitals.
NAHAT recommends 10 that the statutory minimum requirement of 2 inspections of 
an independent hospital each year should be increased to 4 where there is no 
pharmacist present in the hospital. Such inspections, undertaken by Health 
Authorities, in the past have involved Senior Pharmacists such as the District 
Pharmaceutical Officer (DPhO) and/or the Community Services Pharmacist (CSP). 
Other inspections may be undertaken by persons such as the Royal Pharmaceutical 
Society Inspector, Home Office Inspector etc. though those inspections are not 
included in the statutory inspections that a Health Authority is required to carry out.
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The inspection of pharmaceutical services was raised in question 33. Replies 
confirmed that independent hospitals were inspected by the following:
• District Pharmaceutical Officer (DPhO) or the equivalent Senior Pharmacy 
Manager
• Community Services Pharmacist (CSP)
• Royal Pharmaceutical Society Inspector
• Home Office Inspector.
3.7.1. Inspection bv the District Pharmaceutical Officer (DPhO).
Replies indicated that the DPhO or their equivalents Senior Pharmacy Managers 
(SPMs) was visiting 118 (61%) hospitals; the number of his/her visits ranged from 1 
to 4 per year. 1 visit per year was made to 43 (40%) hospitals and 2 visits per year to 
52 (48.5%) of the hospitals. In addition, 3 visits per year were made to 7 (6.5%) 
hospitals and 4 visits to only 5 (5%) hospitals.
Table 3.32 illustrates the number of visits being undertaken by a DPhO/SPM to 
hospitals representing different service provider models.
Table.3.32. Visits bv the DPhO/SPM to hospitals representins different 
pharmaceutical service provider models:-
Pharmaceutical Services Provider Model
Visits by 
DPhO . '
l : * ; . '




25 9 2 1 4 2 43
21 13 6 2 7 3 104
? 3 1 1 2 0 0 21























(Note: 11 missing cases were recorded for this question).
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3.7.2. Inspection bv the Community Service Pharmacist CSP.
CSPs visited 63 hospitals (33%);the number of his/her visits ranged from 1 to 6 per 
year. Of those, 23 (41%) hospitals received 1 visit only and 29 (52%) hospitals 
received 2 visits per year. In addition, 3 hospitals (5%) received 4 visits per year and 1 
hospital received 6 visits per year; 3 of those hospitals received their pharmaceutical 
services from a community pharmacist contracted to provide the service and the other 
hospital had a non-pharmacist providing the service with a pharmacist involved only 
in a supply function. Table 3.33 illustrates the number of visits being undertaken by 
CSPs in hospitals with different providers of the pharmaceutical service.
Table.3.33. Visits bv CSPs to hospitals representing different vharmaceutical 
service provider models:-
Pharmaceutical Services Provider Model 1
TOTAL no. 





34 cases 7 cases 6 cases 3 cases 3 cases 3 cases 
TOTAL =54 =9 =19 =6 =5 =6 




(Note: 7 missing cases were recorded for this question).
3.7.3. Inspection bv the Royal Pharmaceutical Society.
The Royal Pharmaceutical Society’s Inspectors were involved in inspection of 30 
(15.6%) of the hospitals; of those, 27 hospitals stated the number of such inspections. 
The Society’s inspection visits ranged in number between 1 and 2 visits per year. Of 
those, 25 (93%) hospitals received 1 inspection visit per year and, only 2 (7%) of the 
hospitals received 2 inspection visits per year. Table 3.34 illustrates the number of 
visits being undertaken by the RPSGB Inspectors in hospitals with different service 
provider models.
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Table.3.34. Visits bv the RPSGB Inspector to independent hospitals representing 
different pharmaceutical service provider models:-
(Note: 3 missing cases were recorded for this question).
TOTAL no, 





It is noticeable that no inspection visits were made by the RPSGB Inspectors to 
hospitals where a non-pharmacist was responsible for the pharmaceutical services nor 
to those hospitals where a community pharmacist was contracted to provide the 
services.
The fact that RPSGB Inspectors would appear not to be in the habit of visiting 
independent hospitals where no pharmacist is involved in the provision of 
pharmaceutical services would tend to skew the total overall numbers of all 
inspections towards the independent hospitals with a pharmacist present. For that 
reason, and also because it is statutory inspections that are relevant to the NAHAT 
guidelines, it is appropriate to repeat the statistical analyses using only the total 
numbers of inspections by DPhOs and CSPs (Table 3.35).
Pharmaceutical Services Provider Model













CHAPTER 3 Service Providers Survey
Table.3.35. Visits bv DPhOs and CSPs to hospitals representing different 
pharmaceutical service provider mo dels
Pharmaceutical Services Provider Model
Visits by 
DPhO & 
CSP 27, H i Model 4 H K TOTAL













b i s 3(1.5%) 11 ( 1 %) 1(1%) 2(1% ,_ 0 0 7(4.5%)




























(N.B. the given percentages are rounded to allow easy comparison).
Table 3.35 shows a significant difference between the service providers as regards the 
total number of visits undertaken by either the DPhO or the CSP. The Pearson chi- 
square test shows a statistically significant relationship between the combined number 
of visits undertaken by the DPhO and the CSP and the service provider model 
(p=0.01, df=20).
The Least Significant Difference test (LSD) showed significant differences (p=0.0002) 
between service provider models for the combined number of visits undertaken by the 
DPhO and the CSP, especially when comparing the directly-employed or NHS- 
contracted pharmacist with a community pharmacist (Model 3) or when a pharmacist 
was not even involved in supply (Model 6). The more stringent Bonferroni test 
confirmed significant differences between Model 3 and Models 1, 2 and 5. Table 3.36 
shows where the significant differences lie according to LSD and Bonferroni tests.
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Table 3.36. Service provider models which show significant differences usins LSD 
and Bonferroni tests according to the combined number o f  visits undertaken bv the 




















3,6 3,6 1,2,4,5 3 3 1,2
3 3 1,2 ,5 - 3 -
The NAHAT guideline10 recommend that where a pharmacist is employed in an 
independent hospital, the statutory minimum of 2 inspections per year should be 
carried out. However, where no pharmacist is employed, it is recommended that 
inspections be undertaken quarterly. So information obtained from Table 3.35 was 
used to compare the two groups of hospitals i.e. those hospitals with a pharmacist and 
those without. Table 3.37 illustrates the inspection visits of the DPhO and the CSP to 
hospitals with and without a pharmacist.
Table 3.37. Visits bv DPhOs and CSPs to hospitals with and without a pharmacist:-
Hospital Type
No. o f Visits 1 TOTAL
57 9 66
(35%) (5%) (40%)











(6%)■HI 1d%) 0 1_ (1 %)
TOTAL 140 cases 23 cases 163 cases
=246 visits =41 visits = 287 visits
(N.B. the given percentages are rounded to allow easy comparison).
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As can be seen from Table 3.37, 57 hospitals with a pharmacist and 9 hospitals 
without a pharmacist received only 1 visit per year. 69 hospitals with a pharmacist 
received only the minimum statutory number of 2 inspection visits per year. 
Interestingly, 1 hospital with a pharmacist received up to 6 visits per year. Only 2 
hospitals without a pharmacist received the recommended number of inspection visits 
i.e. 4 visits per year. In total, 21 hospitals without a pharmacist received fewer than the 
number of visits recommended by NAHAT. Table 3.37 also shows no significant 
differences between the pharmacist and the non-pharmacist groups in the total number 
of inspection visits undertaken by both the DPhO and the CSP. Neither the Least 
Significant Difference test (LSD) nor the Bonferroni test showed significant 
differences between the pharmacist and non-pharmacist groups.
The combined numbers of inspection visits made by the DPhO and the CSP were also 
cross-tabulated with hospitals grouped on the basis of those with less than 40 beds and 
those with 40 beds or more, in order to obtain information on how frequently the 
different hospitals were officially inspected by either the DPhO or the CSP. No 
significant differences were obtained, using the Pearson chi-square test, between the 
hospitals with less than 40 beds and those with 40 beds or more. Table 3.38 illustrates 
the numbers of statutory inspection visits made to hospitals with less than 40 beds and 
to hospitals with 40 beds or more. In both cases the modal number of visits was 2.
Table 3.38. Combined number o f inspection visits per year made bv the DPhO and 
the CSP to hospitals with less than 40 beds and hosvitals with 40 beds or more:-
< 40 Beds 40+ Beds TOTAL
S ' ,  ' y  *Srf‘'S»J'»v rVfS!w
m
1 23 (15%) 31 (20.5%) 54 (35.5%)
2 31 (20.5%) 49 (32%) 80 (52.5%)
3 4 (2.5%) 4 (2.5%) 8 (5%)
4 6 (4%) 3 (2%) 9 (6%)
6 1 (1%) 0 1 (1%)






(Note: 12 missing cases were reported for this test).
Page 121
CHAPTER 3 Service Providers Survey
A possible relationship between the frequency of statutory hospital inspection visits 
made by the DPhO and CSP and the number of operating theatres was also 
investigated. The number of visits by the DPhO and CSP were cross-tabulated with 
the number of operating theatres (Table 3.39). No significant differences were 
recorded using the Pearson chi-square test which means that the frequency of 
inspection visits by DPhO and CSP is not related to the number of operating theatres. 
Again in all cases the modal number of visits was 2.
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Table 3.39. Number o f inspection visits per year to hospitals with different numbers o f  operatin2 theatres:-
0 1 2 3 4 5 7 TOTAL
1 5 11
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(Note: 11 missing cases were recorded for this test).
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3.7.4. Inspection by Home Office Inspectors.
Hospitals possessing Home Office Licence for Schedule 2 Controlled Drugs were 
usually visited by Home Office inspectors. The Home Office Inspectors visited 89 
(46%) of the hospitals; his/her visits ranged in number from 1 to 3 visits per year. Of 
those, 65 (77%) hospitals received only 1 visit and 14 (17%) hospitals received 2 
visits (i.e. 28 visits in total) while 4 (6%) hospitals received 3 visits per year (i.e. 12 
visits in total). Table 3.40 illustrates the number of visits undertaken by the Home 
Office Inspectors to hospitals representing different service provider models.
Table 3.40. Visits by the Home Office inspectors to hospitals representing different 
pharmaceutical service provider models:-
Pharmaceutical Services Provider Model
Home Office


























3.7.5. Inspection by Others.
Other official inspections of independent hospitals were being undertaken by bodies 
such as:- Police, Fire service, Health & Safety, etc. As those inspection visits were not 
directly related to the pharmaceutical services, they were excluded from the analysis.
3.8. Perceptions o f  the pharmaceutical service providers with resard to inspection:-
The person in charge of provision of the pharmaceutical services in each independent 
hospital was asked to indicate their perception of the inspection process(question 34). 
Table 3.41 illustrates the different perceptions of the providers.
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Table 3.41. Purpose o f the inspection visits as perceived by the providers o f  the 
pharmaceutical services (n=l 79):-








(Note: 13 missing cases were recorded for this question).
* This term was not one offered as a possible perception in the wording of the 
questionnaire, but was used by several respondents.
** Respondents gave more than one response in some cases.
As can be seen from table 3.41, 50% of the comments (140 of 279) indicated that the 
respondent regarded the Health Authority inspections in an advisory way, as a service 
provided by the inspector. Similarly, 11 respondents (6%) regarded the inspections as 
supportive and beneficial for the person responsible for providing the pharmaceutical 
service. On the other hand, 123 (44%) of the comments indicated a recognition that 
the inspection visits are a formed enforcement of the standards required by the Health 
Authority. Five of the responses (2%) referred to the respondent’s perception of the 
visits as "snoopy" which, it is assumed, reflected concern about the objectives of the 
Health Authority and, in particular, of the inspecting pharmacist. It should be noted 
that the percentages in table 3.40 exceed 100% as many respondents gave more than 
one answer.
3.9. Desirable qualities o f the person providing the pharmaceutical services
According to the NAHAT guidelines 10, the person in charge of providing 
pharmaceutical services in independent hospitals should be familiar with and observe 
the statutory requirements and should make adequate arrangements concerning several 
aspects of medicines held and administered in the hospital.
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Respondents were asked to identify the desirable qualities of a person responsible for 
the provision of pharmaceutical services in independent hospitals (question 36). The 
most desirable 5 key qualities were sought and respondents were asked to rank those 
desirable qualities on a scale of:- 
1. (least important) to 5. (most important).
The responses were cross-tabulated with the service provider model represented by the 
actual respondent. No significant differences were found between the qualities 
perceived as desirable and the service provider concerned.
Table 3.42 illustrates the qualities perceived to be desirable in the person providing 
the pharmaceutical services in independent hospitals. As can be seen, 64 out of 148 
pharmacists and 8 out of 15 non-pharmacists placed most important emphasis on 
"knowledge of clinical use of medicines". Only 19 out of 74 pharmacists and 1 out of 
9 non-pharmacists have placed most important emphasis on "knowledge of safe 
handling of parenteral/cytotoxic drugs". In addition, 53 out of 136 pharmacists and 3 







Table 3.42. Personal attributes perceived to be desirable in persons providing pharmaceutical services in independent hospitals. The 
perceptions are those o f the service provider shown in column 2




Knowledge of Clinical 
Use o f Medicines
Networks o f Pharm. 
Contacts
Ability to Interact with 
Other People
Safe Handling of 
Parenteral/Cytotoxic Drugs
Knowledge o f Pharm. 
Legislation
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3.9.1. Training/continuing education o f the pharmaceutical services provider. 
Continuing education and training should allow all aspects of the pharmaceutical 
service to be maintained and developed and enable the person providing the 
pharmaceutical service to play an active role in educating other health-care 
professionals.
All the persons in charge o f pharmaceutical services were asked if they had 
undertaken any training or continuing education programs (question 35). Out of 192 
respondents, 126 (66%) had undertaken training or continuing education programs. In 
an effort to investigate what kinds of programs they had followed, all the respondents 
who responded affirmatively were asked to state what kinds of topics they had studied 
and the approximate hours of training or continuing education they had undertaken 
during the past 12 months. Table 3.43 illustrates the different topics involved and the 
average number of hours for training and/or continuing education programs.
Table 3.43. Hours o f training/continuing education undertaken by the verson 
providing pharmaceutical services in independent hospitals (n=126)
Hours o f  Training/Continuing 
Education Programs
TOPICS No. o f Cases V M M un?
... 1
87 1 100 99 27.5
61 2 240 238 31
Financial; r f lR f  }&& 'r 1 35 1 150 149 15
Safety |
67 1 50 49 8
22 1 50 49 11
S j | p f  I
13 2 90 88 24.4
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3.9.2. Professional liaison.
The respondents were asked to state if they had frequent contact with individual 
medical consultants and the frequency of such contact. 115 respondents (62%) stated 
that there was frequent contact with consultants while 65 (35%) stated that such 
contact did not occur in their hospital. Surprisingly, 5 respondents did not know 
whether there was contact or not. Of the 115 respondents who stated that there was 
contact with individual consultants, 68 had contact with a consultant at least once a 
week and, of these, 2 respondents had contact up to 50 times a week, the mean 
number of times quoted being 7.4.
Several kinds of topics were reported to be usually discussed during such meetings 
with different consultants. Examples were as follows:
• 103 cases referred to discussions about drug therapy.
• 34 cases related to drug expenditure.
• 22 cases dealt with procurement of medicines.
• 11 cases referred to discussions about new drugs.
• 3 cases referred to discussions of case studies relating to individual patients.
• 3 cases concerned general topics, for example regarding developments in the NHS.
3.10. Quality of pharmaceutical services as self-assessed by the person providing the 
service:-
The person providing the pharmaceutical services in each independent hospital was 
asked to make an assessment of the quality of various aspects of the pharmaceutical 
services in their hospital. The question required the person in charge of the 
pharmaceutical services to rate the quality of 12 specified pharmaceutical service 
criteria using one of the following five levels of assessment:- very poor, poor, 
satisfactory, good, very good. This information was used to determine whether there 
were any differences in the perceived quality of the different services in different 
hospitals for example those representing different service provider models.
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The number of responses varied for the 12 different service criteria, dependent in part 
on the number of hospitals where that specific pharmaceutical service was provided.
For 9 of the service criteria, in hospitals with a pharmacist, the average number of 
assessments provided in the responses to the questionnaire was 142 (range 125-150). 
For the other 3 criteria (TV additives, cytotoxics reconstitution and specialised 
production of medicines) in those hospitals, the average number of assessments 
reported was 84 (range 75-90). In contrast, for the hospitals without a pharmacist, the 
average number of assessments for 8 of the service criteria was 20 (range 16-23) and 
for the remaining 4 criteria (ward visits to advise patients, reconstitution of IV 
preparations, cytotoxics reconstitution and specialised production of medicines) was 
10 (range 7-14).
Table 3.44 illustrates the quality assessments as self-assessed by the person providing 
the pharmaceutical services in the independent hospitals with and without a 
pharmacist.
Analysis of the quality assessments, made by the persons providing pharmaceutical 
services, using cross-tabulation of the data coupled with the Pearson chi-square test 
showed no significant differences (p> 0.05) in assessments between hospitals with and 
without a pharmacist for 11 of the service criteria. The only significant difference 
were obtained for "disposal of medicines" (p=0.0365) which is considered as a 
marginally significant difference.
Page 130
CHAPTER 3 Service Providers Survey
Table 3.44. Number o f ASSESSMENTS of the quality o f  various elements o f  
pharmaceutical services provision, in hospitals with and without a pharmacist, as 
self-assessed by the person providing the pharmaceutical service
Assessmen
I - 1f 1 H 1 mm - llllll mmm












Stock control of 
drugs/medicines
i i p p p M 2 5 19 58 65 No 149
iffonrPj&ariii 1 0 1 8 13 23
Expiry date 
checks
3 4 25 60 58 No 150
W riifiS m i' 1 0 3 6 13 23
Ward visits to 
advise patients
pharmacist 1 3 36 50 40 No 130
Non-Phann. 0 0 3 4 4 11
Patient medication 
chart review
Pharmacist, 2 2 22 54 65 No 145
0 1 3 4 10 18
Reconstitution of 
IV preparations
2 1 25 30 28 No 86
1 0 1 4 8 14
Cytotoxic
reconstitution
2 2 9 23 54 No 90
0 0 0 1 6 7
Specialised 
production of med.
PMarrSW 1 1 17 20 36 No 75
0 0 0 1 6 7
Labelling of 
Medicines
B S B S B B B 3 0 8 48 87 No 146
ISSSSSlfiESi 1 0 2 2 11 16
Secure storage of 
medicines
2 0 9 49 84 No 144
M g g p H B ^ 1 0 1 4 17 23
Environmental 
control of storage
2 2 34 35 52 No 125
t^oi®fianh'-' 1 0 2 5 8 16
Disposal of 
medicines
2 0 25 54 64 145
W SrM M ™ : 1 1 1 7 12- 22
Drug
information
Pharmacist 3 1 35 61 43 No 143
1 0 4 4 8 17
* Significant differences between the two categories of service provider models (Pearson chi- 
square, p^0.05).
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The modal assessment in all but one case when self-assessed by a non-pharmacist was 
"very good"; the only exception was for "ward visits to advise patients" and, for that 
criterion, the modal assessment was between "good" and "very good". In contrast, 
for services self-assessed by the pharmacists, although the modal assessment for 8 
criteria was "very good", the mode was reduced to "good" in the case of 4 criteria. 
This could be a reflection of somewhat poorer quality of certain services provided by 
the pharmacists in comparison with those provided by non-pharmacists. There is, 
however, an alternative explanation; that is that a more critical stance was adopted by 
the pharmacists, based on a more detailed knowledge of pharmaceutical procedures 
and standards, possibly leading to a greater degree of discrimination.
It is, of course, impossible to determine which, if either, of these explanations is valid 
simply on the basis of the data in Table 3.44. Further explanation of this very 
important quality consideration is presented in Chapter 4 in the section concerned 
with the inspecting pharmacists’ assessment of quality of pharmaceutical services in 
independent hospitals.
As can be seen from Table 3.44, there were "very poor" self-assessments relating to 
the stock control of drugs in 2 of the hospitals with a pharmacist. These referred to 2 
hospitals with a contracted pharmaceutical service, one with an NHS hospital and the 
other with a community pharmacist. The 5 "poor" assessments for that service 
referred to 2 hospitals where a pharmacist was employed directly by the hospital and 
to 3 hospitals having a contract with a NHS hospital pharmacist. One "very poor" 
assessment for the stock control of medicines was also seen for a hospital in which the 
service provider was a non-pharmacist.
In 3 hospitals with a pharmacist, the exipry-date checking service was assessed as 
"very poor"; one of these cases related to a NHS hospital contract service model and 
the other 2 related to a community pharmacist model. Of the 4 "poor" assessments, 2 
related to a directly-employed pharmacist model and the other 2 to the NHS hospital 
contract model. There was one "very poor" assessment of the exipry-date checking 
service for a hospital where the provider was a non-pharmacist.
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One hospital with a pharmacist was judged to have a "very poor" quality service for 
ward visits to advise patients; this related to a community pharmacist service model. 
"Poor" self-assessments were given in 3 cases, 2 of them relating to the directly- 
employed pharmacist model and the other relating to the NHS hospital contract 
model. No "poor" or "very poor" assessment were made for the hospitals without a 
pharmacist with regard to the ward visits to advise patients.
Two cases were reported of "very poor" quality of the patient medication chart 
review services in hospitals with a pharmacist; one of these referred to the NHS 
hospital contract model and the other to a community pharmacist model. In addition, 2 
"poor" assessments of the patient medication chart review were reported; one 
referred to the directly-employed pharmacist model and the other to a community 
pharmacist model. One hospital without a pharmacist was judged to have a "poor" 
patient medication chart review service. Two of the hospitals with a pharmacist were 
assessed as having a "very poor" service for the reconstitution of IV preparations; in 
1 case the person responsible for providing the service was a NHS hospital pharmacist 
and in the other case a community pharmacist. A further case of a "poor" assessment 
was reported where the provider was a pharmacist directly employed by the hospital. 
One case of a "very poor" service for the reconstitution of IV preparations was 
reported for one of the hospitals without a pharmacist.
The cytotoxics reconstitution service was reported to be "very poor" in 2 cases of 
hospitals with a pharmacist; one of them used a NHS hospital pharmacist service and 
the other used a community pharmacist service. Two cases of "poor" cytotoxic 
services related to a directly-employed pharmacist model and to a NHS hospital 
pharmacist model. There were no "poor" or "very poor" self-assessments for this 
service in hospitals without a pharmacist.
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Specialised production of medicines was reported to be "poor" in 1 hospital and 
"very poor" in another hospital, both with a pharmacist; these 2 cases referred to a 
NHS hospital pharmacist model and to a community pharmacist model respectively. 
There were no "poor" or "very poor" self-assessments of this service in hospitals 
without a pharmacist.
Three cases were reported of "very poor" quality of labelling of medicines in 
hospitals with a pharmacist; these cases referred to a directly-employed pharmacist 
model, a NHS hospital pharmacist model and to a community pharmacist model. One 
case of a "very poor" service for labelling of medicines was reported for a hospital 
without a pharmacist.
Secure storage of medicines was assessed as "very poor" in 2 cases of hospitals with 
a pharmacist; each case referred to a NHS hospital pharmacist model and to a 
community pharmacist model respectively, one case of a "very poor" service for the 
secure storage of medicines was reported in a hospital without a pharmacist.
There were "very poor" self-assessments relating to the environmental control of 
storage conditions in hospitals with a pharmacist; these related to hospitals with a 
contracted pharmaceutical service, one with an NHS hospital pharmacist and the other 
with a community pharmacist. A further 2 cases of a "poor" assessment were 
reported where the providers were a directly-employed pharmacist and the other a 
self-employed pharmacist. One "very poor" self-assessment for environmental 
control of storage conditions was also seen for a hospital where the service provider 
was a non-pharmacist.
Two hospitals with a pharmacist were assessed as having a "very poor" service for 
the disposal of medicines; in one case the person providing the service was a NHS 
hospital pharmacist and the other case was a community pharmacist. Two "cases of 
"poor" and "very poor" services for the disposal of medicines service were reported 
for hospitals without a pharmacist.
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There were 3 "very poor" self-assessments relating to the drug information service in 
hospitals with a pharmacist; 1 of these related to a directly-employed pharmacist 
model and, the other 2 referred to 2 hospitals with a contracted pharmaceutical 
service, one with an NHS hospital contract and the other a community pharmacist 
contract. A further case of a "poor" assessment was reported where the provider was 
a pharmacist employed directly by the hospital. There was one "very poor" 
assessment of a drug information service for a hospital where the provider was a non- 
pharmacist.
The data shown in Table 3.44 are presented in a different way in Table 3.45. Here the 
number of assessments in each section of the Table are converted to values expressed 
as a percentage of the total number of assessments in that row. This is done to 
normalize the data, thereby facilitating comparisons of individual values and of modal 
values.
It should be noted that the percentage figures in Table 3.45 have each been rounded. 
There are therefore some minor discrepancies between the figures quoted in the 
following paragraphs and those derived from Table 3.44.
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Table 3.45. Percenta2e number o f  ASSESSMENTS o f the quality o f various 
elements o f  pharmaceutical services provision, in hospitals with and without a 
pharmacist. as judged by the person providing the pharmaceutical service:-
% o f  providers assessed as








Stock control of 
drugs/medicines
Pharmacist 1 3 13 39 44 No
Non-Pharmacist 4 0 4 35 57
Expiry date 
checks
W a m m if  ' 2 3 17 40 38 No
Non-Pharmacist 4 0 13 26 57
Ward visits to 
advise patients
Pharmacist ~ 1 2 28 38 31 No
Non-Manhacist 0 0 28 36 36
Patient medication 
chart review
Pharmacist 1 1 16 37 45 No
Non-PJbafmacist. 0 7 17 22 56
Reconstitution of 
IV preparations
2 1 29 35 33 No
Noh-Phafmacist 7 0 7 29 57
Cytotoxic
reconstitution
Pharmacist’ 2 2 10 26 60 No
Non-Pharmacist 0 0 0 14 86
Specialised 
production of med.
ph^macast n . 1 1 23 27 48 No
HoSKhafmacist 0 0 0 14 86
Labelling of 
Medicines
ignSpE /..; 2 0 5 33 60 No
Non-Pharmacist 6 0 13 13 68
Secure storage of 
medicines
Pharmacist 1 0 7 34 58 No
No&Pfir^acist 4 0 5 17 74
Environmental 
control of medicine
2 2 28 28 42 No
'¥ldi®ffimiacist 6 0 13 31 50
Disposal of 
medicines
jpSgBBBMWI | 1 0 18 37 44 Yes
N o® hffim cist. 4 4 5 32 54
Drug
information
Pharmacist 2 1 24 43 30 No
Non^fiaSn^ist 6 0 24 23 47
(Note: the given % are rounded to allow easy comparison).
* Significant differences between the two categories of service provider models (Pearson 
chi-square, p^0.05).
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As seen in Table 3.45, certain criteria for which most self-assessments were either 
"good" or "very good", in those hospitals with a pharmacist, were:-stock control of 
drugs/medicines (83%); expiry date check (78%); ward visits to advise patients 
(69%); patient medication chart review (82%); reconstitution of IV preparations 
(68%); cytotoxic reconstitution (86%); specialised production of medicines (75%); 
labelling of medicines (93%); secure storage of medicines (92%); environmental 
control of storage conditions (70%); disposal of medicines (81%); drug information 
(73%).
On the other hand, the criteria that were assigned a high proportion of either "good" 
or "very good" self-assessments for those hospitals with no pharmacist were:- stock 
control of drugs/medicines (92%); expiry date check (83%); ward visits to advise 
patients (72%); patient medication chart review (78%); reconstitution of IV 
preparations (86%); cytotoxic reconstitution (100%); specialised production of 
medicines (100%); labelling of medicines (81%); secure storage of medicines (91%); 
environmental control of storage conditions (81%); disposal of medicines (86%); drug 
information (70%).
Furthermore, certain criteria which were given a percentage of "poor" and "very 
poor" self-assessments for those hospitals with a pharmacist, were as follows:- stock 
control of drugs/medicines (4%); expiry date check (5%); ward visits to advise 
patients (3%); patient medication chart review (2%); reconstitution of IV preparations 
(3%); cytotoxic reconstitution (4%); specialised production of medicines (2%); 
labelling of medicines (2%); secure storage of medicines (1%); environmental control 
of storage conditions (4%); disposal of medicines (1%); drug information (3%).
Similarly, the criteria given a percentage of "poor" or "very poor" self-assessments 
for those hospitals without a pharmacist were:- stock control of drugs/medicines 
(4%); expiry date check (4%); patient medication chart review (7%); reconstitution of 
IV preparations (7%); labelling of medicines (6%); secure storage of medicines (4%); 
environmental control of storage conditions (6%); disposal of medicines (8%); drug 
information (6%).
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A Mann-Whitney test applied to the data in Table 3.44 showed no significant 
differences for 11 of the service criteria between hospitals with and without a 
pharmacist. The only significant difference obtained from this test was for the 
specialised production of medicines (p= 0.0495) which was considered as a 
marginally significant result.
Use of the Kruskal-Wallis test, corrected for ties, showed no significant differences 
(p>0.05) between different service provider models with regards to the perceived 
quality of 10 of the 12 pharmaceutical service criteria. The only 2 slight differences 
that were obtained related to ward visits to advise patients (p= 0.0230) and the 
provision of drug information (p=0.0273).
Taking the mean rank from the Kruskal-Wallis test as an indicator of the perceived 
quality, the different service provider models were placed in rank order, 1 to 6. Table 
3.46 illustrates the mean ranks for each service model together with the level of 
significance shown by the data (rank 1 represents the best quality, rank 2 for the 
second best etc.).
As can be seen from Table 3.46, the directly-employed pharmacist model did not rank 
1 in any case but only ranked 2 in two cases and ranked 3 in 4 cases, interestingly, the 
directly-employed pharmacist model ranked 5 for specialised production of medicines, 
labelling of medicines and environmental control of storage conditions, and ranked 6 
(the worst) for ward visits to advise patients, for patient medication chart review and 
for the cytotoxics reconstitution services. On the other hand, the NHS hospital 
pharmacist model was ranked the best for expiry date checks and for secure storage of 
medicines, but surprisingly ranked 6 for drug information.
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Table 3.46. Mean rank values IKruskal-Wallis Test (Corrected for Ties)I as 
measures o f the perceived Quality o f pharmaceutical services as self-assessed by 
pharmacists and non-pharmacists involved in service provision *:-
g p p  Pfi
. '■ J ' J s y p l . s -~ .
Service provider model |
P- Directly Contracted Non-Pharnu
NHS CP Self none except
value employed employed at all supply
Stock control o f  
drugs/medicines
0.1953 3 2 1 6 5 4
Expiry date 
checks
0.3647 2 1 4 6 5 3
Ward visits to 
advise patients
6 5 3 4 2 1 (i)
Patient medication 
chart review
0.1374 6 5 1 4 3 2
Reconstitution of 
IV preparations
0.7042 3 5 2 1 4 6
Cytotoxic
reconstitution
0.0509 6 5 3 1 2 4
Specialised 
production of med.
0.4731 5 4 2 3 1® 6
Labelling of 
Medicines
0.2047 5 4 3 6 2
Secure storage of 
medicines
0.3273 3 1 2 6 5 4
Environmental 
control of medicine
0.7134 5 2 3 6 4 J(4)
Disposal of 
medicines
0.5372 3 4 1 6 2 5
Drug
information
0.02?3„ 2 6 5 4 3
(*A mean rank o f 1 represents the provider model calculated to be of best quality 
based on the providers’ self-assessments. The shortcomings of these data are 
discussed in the text).
Notes:- (1) responses for 2 hospitals, both assessed as “good44 and “very good”.
(2) responses for only 1 hospital, assessed as “good”.
(3) responses for 5 hospitals, each assessed as “very good”.
(4) responses for only 2 hospitals, both assessed as “very good”.
(5) responses for 3 hospitals, all assessed as “very good”.
Page 139
CHAPTER 3 Service Providers Survey
Table 3.46 showed that the best ranks were assigned to the community pharmacist 
model as this provider model did not rank less than 3 except for expiry date check and 
drug information services (ranked 4 and 5 respectively). The worst ranks were 
assigned to the self -employed pharmacist model; this model ranked 6 for six of the 
services but ranked the best for the reconstitution of IV and cytotoxic preparations. 
Surprisingly, the best rank for the specialised production of medicines, labelling of 
medicines and the drug information services was assigned to the non-pharmacist 
model which , for these 3 service criteria, was represented by 1 hospital self-assessed 
as having a "good” specialised production of medicines service and, by 5 hospitals 
self-assessed as having a "very good" labelling of medicines service and, by 3 
hospitals assessed as having a "very good" drug information service. In addition to 
that, in the case of ward visits to advise patients and for the environmental control of 
storage conditions service, the best-ranked model was where the pharmacist acted 
only as a supplier of medicines which, however, for those service criteria, was 
represented by only 1 hospital assessed as having "very good" ward visits to advise 
patients and, by only 2 hospitals assessed as having "very good" environmental 
control of storage conditions service.
An objective appraisal of these data leads one to the conclusion that they are seriously 
flawed. However, if that is the case, then the potential implications are extremely 
important because they may raise questions about the capability, at least of some 
persons involved in the provision of pharmaceutical services in independent hospitals, 
to judge the quality of the services they are providing. For that reason it was decided 
that some independent and, as far as possible, objective assessment was needed of the 
quality of the pharmaceutical services evaluated here. That was the subject of a further 
study which is reported in Chapter 4 ("Pharmaceutical services provision in 
independent hospitals as perceived by pharmacists involved in their statutory 
inspection") of this thesis -  a study which provided confirmatory evidence that 
differences in the quality assessments reported here, and reflected in the rankings 
presented in Tables 4.31-2 and 4.33, were dependent on differences in the scale of 
scrutiny by pharmacists and non-pharmacists when appraising pharmaceutical 
services.
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In an effort to find out who actually was involved in providing each of the 12 
specified pharmaceutical service elements which were used as a basis for assessing the 
quality of service provision in the independent hospitals, the respondents were asked 
to indicate which of the following persons was involved in the case of each service in 
their hospital:
• in-house pharmacist
• a community pharmacist





Table 3.47 illustrates the different providers who were identified. Also Tables 3.48 
and 3.49 show the different providers in hospitals with and without a pharmacist 
respectively.
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Table 3.47. Providers o f the 12 specified pharmaceutical services in all independent hospitals with and without a pharmacist:-



































TOTAL no. of cases
(N.B. the percentage exceeds 100% as more than one provider involved). 
* Comm. Comp.= Commercial Company.
n p ■' lh  r f f e i l f i n * * * ' ■ ~ 7 ~
, r n ar m ^ a t . Pharm
-acist












Others T O T A L
S6cJ|%:- |  |fj«storag>4 * of- 96 8 21 48 26 0 3 0 0 0 0 152
medicines 63% 5% 14% 32% 17% 2% 133%
L ab ellin g  o f 96 13 39 0 42 1 4 0 0 0 0 155
62% 8% 25% 27% 1% 3% 126%
Expiry date check-; - 69 8 24 38 57 0 2 0 0 0 0 156
44% 5% 15% 24% 36% 1% 129%
80 9 18 30 18 0 0 1 0 0 4 128
62% 7% 14% 23% 14% 1% 3% 124%
86 15 38 12 23 1 3 5 0 0 10 154
56% 10% 25% 8% 15% 1% 2% 3% 6% 126%
77 8 27 27 46 0 1 1 0 0 0 154
drugs/medicines 50% 5% 17% 17% 30% 1% 1% 121%
Reconstiti tion of IV 12 1 20 55 8 0 17 0 0 0 0 96
12% 1% 21% 57% 8% 18% 117%
Drug Information 93 13 56 3 11 1 1 0 0 0 0 152
61% 9% 37% 2% 7% 1% 1% 113%
c j{ s tc > |ic  toipsipi p ip si| 28 0 54 5 18 0 9 1 1 0 3 100
l i o & t i t u f io lr  111' i ‘ , 28% 54% 5% 18% 9% 1% 1% 3% 119%
92 5 26 17 6 1 9 0 0 0 0 136
68% 4% 19% 12% 4% 1% 7% 115%
10 3 60 1 5 4 1 2 0 0 1 78
13% 4% 77% 1% 6% 5% 1% 3% 1% 111%
98 6 38 8 3 0 13 0 0 0 0 154R ?{%£& 64% 4% 25% 5% 2% 8% 108%
T O T A L  no. o f  cases 837 89 421 244 263 8 63 10 1 0 18 1615
(N.B. the percentage exceeds 100% as more than one provider involved). 
* Comm. Comp.= Commercial Company.
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Table 3.49. Providers o f  the 12 specified pharmaceutical services in independent hospitals WITHOUT A PHARMACIST:-
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TOTAL no. of cases 1 8 8 23 114 13 4 22 2 1 8 5 208
* The pharmacist in the first column is a visiting pharmacist.
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As can be seen from Table 3.47, the main provider of most pharmaceutical services in 
independent hospitals considered as a whole (i.e. including those with and without a 
pharmacist) is the in-house pharmacist. The exceptions relate to the following 
services: IV additives, cytotoxics reconstitution and specialised production for the 
hospital. The provider mainly involved with IV additives was the nurse. As seen in 
Tables 3.48 and 3.49 that was the case whether an independent hospital had an in- 
house pharmacist or not. The second most frequent provider identified for secure 
storage of medicines and environmental control of storage conditions in independent 
hospitals generally was a nurse. The NHS hospital pharmacist was identified as the 
second main provider of:- ward visits to advise patients; patient medication chart 
review; IV reconstitution; disposal of medicines, and; drug information. For hospitals 
without a pharmacist, the results in Table 3.48 show that it was a nurse who was most 
often involved in providing each of the pharmaceutical services except for cytotoxics 
reconstitution, specialised production of medicines and drug information. And the 
nurse was the second most frequent provider of cytotoxics reconstitution and drug 
information. Also for hospitals where no pharmacist was employed or contracted to 
provide pharmaceutical services, a visiting pharmacist from an NHS hospital was 
identified as the main provider for cytotoxics reconstitution, specialised production of 
medicines and drug information. Neither the Least-Significant Difference test nor the 
Bonferroni test showed any significant differences between service models, when 
comparing the data in tables 3.48 and 3.49.
3.11. Providers opinions as to which pharmaceutical services could be significantly 
improved in independent hospitals:-
The questionnaire asked whether any aspects of the pharmaceutical services in the 
hospital surveyed could be significantly improved (question 39). Out of 192 hospitals 
surveyed, 117 responses (61%) stated that there are some aspects which could 
improved. But 35 pharmacists and 7 non-pharmacists stated that there were no such 
aspects which could be improved. In addition, 12 pharmacists and 8 non-pharmacists 
said that they did not know whether or not there were any aspects that could be 
improved, and 13 respondents (11 pharmacists and 2 non-pharmacists) did not answer 
this question.
Page 145
CHAPTER 3 Service Providers Survey
All the respondents who stated that there were some aspects that could be improved 
were asked to identify those aspects. Table 3.50 illustrates the various aspects of 
pharmaceutical services that respondents considered could be significantly improved.
Table 3.50. Aspects o f pharmaceutical services that it was suggested could be 
sisnificantlv improved in independent hospitals as stated by pharmacist and non- 
pharmacist:-
- Aspects o f  Pharmaceutical Services Pharmacist | Non-pharmacist
More staff needed (high work load), lack of time 37 3
Ward services (clinical pharmacy) 25 2
Patient contact 22 1
Provision o f IV, TPN, Cytotoxics 21 -
Pharmacy on site needed 9 6
Training 11 1
Stock control 9 2
Computerised service needed 8 -
Space for consultation & dispensing 6 -
Increase the efficiency of purchasing power 6 -
Good liason with consultants 6 -
Audit system 5 -
Faster service (reduce patient waiting times) 4 -
Weekend supply 3 -
Drug information service 3 -
Out-patient services needed 2 -
Pain control team development 2 -
Introduction of formulary 1 -
Illegal dispensing by RMO 1 -
193 15
(N.B. the percentage exceeds 100% as more than one aspect was given).
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One of the important issues abstracted from Table 3.50 was that 13% of the cases 
stated that the pharmaceutical service could be significantly improved by the provision 
of an "pharmacy on-site". In these instances it would seen that the situation could at 
least be improved by utilising the expertise of the NHS hospital pharmacists. Though 
some independent hospitals are served by a community pharmacist, lack of hospital 
experience may prove to be a disadvantage. Thus, it seems sensible that where no 
pharmacist is employed, the supply of a pharmaceutical service should be provided by 
the local NHS hospital pharmacy. Here, the many pharmacists employed, have 
between them a greater depth of knowledge relating to acute procedures than would 
normally be possible from one pharmacist based at the local community pharmacy. 
However, an alternative scenario might involve a pharmacist with hospital experience 
operating from a practice base in a local community pharmacy.
It would be hoped, that in a case where a local community pharmacist does undertake 
to supply an acute independent hospital, he/she would maintain strong links with the 
NHS hospital pharmacy in order to obtain current knowledge of hospital procedure. 
Also, it must be remembered that the consultants working in independent hospitals 
often make assumptions that the same pharmaceutical service is available to them and 
they will tend to "carry-over" their practices they use in the NHS to their work in the 
independent hospital sector.
3.12. Pharmaceutical Legislation applying to independent hosvitals.
Respondents were asked if there were any aspects of pharmaceutical legislation which 
create particular difficulties in independent hospitals (question 40). Sixty of the 
respondents (33%) stated that there were aspects of pharmaceutical legislation which 
created difficulties.
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Those 60 respondents also gave details. Half (30) of the respondents considered there 
was a need for specific defined legislation for independent hospitals, while 10 (16.7%) 
of them called for a change in the licensing requirements relating to Controlled Drugs 
(CDs). Three (5%) of the respondents expressed the view that problems arise because 
the law applies to a registered pharmacy rather than to a registered pharmacist. Five 
(8.3%) of the respondents claimed that there is illegal dispensing of drugs by the 
doctors and nurses. A further 4 (6.7%) of the respondents stated that they did not stock 
Controlled Drugs in their hospital and they believed there was a need for new 
simplified legislation to enable them to stock such drugs. In addition, 8 (13%) of the 
respondents gave other reasons as to why revised legislation was needed such as:- 
CDs are sometimes not available in NHS hospitals, and; the NHS does not accept the 
return of CDs.
3.13. Opportunities for pharmacists in independent hospitals 
It was of interest to determine whether the providers of pharmaceutical services in 
independent hospitals considered that different opportunities existed in independent 
hospitals compared with those in NHS hospitals. Respondents were asked to state if 
there were specific reasons for further opportunities being available in independent 
hospitals in comparison with NHS hospitals (question 41). The majority of replies 
related to the greater freedom associated with work in independent hospitals than in 
NHS hospitals; 47% of the respondents expressed a feeling of greater freedom to 
practice their profession in independent hospitals, while others (29%) mentioned their 
satisfaction with the direct management. Some others (24%) stated that in independent 
hospitals there was more staff contact than in NHS hospitals. A further 22% referred 
to the commercial challenge which exists in the private sector. Others (31%) stated 
that in independent hospitals there was more opportunity to follow-up cases and that 
the pharmacist was more aware of how the hospital functioned. In 11% of the replies, 
respondents referred to the benefits of purchasing arrangements in independent 
hospitals being more flexible than in NHS hospitals. Finally 8% of the respondents 
referred to the relative absence of "politics" in independent hospitals, as a result of 
which they were able to practice more freely. The sum of the above percentages 
exceeds 100% because many of the respondents gave more than one reason.
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3.14. Disadvantages associated with the provision o f  pharmaceutical services in 
independent hospitals
All the respondents were asked if they saw any disadvantages associated with the 
provision o f pharmaceutical services in independent hospitals (question 42). Table 
3.51 illustrates the various disadvantages which were identified in the replies.
Table 3.51. Disadvantages Associated with the Provision o f Pharmaceutical 
Services in Independent Hospitals
Non-ph armacist
Isolation from other pharmacists 43 2
No opportunity for continuing education 16 2
Limited role 16 1
No career structure 15 1
Small number of staff (high work load) 14 -
Lack of support 10 1
Lack of access to consultants 9 -
Less professional back-up 9 -
Small department 8 -
Less clinical involvement 8 -
Not for qualified pharmacist due to 
routine practice
8 -
No purchase power 4 3
Small stock of medicines 6 1
Not a job for life 4 2
Poor supply 5 1
Consultants visit after closing time 5 -
No in-house pharmacy department 3 2
Small number of beds 4 1
Unusual prescriptions 4 1
Less money 3 1
Lack of formulary 3 -
No hierarchy 3 -
Financial problems with drug companies 2 1




(N.B. the sum of the percentages exceeds 100% as many respondents stated more than
1 disadvantage).
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Table 3.51 shows that the main perceived disadvantage associated with the provision 
of pharmaceutical services in independent hospitals was isolation from other 
colleagues in other hospitals, especially from those colleagues working in NHS 
hospitals. In addition, several of the pharmacists working in the private sector claimed 
that the opportunity for continuing education was quite limited compared with that in 
NHS hospitals. Surprisingly, others expressed an opinion that the pharmacist’s role in 
the independent hospitals was quite limited.
However, apart from the concern about isolation referred to by 36% of the 
respondents, the other concerns were each expressed by fewer than 15% of those 
surveyed.
All respondents were asked to indicate whether they or their hospitals would wish to 
be acknowledged in any future report. A complete list of those respondents and their 
hospitals who wish to be acknowledged can be found in Appendix XI.
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CHAPTER FOUR
SURVEY OF THE SENIOR PHARMACISTS INVOLVED IN THE 
STATUTORY INSPECTIONS OF INDEPENDENT HOSPITALS.
4. RESULTS AND DISCUSSION
4.1. Response rate and General findims.
Questionnaires were sent out to 230 SPMs whose responsibilities involved the 
inspection of pharmaceutical services in independent hospitals in a total of 219 Health 
Authority/Health Board 'Districts'; of the UK; that was because in 10 of the Districts 
in England, more than one pharmacist was stated to be involved in inspections.
Completed questionnaires were received initially from 80 respondents. In a further 27 
responses, the respondent certified that there was no independent hospital in the 
geographical area of responsibility of the Health Authority/Health Board concerned. 
Following the reminder, Appendix VI, 13 more completed questionnaires were 
received. Those 120 replies (4 responses in joint names of 2 SPMs) represented a 
response rate of 54%, and embraced 55% of the districts. In addition, 52 respondents 
(23%) indicated that they were not involved in the statutory inspection of independent 
hospitals. This high number of negative responses highlighted the difficulties which 
were encountered in identifying the relevant SPM in certain Districts, as described in 
the Methods section (Chapter 2, p 65). Following contact with Nursing Homes 
Registration Officers in the 74 Health Authorities concerned - some of them formed 
by merger of former District Health Authorities and which embraced 89 of the 
districts for which no confirmatory evidence could be obtained regarding the identity 
of the pharmacists involved in inspection - 18 more responses were obtained from 
senior pharmacy managers involved in inspection of independent hospitals.
Thus, information was received from 138 (63%) of the 219 Districts first surveyed 
and, in total, the replies covered 228 independent hospitals -  that is 89% of them, 
based on an estimated (as described in Chapter 3) total of 257 independent hospitals in 
the UK..
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Table 4.1. Summary o f the responses to Questionnaire #2:-
Response No. o f  Districts Response Rate
Completed Questionnaire 111 50.5%
Not involved in the inspection of IHs 52 23.5%
No IHs in the District 27 12.5%
No response at all 29 13.5%
TOTAL 219 Districts 100%
To ensure that the questionnaire was addressed to the right person, a question was 
asked to check whether the SPM was involved in the statutory inspection of 
independent hospitals or not (question 1). Of the 111 SPMs, 109 (98%) replied that 
they or persons under their direction, were involved in inspection of the 
pharmaceutical services in independent hospitals. The other 2 SPMs, returned a 
completed questionnaire, although they stated that they were not involved in such 
inspections. It is not a legal responsibility of the DPhO, but of the District Health 
Authority, to inspect the independent hospitals, though it would be expected that the 
DPhO would be involved in the inspection of pharmaceutical services. He may also 
delegate this responsibility to a community Services Pharmacist (CSP). The term 
"Senior Pharmacist" was used to include the DPhOs, after it was ascertained that, in 
some trust districts, the term DPhO had been made obsolete.
Therefore, one aim of Questionnaire # 2 was to identify the job title and 
responsibilities of the person who undertakes the inspection (question 2). Of the 
people involved (Table 4.2), it was interesting to see that 45 (40.5%) of the District 
Pharmaceutical Officer (DPhO) or Senior Pharmacy Managers (SPMs) were 
personally involved in inspection; 31 (28%) were Community Services Pharmacists 
(CSPs); 26 (23.4%) were described as either a Principal Pharmacist or a Chief 
Pharmacist; 11 (10%) were Pharmaceutical Advisors; and the remaining individuals 
(12.6%) have other job titles including Registration Officer, Pharmaceutical 
Consultant, Clinical Services Manager or Pharmacy Control Service Manager. In 
some Districts, the respondent gave more than one job title, possibly indicating that 
more than one person was involved in inspection, or that he/she had several roles.
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Table 4.2. Job Titles o f the persons who undertake the statutory inspection o f  
independent hosvitals:-














(Note: The percentage total is larger than 100% because in several districts, more 
than one title was listed).
The majority of the respondents (70%) were employed by an NHS Trust while 25% of 
them were employed by a Health Commission. Also 17 respondents stated that they 
had more than one employer.
The number of independent hospitals in each District varied from none up to 10 
(Table 4.3). Most Districts (72%) had between 1 and 3 independent hospitals while 
7% of them had between 4 and 6 independent hospitals. In 3 Districts there were more 
than 7 independent hospitals and the maximum number, in only one District, was 10. 
In addition, 27 Districts (20%) had no independent hospitals.
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Table 4.3. Number o f Independent Hospitals per District:-
No. o f District % o f Districts
0 27 19.6 Mean = 2.05
" yT / :  - 56 39.8
2 32 23.2
12 8.7 Median = 2
4 2 1.5
, 5  : 3 2.2
6 4 2.9 Minimum = 0
7 1 0.7
1 0.7
10 1 0.7 Maximum = 10
TOTAL 138 Districts = 
228 IHs
100%
4.2. Inspection o f Independent Hospitals.
Have all those independent hospitals previously been inspected at sometime? This 
question was asked of all the respondents. The aim of this question was to identify 
whether all o f the hospitals in the respondent’s District had been inspected previously 
as required by legislation. Of the 111 SPMs, 109 (98.2%) replied that the independent 
hospital(s) in their area of responsibility had been inspected previously. In only one 
case, the respondent indicated that that was not the case, and one other respondent 
stated that he/she did not know whether this had been carried out previously or not.
4.2.1. Inspector’s perception with resard to inspection.
In an effort to find out the perception of the person who undertakes the inspection, a 
question was asked about whether the inspection process was seen as having an 
advisory function or achieving an enforcement of standards or merely as an 
administrative necessity having to be carried out by the Health Authority or perceived 
in some other way.
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Of the inspectors who responded, 83% indicated that they viewed the inspection as an 
enforcement of standards, 73% as advisory, 12% as an administrative necessity, while 
17.1% of the respondents specifically referred to the fact that the inspection is a 
statutory requirement of the Health Authority. In addition, 15% of them wrote that 
they regard inspection as a good practice to raise the standards and to support the 
quality of the pharmaceutical services. Finally, 2% said that they regard inspection as 
an educational process as well as a very good means for ensuring a long standing 
relationship between the inspector and the hospital. The total of opinions exceeded 
100% as many respondents gave more than one perception.
4.2.2. NAHAT recommendations with resard to the employment o f  a 
pharmacist within Independent Hospitals.
The NAHAT guidelines relating to pharmaceutical services provision in acute 
independent hospitals make a recommendation with regard to the establishment of a 
pharmacy department within an IHs 10. The recommendation, in general, is that a 
pharmacy department should be established whenever possible in an independent 
hospital, with provision of appropriate out-of-hours cover. However, these guidelines 
offer advice and guidance which is subject to variation according to the number and 
type of patients being treated in a particular IH. Thus, if the hospital consists of less 
than 40 beds and has no operating theatre, the guidelines suggest the need merely for 
pharmaceutical advice on the level of service required. If the hospital consists of less 
than 40 beds but has one or more operating theatres, the services of a pharmaceutical 
department are said to be needed and, if the hospital has 40 beds or more, then the 
services of a pharmaceutical department are needed regardless of the number of 
operating theatres. Table 4.4. summarises these recommendations.
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Table 4.4. Summary o f the NAHAT recommendations 10 with regard to the 
establishment o f a pharmacy department within an independent hospital:-
Hospital Size
Less than 40 beds No operating theatre Pharmaceutical advice only
Less than 40 beds One or more operating theatres A pharmacy department is needed
40 beds or more No operating theatre A pharmacy department is needed
40 beds or more One or more operating theatres A pharmacy department is needed
4.2.3. Inspector’s perception with resard to the need to employ a pharmacist 
in an independent hospital:-
With reference to the above-mentioned guidance from NAHAT, the respondents were 
asked to express their perceptions regarding the employment of the services of a 
pharmacist in independent hospitals (question 10).
Most (96 = 86%) of the 111 respondents considered that all independent hospitals 
should employ the services of a pharmacist. This figure was even higher than that 
recorded in a previous study 12 (72%), indicating that most o f the inspectors consider 
the services of a pharmacist to be important within all independent hospitals.
Those 96 respondents were asked how a requirement for an IH to employ the services 
of a pharmacist might be enabled. 61% of them felt that this should be achieved 
through legislation. A further 59% referred to the fact that this could be enabled if it 
was specified as a requirement by the registering Health Authority. Three respondents 
suggested that, if the benefit of employing pharmacist within an independent hospital 
was to be quoted, that would be considered as a requirement to employ a pharmacist. 
In addition, 4 respondents indicated that the Health Authority has the power to advise 
a hospital to employ the services of a pharmacist. The total exceeded 100% as many 
respondents gave more than one answer.
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The opinions of SPMs regarding the possible need for legislation as opposed to 
relying on a requirement of the registering Health Authority were sought also in the
19previous survey of Senior Pharmacy Managers on this topic . The responses of SPMs 
in the previous study were compared with those in the present study. The present 
results show that (question 12) there was a slight increase of 6% over the previous 
study in the number of SPMs who thought there was a need for legislation to ensure 
that pharmacists were employed by the IHs. And there was an even larger increase of 
17% in the number who considered that employment of a pharmacist in IHs should be 
achieved through the requirements of the Registering Authority.
The remaining 14 respondents who stated that the employment of a pharmacist’s 
services is not essential, gave several reasons. 11 respondents stated that this would 
depend on the number of beds and on the range and type of procedures being carried 
out within the hospital, while 2 respondents referred to the ability of the hospital to 
enter into a contract with a NHS hospital for the provision of its pharmaceutical needs 
rather than to employ a pharmacist showed that be non-viable financially. Finally, 1 
respondent referred to the client needs.
4.2.4. Inspection and the recommendations made bv the NAHAT guidelines.
The NAHAT guidelines recommend that the statutory minimum requirement of 2 
inspections each year should be increased to 4 where no pharmacy department exists 
in an independent hospital10 . The results obtained from this study showed that, of the 
228 independent hospitals for which data were supplied (question 6), 98 (43%) were 
inspected less frequently than recommended by the NAHAT guidelines.
Reasons given by SPMs for why certain hospitals were inspected less frequently than 
the recommendations were (question 7) : lack of time for inspection (54.1%); 
confidence in the service provided by a pharmacist (26.5%); confidence in services 
provided by others (7.1%); lack of staff for inspection (17.3%); other higher priority 
commitments within the NHS (15.3%).
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Other reasons were reported by 33.7% of the respondents, such as : 14 respondents 
stated that they follow the minimum requirement, 4 inspectors surprisingly referred to 
the fact that their Health Authorities require one visit per year, 4 respondents indicated 
that they do less inspection visits and this depends on the success of the hospital to 
provide a satisfactory service, lack of funding for inspection was reported by 3 
respondents, 2 respondents indicated that they do liaise with the IHs without visiting, 
2 inspectors stated that inspection is not required by their Health Authorities, and 
finally, 4 respondents stated that these procedures were introduced only recently in 
their Health Authority. In addition, in 11 cases the inspector gave no reasons. The total 
exceeded 100% as many respondents gave more than one reason.
When these findings were compared with the findings obtained in the previous study 
12, the situation appears to be more or less still the same except for the factor of "other 
higher priority commitments within the NHS", the number of respondents who 
indicated this reason in 1992 dropped by more than half (from 35% to 15.3%) in the 
current study.
The number of independent hospitals in each Health Authority District may also affect 
the frequency of visits by the inspector. To find out this effect, the numbers of 
independent hospitals in each Health Authority were cross-tabulated with the 
inspector’s response as to whether any independent hospitals were inspected less 
frequently than recommended by NAHAT guidelines. Table 4.5 shows that effect.
As can be seen from Table 4.5, Health Authorities with 6, 7 and 8 independent 
hospitals have less frequent inspection visits than recommended by NAHAT 
guidelines. In the Health Authorities with 4 IHs, all the IHs received less frequent 
inspection visits than recommended by NAHAT guidelines. At the same time, for 
Health Authorities with 1 or 2 independent hospitals, nearly half of them (44%) have 
less frequent inspection visits than recommended by NAHAT guidelines. That 
explains why the chi-square test shows no significant relation between the number of 
independent hospitals in each Health Authority and the lower frequency of inspection 




Table 4.5 Comparison o f  the number o f independent hospitals in each Health Authority with the frequency o f inspection visits 
relative to that recommended by NAHA/  :-
i t y .
/ 2 3 4 5 6 7 10 TOTAL
Less Frapienlly. Yes 23 14 6 2 0 1 1 1 0 48
than M ( T " No 29 18 6 0 3 3 0 0 1 60
T O T A L 52 32 12 2 3 4 1 1 1 108









CHAPTER 4 Senior Pharmacists Survey
4.2.5. Inspection frequency and the presence o f a pharmacist.
NAHAT 10 recommends that a pharmaceutical service should be established in an 
acute independent hospital with a pharmacist in charge of that service. NAHAT 10 also 
recommends that the statutory minimum requirement of 2 inspections each year 
should be increased to 4 where no pharmacy department exists.
In an effort to find out the inspectors’ views with regard to these recommendations, a 
question was asked about whether more frequent inspection visits are needed in those 
hospitals without a pharmacist present (question 13). Table 4.6 shows the results.
As can be seen from Table 4.6, out of 100 inspectors, 77% of them considered that 
more frequent inspection of an independent hospital is needed where no pharmacist is 
present. This figure is high when compared with the figure (37.2%) obtained from the
17last survey . In the present survey, several reasons were given by the respondents 
regarding the need for higher frequency of inspection. 21.3% stated that the 
pharmaceutical standards are likely to be lower due to the absence of a pharmacist. 
20% referred to the fact that they do more inspection visits just to ensure that the 
guidelines are adhere to, while 15% stated that staff without experience may handle 
the pharmaceutical products in a hazardous way; 12.5% stated that the presence of a 
pharmacist within the hospital would help to optimise the adequacy and accuracy of 
the treatment; 9% stated that they do more inspection visits just to monitor the 
performance of the pharmaceutical suppliers. On the other hand, 23% of the 
respondents did not agree at all with the need for an increase in the frequency of 
inspection visits whether the hospital was one with or without a pharmacist. Some of 
them suggested that the same frequency of inspection was appropriate for both types 
of hospitals (i.e. hospitals with or without a pharmacist) but that a different inspection 
procedure was called for; some others stated that every hospital should be assessed 
individually regardless of any other criteria; while others stated that there was no need 
at all for more inspections if the hospital is only small. 11 respondents did not give 
any comments to this question.
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Table 4.6. The effect o f the absence o f a pharmacist on the required frequency o f  
inspection as perceived by the inspecting pharmacists:
Frequently
Yes No TOTAL
More Yes N/A* 77 77%
Frequently No 2 21 23%
TOTAL 2% 98% 100%
(N.B. 11 missing cases in this test. The sample size is 100).
* N/A= Not Applicable.
4.2.6. Appropriateness o f the NAHAT guidelines.
77% of the respondents considered that the NAHAT guidelines on inspection are 
appropriate and logical (question 14). However 24 respondents (23%) said they did 
not consider the guidelines appropriate either because they thought that the CSP 
guidelines were more comprehensive than NAHAT or because they felt that the 
NAHAT guidelines needed to be updated. Some respondents were concerned that not 
all standards for inspection were included in NAHAT, or that the NAHAT guidelines 
are not appropriate for hospital inspections, and 2 respondents considered that the 
NAHAT guidelines are not powerful enough.
The inspectors’ perceptions with regard to employing the services o f a pharmacist in 
all independent hospitals were cross-tabulated with his/her perception as to whether 
the NAHAT guidelines on inspection are appropriate. Table 4.7 shows the results.
Table 4.7. The inspector’s perception with resard to the need for employment o f  a 







I TOTAL 82 24 106
(N.B. 5 missing cases were obtained from this test).
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4.2.7. How closely are the NAHAT guidelines adhere to.
Most of the respondents (96%) considered that these guidelines are closely adhere to 
(question 15).
The opinion of the inspecting pharmacist, with regard to his/her perception of the need 
to employ the services of a pharmacist in all independent hospitals, was cross­
tabulated with his/her perception as to whether the NAHAT guidelines on inspection 
are closely adhered to. Table 4.8 shows the results.
Table 4.8. The inspector's perception with resard to the need to employ a 
pharmacist within all independent hospitals and their opinion on whether NAHA T 






In some Health Authority Districts which had more than one IH, an inspector from a 
neighbouring District Health Authority may share expertise in the inspection 
procedures. This also is the case, sometimes, when an inspecting SPM is involved in 
the provision of pharmaceutical services at an IH which he/she would normally 
inspect. Since the inspection documents may differ from one Health Authority to 
another, as well as its procedures, this may lead to more than one set of procedures 
being used for inspection of different IHs in the same District. A question was then 
asked about which documented procedures were used for inspection of pharmaceutical 
services in independent hospitals (question 16), and whether any other documents 
were used for this purpose.
TOTAL
(N.B. 7 missing cases were obtained from this test).
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40% of the respondents stated that their Local Health Authority has documented 
procedures for the inspection of the pharmaceutical services in independent hospitals. 
The remaining 60% do not have such documented procedures for the inspection but 
they use various guidelines such as : NAHAT guidelines (55.6%), CSP guidelines 
(51%); NHS guidelines (11%) and/or a specialised checklist at each visit (19.5%). The 
total exceeds 100% as more than one standard may be used during inspection.
4.2.9. Follow-up visits.
As was mentioned before, a minimum of 2 inspection visits per year are required by 
statue. One of these visits could be announced which gives the inspecting team the 
opportunity to meet the person-in-charge while an unannounced visit gives the 
inspecting team an opportunity to see the "day-to-day" running of the services 
provided 10.
After the visit for the purpose of inspection has taken place at an independent hospital, 
a comprehensive report should be submitted to the hospital. This report usually 
includes an assessment of the current pharmaceutical status within the hospital and, 
makes statements if the hospital needs to improve some of its pharmaceutical services. 
Sometimes, if quality deficiencies are reported, a follow-up visit needs to be made. In 
order to ascertain whether this is the case, two relevant questions were asked 
(questions 17 and 18).
93% of the respondents stated that a written report is submitted to the hospital 
following an inspection visit (question 17 and 18). 90% of the respondents confirmed 
that a follow-up inspection visit is undertaken if any quality deficiencies are reported 
or identified as a result of the first visit.
4.3. Providers o f pharmaceutical services in independent hospitals:-
4.3.1. The NAHAT recommendations as to whether a hospital should employ 
the services o f  a pharmacist.
Returning to the NAHAT guidelines 10 , these state that, if a pharmacist is present 
within a hospital, he/she should be responsible for the preparation, purchasing, 
quality, storage, dispensing and distribution of all medicines and pharmaceutical 
supplies, as well as for ward-based pharmacy services.
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Also the pharmacist should advise on drug therapy, dosage, patient counselling and 
discharge medicine, and the pharmacist should be involved in the provision of such 
services as Total Parenteral Nutrition (TPN), Intravenous Additives (IV additives), 
cyto-toxic preparations and reconstitution. On the other hand, if the hospital has no 
pharmacist present, the hospital should obtain on-going advice from a pharmacist 
having experience of the type of service provided by the unit, to ensure that 
appropriate arrangements are made for pharmaceutical services including out-of-hours 
arrangements.
4.3.2. Provision o f pharmaceutical services.
In an effort to obtain a comprehensive description of the main providers of 
pharmaceutical services in each independent hospital, seven different service provider 
models were specified in the questionnaire. For the 228 independent hospitals on 
which information was supplied, the findings are illustrated in Table 4.9.
Table 4.9. Nature o f the persons who provide the pharmaceutical services to 
independent hospitals
Service provider model No. o f Cases %
Pharmacist(s) employed directly by the hospital 112 49.3
Pharmacists) contracted from an NHS hospital 49 21.6
Community Pharmacists) 25 11
Independent (self employed) Pharmacists) 3 1.3
Non-Pharmacist 10 4.4
Pharmacist provision only as a 22 9.7
Pharmacist not involved at all 6 2.7
TOTAL 227 100%
(N.B. Only 1 missing case is recorded in this test).
When the data were analysed, it was decided to merge the 'pharmacist not involved at 
all' category with the 'non-pharmacist' category.
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4.3.3. Hours o f pharmaceutical services provision.
The time spent by the person providing a pharmaceutical service ranged from no hours 
spent at all for the provision of the pharmaceutical service to a maximum of more than 
40 hours per week. Table 4.10 categorises the different number of hours spent by the 
person providing pharmaceutical services in independent hospitals per week.
Table 4.10. Hours o f pharmaceutical service in independent hospitals (n=228):-
0 Hours/week 27 13
1 to < 5 hours/week 31 15
5 to <15 hours/week 34 16.4
15 to < 30 hours/week 24 11.6
30 to <40 hours/week 70 33.8
40+ 21 10.2
TOTAL 207 100%
(N.B. 21 missing cases were recorded from this test).
In order to find out how many hours per week were spent by the person(s) providing 
pharmaceutical services in independent hospitals, Table 4.9 was cross-tabulated with 
Table 4.10 as shown in Table 4.11.
Very highly significant differences (p= 0.0001, df = 36) were obtained from the cross­
tabulation (table 4.11) of different pharmaceutical service provider models and the 
number of hours spent per week in the provision of pharmaceutical services. A 
confirmatory finding of highly significant differences was obtained from the Kruskal- 
Wallis-one-way-Anova test (p= 0.0001) which means that there are significance 
differences between the different persons providing pharmaceutical services in term of 
the time spent per week by the person(s) providing the service.
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Table 4.11. Hours o f pharmaceutical services per week spent by person (s) responsible for providing the service:-
Hours o f Pharmaceutical
Service Provider Model 0 hours < 5 hours 5 to <15 15 to <30 30 to < 40 40+ TOTAL
Pharmacist Employed Directly 0 2 5 14 65 22 108
NHS Hospital Pharmacist 0 14 22 6 2 1 45
Community Pharmacist 5 7 6 2 2 0 22
Independent (Self Employed) Pharmacist 0 0 1 0 1 1 3
Non-Pharmacist 11 1 0 1 0 0 13
Pharmacist as a Supplier only 11 7 0 0 0 0 18
TOTAL 27 31 34 23 70 24 209
(N.B. 19 cases were obtained from this test as a result of some respondents not indicating who provided the services in some IHs).
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4.3.4. Description o f pharmaceutical service.
4.3.4.1. Services provision by a pharmacist employed directly by the 
hospital.
The inspecting pharmacists replied that at 112 (49.3%) of the hospitals there was a 
pharmacy service provided by a pharmacist employed directly by the hospital. Of 
those 112 hospitals, 69 hospitals (62%) received a comprehensive pharmaceutical 
service while, in 10 hospitals (9%), the service was described by the inspecting 
pharmacist as partial. Table 4.12 shows the results.
Table 4.12. Descriptions used by the inspecting pharmacists to describe the 
pharmaceutical services provided by a pharmacist employed directly by the 
hospital:-
Service Description No. o f Cases %
Comprehensive 69 61.6
Partial 10 8.9
Either Comprehensive / Partial* 33 29.5
TOTAL 112 100%
(N.B. Only 1 missing case was recorded in this test).
(* Some inspectors did not indicate whether the service was comprehensive or partial; 
as a result, the row in the above table (either comprehensive /partial} was used to 
differentiate their responses from the others. Such service was considered in the 
analysis of the data to be "at least partial").
The hours spent by a person providing pharmaceutical services varied from one 
hospital to another; this would depend on the size of the hospital, the type of the 
hospital as well as the existence of an operating theatre within that hospital. It 
therefore was necessary to identify those hospitals which the inspectors said received 
either a "comprehensive" or "partial" pharmaceutical service and to relate this to the 
number of hours spent by the person providing pharmaceutical services per week.
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The results in Tables 4.12 were therefore cross-tabulated with those in Table 4.10. 
The responses of the inspecting pharmacists confirmed that 57 (53%) of these 
hospitals received a "comprehensive" pharmaceutical service of at least 30 and up to 
40 hours/week. Surprisingly, 1 hospital with 40 beds and 2 operating theatres which 
received a pharmaceutical service of less than 5 hours/week provided by a pharmacist 
employed directly by the hospital, was considered by the inspector to receive a 
"comprehensive" pharmaceutical service. On the other hand, 2 hospitals, one of them 
with 116 beds and 5 operating theatres, which received a pharmaceutical service of 
more than 40 hours/week, were reported by the inspector to receive only a "partial" 
pharmaceutical service provided by a pharmacist employed directly by the hospital.
4.3.4.2. Services provided by an NHS hospital pharmacist.
In 49 hospitals, the pharmacy services were provided by a pharmacist contracted from 
an NHS hospital. According to the inspectors, in at least 39% of those hospitals the 
service was "comprehensive" (Table 4.13). The inspecting pharmacists responses 
showed that among those hospitals, 3 of them received a "comprehensive" 
pharmaceutical service of more than 40 hours/week. Surprisingly, in the case of 1 
hospital with 150 beds and 3 operating theatres it was considered by the inspector to 
receive a "comprehensive" pharmaceutical service despite less than 5 hours/week 
service being provided by an NHS pharmacist.
Table 4.13. Descriptions used by the inspecting pharmacists to describe the 
pharmaceutical services provided by a pharmacist contracted from an NHS 
hospital
Service Description No. o f Cases %
gjjhprehensive 19 38.8
Partial 13 26.5
Either Comprehensive /  Partial 17 34.7
TOTAL 49 100%
(N.B. Only 1 missing case is recorded in this test).
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4.3.4.3. Services provided by a community pharmacist.
Of the 26 hospitals which received a pharmaceutical service provided by a 
Community Pharmacist, in only 3 cases was the service described by the inspectors as 
"comprehensive"(Table 4.13). However, 1 hospital with 37 beds and 1 operating 
theatre was considered to receive a "comprehensive" pharmaceutical service 
provided by a Community Pharmacist despite the fact that the inspector’s response 
indicated that no time (0 hours/week) was spent at the hospital.
Table 4.13. Descriptions used by the inspecting pharmacists to describe the 
pharmaceutical services provided by a community pharmacist
Service Description No. o f Cases %
Comprehensive 3 11.5
Partial 12 46.2
Either Comprehensive /Partial 11 42.3
TOTAL 26 100%
(N.B. Only 1 missing case is recorded in this test).
4.3.4.4. Services provided by a self-employed pharmacist.
In 3 hospitals, the pharmaceutical services were provided by a self-employed 
pharmacist (Table 4.14). One of these three hospitals, which has 33 beds and 2 
operating theatres, was considered to receive a "comprehensive" pharmaceutical 
service of only 15 hours/week provided by a self-employed pharmacist.
Table 4.14. Descriptions used by the inspecting pharmacists to describe the 
pharmaceutical services provided by an independent (self employed) pharmacist
Service Description No. o f  Cases %
'CofitpMlnsiye ’ ; 2 66.7
Either Comprehensive/Partial 1 33.3
TOTAL 3 100%
(N.B. Only 1 missing case is recorded in this test).
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4.3.4.5. Services provided bv a non-pharmacist.
In 16 hospitals, the pharmaceutical service was provided by a non-pharmacist (Table 
4.15). One of those hospitals, with 5 beds and no operating theatres, was considered to 
receive a "comprehensive" pharmaceutical service through a commercial 
organisation, while in the others the services are provided through either a technician 
or a wholesaler and their services were considered to be at least "partial" services.
Table 4.15. Descriptions used by the inspecting pharmacists to describe the 
pharmaceutical services provided bv a non- pharmacist
Service Description No. o f Cases %
Comprehensive 1 10
Partial 2 20
Either Comprehensive./Partial 7 70
TOTAL 10 100%
(N.B. Only 1 missing case is recorded in this test).
4.3.4.6. Services provided bv a non-pharmacist where a pharmacist 
acted only as a supplier.
In 22 hospitals, the only input of the pharmacist was a supply function. 11 of them, 
some with no beds and with a maximum of 63 beds, with up to 2 operating theatres, 
received such an input of less than 5 hours/week. This supply function input may be 
obtained either from community pharmacists (3 hospitals) or from NHS hospital 
pharmacists (17 hospitals). Two other hospitals indicated that they received a supply 
function, but they did not indicate its source. Of the total of 228 independent hospitals 
surveyed, there was only 1 hospital from which no information was available 
regarding the person who provided the pharmaceutical services.
In order to obtain general findings between the different provider models, the decision 
was made to regard hospitals that received a pharmaceutical service by any of the 
above mentioned provider models as receiving a service regardless of whether this 
service was "comprehensive" or "partial".
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4.4. Comparison o f different IHs based on the availability o f a pharmacist or a non­
pharmacist, and the number o f beds and overatins theatres.
4.4.1. Services obtained from a vharmacist or a non-pharmacist.
Table 4.9 listed the different service provider models that applied in the IHs surveyed. 
In an effort to examine the differences between hospitals that obtain their 
pharmaceutical services through a pharmacist (either employed by the hospital, or 
contracted from an NHS hospital, a community pharmacist or a self-employed 
pharmacist) and those hospitals which have no pharmacist involvement, the 
independent hospitals were divided into two groups. These two groups were: Group I- 
hospitals where a pharmacist was employed directly by the hospital, or contracted 
from an NHS hospital, or from a community pharmacy or as a self-employed 
pharmacist; and Group II- hospitals where the service provision was by a non­
pharmacist or where a pharmacist was involved only as a supplier. Table 4.16 shows 
the numbers of IHs obtaining pharmaceutical services by each group.
Table 4.16. The numbers o f IHs with services provided by a vharmacist or non- 
pharmacist
Provider Frequency %
Pharmacist (Group I) 189 83.3
Non-Pharmacist (Group II) 38 16.7
TOTAL 227 100%
(N.B. only 1 missing case v/as recorded in this test).
The results in Table 4.16 were cross-tabulated with the number o f hours per week 
spent by the person(s) providing pharmaceutical services in order to find out how 
many hours per week were spent by pharmacists and non-pharmacist for the provision 
of pharmaceutical services. The results are shown in Table 4.17.
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Table 4.17. Distribution o f hours o f service per week for the provision o f  






As can be seen from Table 4.17, interestingly, 22 of the non-pharmacists provided 
zero hours for the provision of pharmaceutical services to independent hospitals. This 
seems very strange situation because even the non-pharmacists was a pharmacist 
acting as a supplier, he/she should spend sometime in the hospital for the orders or 
delivery.
Very highly significant differences were obtained from the cross-tabulation of the two 
groups of providers and the hours spent per week for the provision of pharmaceutical 
services, using the Pearson chi-square test (p= 0.0001, df = 12). This means that the 
hours of service for the two groups of providers are statistically different. The Mann- 
Whitney test also confirmed that the two groups are statistical different (p= 0.0001).
4.4.2. Numbers o f beds within independent hospitals.
The independent hospitals range in size, based on the numbers of beds, from 3 beds to 
as large as 390 beds. The mean is 50 beds, the mode is 30, and the median is 40 beds.
In an effort to compare hospitals having less than 40 beds ( 0 - 3 9 )  with those having 
40 beds or more, the hospitals were divided into two groups. Hospitals with less than 
40 beds are considered as group B l, and hospitals with 40 beds and more are 
considered as group B2 (Table 4.18). The figure < 40 and > 40 are the figures used by 
NAHAT guidelines to distinguish between small and large hospitals. But that is not to 
say that any hospital with < 40 beds is necessarily a physically small hospital.
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Table 4.18. Numbers o f  hospitals with less than 40 beds and 40 beds or more:-
Bed Number Frequency %
Less than 40 (Group B l) 78 45.6
40 and more (Group B2) 93 54.4
TOTAL 171 100%
(N.B. 57 missing cases were recorded in this test. The sample size is 228).
The distribution of the service provider model with respect to hospital 'size', based on 
hospitals with less than 40 beds and those with 40 beds or more, was examined by 
cross-tabulating Table 4.9 with Table 4.18. The results are shown in Table 4.19.
Table 4.19. Distribution o f the service provider model in hospitals with <40 Beds 
and hospitals with 40 Beds or more:-















40+ 62 16 6 2 2 5 93(54.7%)
TOTAL 74 41 21 3 12 19 170
(N.B. 58 missing cases were recorded in this test).
The Pearson chi-Squared test was used to find out the significance of any differences 
between the two groups. Very high significance (p= 0.0001, df= 6) was obtained from 
this test, which means that there are significant differences in service provider models 
between hospitals with less than 40 beds and those with 40 beds or more. In other 
words, it is highly likely that there is a statistical relationship between the hospital 
beds number and the provider of the pharmaceutical services to those hospitals.
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The Kruskal-Wallis-One-Way Anova test was also applied here to confirm that there 
was a relationship between hospital beds number and the person providing the 
pharmaceutical services. A very highly significant result (p= 0.0001, df= 6) was 
obtained from this test, which indicates that the two variables are statistically different 
from each other.
The hospitals grouped on the basis of pharmacist (Group I) and non-pharmacist 
(Group II) provider were also cross-tabulated with the hospitals with < 40 beds and 
hospitals of 40 beds or more. Table 4.20 shows the results.
Table 4.20. Distribution o f the pharmacist (I) and non-pharmacist (II) groups in 
hospitals o f  <40 beds and hospitals o f 40 beds or more:-
G R O U P
I (Pharmacist) II (Non-Pharmacist) TOTAL
Beds <40 53 24 77
40+ 86 7 93
T O T A L 139 31 170
(N.B. 58 missing cases were recorded in this test).
A Pearson chi Square test showed a very highly significant result (p= 0.00021, df= 1), 
which means that there are very large differences between the beds groups for the 
pharmacist and non-pharmacist groups.
Because the number of variables here does not exceed two, the Mann-Whitney test is 
useful to apply to find out the differences between the two groups. A very highly 
significant result (p= 0.0001) was obtained here, which means that there is a statistical 
relationship between the two groupings.
4.4.3. Operating theatres within independent hospitals.
Another recommendation of NAHAT with regard to the employment of the 
pharmacist in independent hospitals relates to the number of operating theatres. The 
NAHAT guidelines recommend that if the hospital has an operating theatre, there 
should be a pharmacy department10.
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In order to find out how the service provider models were distributed in hospitals with 
different numbers of operating theatres, the results in Table 4.9 for the service 
providers were cross-tabulated with the numbers of operating theatres within 
independent hospitals. Table 4.21 shows the results.
Table 4.21. Distribution o f the service provider models in independent hospitals 












7 8 3 0 3 3 24
^ S M ip a 16 13 13 0 13 12 67
32 17 5 2 0 3 59
10 3 1 1 0 1 16
3 0 1 0 0 0 4
3 0 0 0 0 0 3
1 0 0 0 0 0 1
TOTAL 72 41 23 3 16 19 174
(N.B. 54 missing cases were recorded in this test).
Table 4.21 shows that the pharmacist employed directly by the hospital appeared in all 
hospitals with different numbers of operating theatres. Despite the NAHAT 
guidelines, surprisingly, 13 hospitals having 1 operating theatre receive their 
pharmaceutical services via a non-pharmacist and in 16 hospitals in which the number 
of operating theatres ranged from 1 to 3 the only input from a pharmacist was a 
pharmacist involved as a supplier. The responses to Questionnaire # 1 showed that 
nearly the same number of hospitals (i.e. 12) having 1 and 2 operating theatres receive 
its pharmaceutical services via non-pharmacist and 7 hospitals with 1 and 2 operating 
theatres the only input from a pharmacist was a pharmacist involved as a supplier.
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A slightly significant result of (p= 0.046, df = 36) was observed here from the Pearson 
chi-square test. The Kruskal-Wallis 1 -Way Anova test was also applied; in that test a 
very highly significant result (p= 0.0001, df = 6) was obtained, which means that there 
is a statistical relationship between the service provider model and the number of 
operating theatres.
The same tests as before were applied to find out if there were any significant 
differences between hospitals with different numbers of operating theatres with regard 
to those with a pharmacist and those without. Table 4.22 shows the results.
Table 4.22. Provision o f pharmaceutical services by pharmacists or non­
pharmacists in IHs with different numbers o f operating theatres:-
i8 S . ^}perat/ - in g T
U ' +L
0 1 2 3 4 5 7 TOTAL
Service Pharmacist 18 42 56 15 4 3 1 139
Provider Non-Ph armacist 6 25 3 1 0 0 0 35
TOTAL 24 67 59 16 4 3 1 174
(N.B. 54 missing cases were recorded in this test).
From Table 4.22, it can be seen that pharmacists were involved in providing 
pharmaceutical services in hospitals ranging from those with none and up to 7 
operating theatres. On the other hand, non-pharmacists, surprisingly, were involved in 
providing pharmaceutical services not only where there was no operating theatre but 
also in hospitals with 1, 2 and 3 operating theatres.
To find out the distribution of pharmacist (group I) and non-pharmacist (group II) in 
different types of IHs (i.e. those IHs with less than 40 beds or 40 beds or more, and 
having different numbers of operating theatres), the results of Table 4.20 were cross­
tabulated with Table 4.22. The results are shown in Table 4.23 and Figures 4.1 and
4.2.
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As shown in Table 4.23, there were no hospitals with less than 40 beds and more than 
3 operating theatres. In 14 of the hospitals with less than 40 beds and 1 or 2 operating 
theatres non-pharmacists were responsible for pharmaceutical services. Non- 
pharmacists were also involved in pharmaceutical service provision in 7 hospitals 
with 40 beds or more and up to 3 operating theatres. In contravention of the NAHAT 
guidelines, 20 hospitals with one or more operating theatres did not employ a 
pharmacist for the provision of the pharmaceutical service.
The very highly significant result (p= 0.00192, df = 6) obtained from the Pearson chi- 
square test, indicated that there is a very highly significant variation in the number of 
hospitals served by pharmacists and by non-pharmacists as the number of operating 
theatres and beds number changes. The Mann-Whitney test was also applied here, a 
very highly significant result (p= 0.0001) being obtained.
In summary, the provision of pharmaceutical services in independent hospitals by 
pharmacists and non-pharmacists with respect to the mean number of beds and 
different numbers of operating theatres are illustrated in Table 4.24.
Table 4.24. Summary o f the provision o f pharmaceutical services in independent 
hospitals (n=158) by a pharmacist or a non-pharmacist
No. o f Operating 0 1 2 3 4 5 7 T
Mean No. o f Beds 73.3 30.4 53.9 57.8 120.7 165.7 160 O
Pharmacist 18 38 51 14 3 3 1 128 T
Non-Pharmacist 6 20 3 1 0 0 0 30 A
TOTAL NO. OF IHs. 24 58 54 15 3 3 1 158 L
(N.B. 70 missing cases were recorded in this test).
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Table 4.23. Overall distribution o f  pharmacists’ and non-pharmacists ’ involvement in service provision in hospitals with 
less than 40 beds and hospitals with 40 beds or more and different numbers of operating theatres:-
PHARMACIST NON-PHARMACIST
Beds Beds
< 40 40 + TOTAL < 40 40 + TOTAL
0 1 10 17 MBit 0 5 1 6
1 30 7 37 1 13 3 16
2 11 40 51 Operating 2 1 2 3
3 1 13 14 tMfms 3 - 1 1
4 - 3 3 4 - - -
5 - 3 3 5 - - -
flHEMi 7 - 1 1 liii 7 - - -
TOTAL 49 77 126 TOTAL 19 7 26
(N.B. 76 missing cases were recorded from this test), 
("-"no record of a hospital in that category).
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□  Pharmacist
□  Others
Figure 4.1. Distribution of the service provision by  
pharm acists and non-pharmacists in hospitals with < 40 
beds and different numbers of Operating Theatres
0 1 2 3 4 5 7
No. of Operating Theatres
No. of Hospitals with 
< 40 Beds
Figure 4.2. Distribution of the pharm acists and non­
pharm acists in hospitals with 40 Beds or more and different 
numbers of Operating Theatres
No. of Hospitals with 
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4.5. Inspection visits to hospitals with and without a pharmacist
NAHAT recommends that the statutory minimum requirement each year of 2 
inspection visits to independent hospitals should be increased to 4 where no 
pharmacist is present10. Based on these guidelines, the number of inspections per year 
were cross tabulated with the number of hospitals with different service providers to 
find out whether there are any differences in the frequency of the inspection visits 
between those hospitals with different service providers. Table 4.25 shows the results.
Table 4.25. Number o f inspection visits per year to hospitals with different 
pharmaceutical service providers
As can be seen from Table 4.25, 2 hospitals received no inspection visits at all in the 
previous 12 months. In one of these hospitals, there was no pharmacist involvement in 
pharmaceutical services at all. 46 hospitals received only 1 inspection visit, and 8 of 
those had no pharmacist in the hospital at all. Moreover, 18 hospitals with no 
pharmacist, received the statutory minimum number of 2 inspection visits per year. 
Only 3 hospitals received more than 4 inspection visits including 2 hospitals with no 
pharmacist present which received 5 and 8 visits respectively. Only 5 hospitals with 
no pharmacist present received the NAHAT recommended number of 4 visits per 
year.
W M SM m yte■
PROVIDER
(N.B. 47 missing cases were recorded in this test),
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The very highly significant result (p=0.00181, df = 42) obtained from the Pearson chi- 
square test, indicated that there is a very highly significant variation in the number of 
inspection visits to hospitals served by different service providers.
The number of inspection visits per year were cross-tabulated with the number of 
hospitals with and without a pharmacist. Table 4.26 shows the results.
Table 4.26. Numbers o f  inspection visits per year to hospitals with and without a 
pharmacist:-
0 1 2 3 4 5 6 8 TOTAL
Pharmacist 1 38 95 4 8 0 1 0 147
Non-Pharmacist 1 8 18 0 5 1 0 1 34
(N.B. 47 missing cases were recorded in this test).
Thirty eight hospitals with a pharmacist, received only 1 inspection visit per year, 
which is below the figure of 2 recommended by NAHAT and required by statute. 
Although 26 hospitals, in which no pharmacist was involved in service provision, 
received at least 1 and up to 3 inspection visits during the year, that was still below the 
figure of 4 recommended by NAHAT.
Very highly significant differences were obtained by the Pearson chi-square test (p= 
0.0001, df = 7) which means that there are very large differences between the number 
of inspection visits to hospitals with and without a pharmacist. On the other hand, the 
finding of a Mann-Whitney test revealed no significant differences between the 
pharmacist/non-pharmacist groups and the number of inspection visits.
In an effort to find out whether the number of operating theatres has any effect on the 
number of inspection visits per year, the numbers of inspection visits per year were 
cross-tabulated with the numbers of hospitals with different numbers of operating 
theatres. Table 4.27 shows the results.
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Table 4.27. Number o f  inspection visits ver year to hospitals with different numbers 
o f operating theatres
/* . Operating Theatres
0 1 2 3 4 5 7 TOTAL
v 0 0 1 0 0 0 0 0 1
i 2 18 12 6 0 0 0 38
2 17 32 38 7 4 2 1 101
-I 3 2 1 0 2 0 0 0 5
i § § 4 1 9 3 0 0 0 0 13
B 5 0 1 0 0 0 0 0 1
6 0 0 0 0 0 0 0 0
7 0 0 0 0 0 0 0 0
S \ 8 1 0 0 0 0 0 0 1
TO T A L 23 62 53 15 4 2 1 160
(N.B. 68 missing cases were recorded from this test).
As can be seen from Table 4.27, 1 hospital with 1 operating theatre received no visits 
at all. Furthermore, 36 hospitals with one or more operating theatres received only one 
inspection visit per year. In addition, more than half of the hospitals (63%) received 
the statutory minimum number of inspection visits (i.e. 2). The Pearson chi-square test 
shows no significant relationship between the numbers of inspection visits per year 
and the different numbers of operating theatres.
4.6. Level o f compliance with NAHAT guidelines
In an effort to find out the level of compliance with the NAHAT guidelines 
concerning the number of inspection visits and the presence of a pharmacist within the 
independent hospitals, the pharmacist/non-pharmacist groups were cross-tabulated 
with the number of inspection visits per year in hospitals with different number of 
operating theatres and hospitals having less than 40 beds and hospitals with 40 beds or 
more. The findings of this relation are illustrated in Tables 4.28 and 4.29 respectively.
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Tables 4.28 and 4.29 shows that out of 116 hospitals with a pharmacist (either 
employed directly by the hospital, contracted from an NHS hospital, a community 
pharmacist or by a self-employed pharmacist), 29 hospitals with 1-3 operating theatres 
received only one inspection visit per year. 11 hospitals with a pharmacists and up to 3 
operating theatres received 3 and 4 inspection visits per year. On the other hand, out of 
30 hospitals without a pharmacist, 23 hospitals with from 1-3 operating theatres, 
received only 1 or 2 inspection visits per year. Moreover, only 6 hospitals with 1 
operating theatre and no pharmacists received 4 to 5 inspection visits per year. 1 
hospital with no pharmacist and no operating theatre received 8 visits in the year.
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Table 4.28. Summary o f the numbers o f  inspection visits per year to hospitals with LESS THAN 40 BEDS and with and without a
pharmacist and bavins different numbers o f operating theatres
VISITS
NUMBER
Operating Theatres Operating Theatres
0 1 2 3 4 5 7 TOTAL 0 1 2 3 4 5 7 TOTAL
,0 - - - - - - - - - - - - - - - - -
' - 13 2 - - - - 15 1 4 - - - - - 5
6 12 7 - - - - 25 4 8 1 - - - - 13
- 1 - 1 - - - 2 - - - - - - - -
- 4 - - - - - 4 - 4 - - - - - 4
5 - - - - - - - - - 1 - - - - - 1
6 - - - - - - - - - - - - - - - -
s s t s n n
- - - - - - - - - - - - - - - -































(N.B. 82 missing cases were reported from this test).
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Table 4.29. Summary o f the numbers o f  inspection visits per year to hospitals with 40 BEDS OR MORE and with and without a
pharmacist and bavins different numbers o f operating theatres




Operating Theatres Operating Theatres
0 1 2 3 4 5 7 TOTAL 0 1 2 3 4 5 7 TOTAL
0 - - - - - - - - - - - - - - - -
1 - 8 5 - - - 14 - 1 1 1 - - - 3
7 7 25 6 3 2 1 51 - 1 1 - - - - 2
3 1 - - 1 - - - 2 - - - - - - - -
4 - - 3 - - - - 3 - 1 - - - - - 1
3 - - - - - - - - - - - - - - - -
6 - - - - - - - - - - - - - - - -
7 - - - - - - - - - - - - - - - -
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4.7. Assessment o f service quality including the emphasis placed by the inspectors 
on particular criteria durins inspection of pharmaceutical services:-
The questionnaire asked the SPMs to state what emphasis they placed on each of 13 
specified pharmaceutical service criteria during their inspection of independent 
hospitals (question 19). They were also asked to give their assessment of the quality of 
each of those services in each of the hospitals that they inspected (question 19).
Three possible levels of emphasis were given in the questionnaire : unimportant, quite 
important, very important. And five possible levels of assessment were given in the 
questionnaire: very good, good, satisfactory, poor, very poor.
This information was used to determine whether there were any differences in 
emphasis and assessment between different hospitals, for example those with a 
pharmacist and those without.
4.7.1. Emphasis.
The emphasis placed by the inspecting pharmacists during inspecting IHs were cross­
tabulated with each of the 13 pharmaceutical services in hospitals with different 
service providers (i.e. pharmacist and non-pharmacist). The results are shown in Table 
4.30.
Table 4.30 shows that, of the 13 pharmaceutical services, for 10 of them, the number 
of responses received with regard to the emphasis placed by the inspector during 
inspection was on average 156 (range 145 to 161) responses for hospitals with a 
pharmacist, and on average 34 (range 28 to 37) responses for hospitals without a 
pharmacist. For the other 3 criteria (TV, Cytotoxics and TPN) the corresponding 
figures were 98 on average (range 86 to 107) responses for those hospitals with a 
pharmacist and, on average 16 (range 14 to 19) responses for those without a 
pharmacist.
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Table 4.30. EMPHASIS placed by the inspectors durins inspection o f  the various 













Pharmacist 11 (7%) 66 (41%) 84 (52%) No 161
Others 1 (3%) 17 (46%) 19 (51%) 37
Secure Storage 
of Medicines
Pharmacist 3 (2%) 15 (9%) 143 (89%) No 161
Others 0 3 (8%) 34 (92%) 37
Comprehensive
Labelling
Pharmacist'' 4 (3%) 15 (9%) 140 (87%) No 159
Others 0 2 (6%) 32 (94%) 34
Qualification & 
Training of Staff
PJdai^iacist 12 (8%) 60 (38%) 84 (54%) No 156
( S ir s  i 0 r 8 (24%) 10 (29%) 16 (47%) 34
Stock Control & 
Record Keeping
Pharmacist, 6 (4%) 45 (28%) 110 (68%) No 161
0 5 (14%) 32 (86%) 37
Environmental 
Storage of Med.
Pharmacist 4 (2%) 35 (22%) 122 (76%) No 161
Others 0 13 (35%) 24 (65%) 37
Monitoring of 
Drug Therapy
Pjiarmacist 13 (8%) 41 (28%) 96 (64%) No 150
•Cfffieres-. 6(21%) 7 (25%) 15 (54%) 28
Disposal of 
Medicines
^ h a rm in il 2 (2%) 67 (42%) 90 (56%) No 159
Others 2 (5%) 19 (53%) 15 (42%) 36
Procedures in 
I.V. Additives
Pharmacist 14(13%) 22 (21%) 71 (66%) No 107
Others 4 (21%) 3 (16%) 12 (63%) 19
Procedures in 
Cyto-toxics
Pharmacist 8 (8%) 19(19%) 74 (73%) No 101
'OthirslSiS 2 (14%) 2 (14%) 10 (72%) 14
Procedures in 
TPN
Pharmacist 8 (9%) 18 (21%) 60 (70%) No 86
Others 2 (13%) 3 (20%) 10 (67%) 15
Drug
Information
Pharmacist 14 (9%) 61 (42%) 71 (49%) No 146
Ot 6 (21%) 13 (45%) 10 (34%) 29
Antibiotic/Cross 
Infection Policy
Pharmacist 12 (8%) 84 (58%) 49 (34%) No 145
Others 2 (6%) 15 (47%) 15 (47%) 32
* Significant differences between the two categories of service provider models (Pearson 
chi-square, P^0.05).
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Analysis of the emphasis placed by the SPMs, was performed using cross-tabulation 
of the data coupled with a Pearson chi-square test as well as the Mann-Whitney test. 
The results showed no significant differences (p^0.05) in emphasis between hospitals 
with and without a pharmacist.
For each of the service criteria, the following figures represent the total numbers of 
inspectors (expressed as a percentage) who placed either a "quite important" or a 
"very important" emphasis on that criterion during inspection of the hospitals. For 
hospitals with a pharmacist: procurement of medicines (93.2%); secure storage of 
medicines (98.1%); comprehensive labelling (97%); qualification and training of the 
staff (92.5%); stock control and record keeping (96%); environmental storage of 
medicines (97.5%); monitoring of drug therapy (91%); disposal of medicines (98.7%); 
IV. additives (86.7%); cytotoxics (92%); TPN (90.7%); drug information (90.4%) and 
antibiotic/cross infection policy (91.7%). The corresponding values for hospitals 
without a pharmacist were: procurement of medicines (97.3); secure storage of 
medicines (100%); comprehensive labelling of medicines (100%); stock control and 
record keeping (100%); environmental storage of medicines (100%); disposal of 
medicines (94%) and antibiotic/cross infection policy (93.7%). In comparison with 
hospitals with a pharmacist, surprisingly, the inspectors placed less emphasis on the 
following services when inspecting the hospitals without a pharmacist (the percentage 
figures are again calculated as explained above):- qualification and training of the staff 
(76%); monitoring of the drug therapy (76.6%); IV-additives (78.9%); cytotoxics 
(85.6%); TPN (86.7%) and drug information (79.3%).
4.7.2. Assessment o f  the quality o f service provision.
Tables 4.31 and 4.32 presents the results for quality assessment given by the 
inspecting pharmacists for each of the service criteria in different hospitals. Table 4.31 
presents the data as the number of inspectors assigning a particular quality assessment 
and Table 4.32 shows the same data expressed as percentage values. Analysis of the 
quality assessment opinions given by the SPMs, using cross-tabulation of the data 
coupled with the Pearson chi-square test showed significant differences (p^0.05) in 
quality for 9 of the service criteria, as assessed by the SPMs, between hospitals with 
and without a pharmacist.
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Table 4.31. Number o f ASSESSMENTS o f quality given by the inspectors for the 
various pharmaceutical services in hospitals with and without a pharmacist:-
Nos. o f  provider assessed as
52 VeryGood Good Satisf­actory Poor VeryPoor Sig* TOTAL
Procurement of 
Medicines
H1I181SM 76 60 21 0 0 Yes 157
6 16 14 0 1 37
Secure Storage 
of Medicines
PhimnadsL 63 68 27 0 0 Yes 158
10 15 7 5 0 37
Comprehensive
Labelling
Pharmacist 70 60 24 1 0 Yes 155
Others' * £ - 7 11 13 3 0 34
Qualification & 
Training of Staff
Phafm§&§£; 57 56 28 8 0 Yes 149
6 9 13 1 2 31
Stock Control & 
Record Keeping
P tegSm sS 64 55 32 6 0 Yes 157
g ^ n m 4 16 14 2 1 37
Environmental 
Storage of Med.
WS8S$8Bsi 41 67 45 5 0 No 158
m 7 12 15 2 1 37
Monitoring of 
Drug Therapy
BBISiSsir 28 53 44 14 6 Yes 145
0 7 9 8 4 28
Disposal of 
Medicines
46 67 41 1 1 Yes 156
t g i S l l l l g 4 8 22 1 0 35
Procedures in 
I.V. Additives
Pharniacilt 21 29 33 9 2 No 94
IS iS iflf 0 4 10 3 0 17
Procedures in 
Cyto-toxics
22 34 25 8 4 No 93
QifierslBE 2 3 4 2 0 11
Procedures in 
TPN
ISSlggBB 20 25 23 5 3 No 76
0 4 6 2 0 12
Drug
Information
Phlfficfsf; 23 53 54 5 5 Yes 140
SSISlillll 1 6 12 5 4 28
Antibiotic/Cross 
Infection Policy
PhafmacifX 16 43 69 9 1 Yes 138
i l g i i S I S i 2 3 12 9 3 29
* Significant differences between the two categories of service provider models
(Pearson chi-square, P^0.05).
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Table 4.32. Percentage number o f ASSESSMENTS o f Quality given by the 
inspectors for the various pharmaceutical services in hospitals with and without a 
pharmacist:-










Procurement of Pharmacist 48 38 14 0 0 Yes 157
Medicines Others 16 43 38 0 3 37
Secure Storage Pharmacist 40 43 17 0 0 Yes 158
of Medicines Others 27 40 19 14 0 37
Comprehensive Pharmacist 45 38 16 1 0 Yes 155
Labelling Others U U 21 32 38 9 0 34
Qualification & n t  -  ♦  “ r t vPharmacist 38 38 19 5 0 Yes 149
Training of Staff Others 19 29 42 3 7 31
Stock Control & Pharmacist 41 35 20 4 0 Yes 157
Record Keeping Others 11 43 38 5 3 37
Environmental Pharmacist 26 42 29 3 0 No 158
Storage of Med. Others 19 32 41 5 3 37
Monitoring of Pharmacist 19 37 30 10 4 Yes 145
Drug Therapy Others 0 25 32 29 14 28
Disposal of Pharmacist 29 43 26 1 1 Yes 156
Medicines Others 11 23 63 3 0 35
Procedures in Pharmacist 22 31 35 10 2 No 94
I.V. Additives Others 0 23 59 18 0 17
Procedures in Pharmacist 24 36 27 9 4 No 93
Cyto-toxics Others 18 27 37 18 0 11
Procedures in Pharmacist 26 33 30 7 4 No 76
TPN Others 0 33 50 17 0 12
Drug T Y l &Pharmacist 16 38 38 4 4 Yes 140
Information Others 4 21 43 18 14 28
Antibiotic/Cross Pharmacist' 12 31 50 6 1 Yes 138
Infection Policy Others | | 7 11 41 31 10 29
(Note: the given % are rounded to allow easy comparison).
* Significant differences between the two categories o f service provider models 
(Pearson chi-square, P^0.05).
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For each of the service criteria, the following figures represent the total numbers of 
hospitals (expressed as a percentage) who received either a "good" or a "very good" 
assessment by the inspectors on that criterion during their inspections. The results are 
taken from figure 4.32 for hospitals with a pharmacist: procurement of medicines 
(86%); secure storage of medicines (73%); comprehensive labelling of medicines 
(83%); qualification and training of the staff (76%); stock control and record keeping 
(76%); environmental storage of medicines (68%); monitoring of the drug therapy 
(56%); disposal of medicines (72%); IV-additives (53%); cytotoxics (60%); TPN 
(59%); drug information (54%) and antibiotic/cross infection policy (43%). The 
corresponding values for hospitals without a pharmacist were: procurement of 
medicines (59%); secure storage of medicines (67%); comprehensive labelling of 
medicines (53); qualification and training of staff (48%); stock control and record 
keeping (54%); environmental storage of medicines (51%); monitoring of drug 
therapy (25%); disposal of medicines (34%); IV-additives (23%); cytotoxics (45%); 
TPN (33%); drug information (25%) and antibiotic/cross infection policy (18%).
Furthermore, the criteria given either a "poor" or "very poor" assessment (the 
percentage figures are again calculated as explained above) by the inspectors during 
inspection in hospitals with pharmacist were: comprehensive labelling of medicines 
(1%); qualification and training of staff (5%); stock control and record keeping (4%); 
environmental storage of medicines (3%); monitoring of drug therapy (14%); disposal 
of medicines (2%); IV-additives (12%); cytotoxics (13%); TPN (11%); drug 
information (8) and anti-biotic/cross infection policy (7%). The corresponding values 
for hospitals without a pharmacist were: procurement of medicines (3%) storage of 
medicines (14%); comprehensive labelling of medicines (9%); qualification and 
training of staff (10%); stock control and record keeping (8%); environmental storage 
of medicines (8%); monitoring of drug therapy (43%); disposal of medicines (3%); 
IV-additives (18%); cytotoxics (18%); TPN (17%); drug information (32%) and anti­
biotic/cross infection policy (41%).
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A comparison was made between hospitals with and without a pharmacist, based on 
the inspectors’ assessments of quality of each service criterion. Use of the Kruskal- 
Wallis test, corrected for ties, confirmed that there were significant differences 
(p^0.05) between different models of service provision as regards the perceived 
quality of 9 of the 13 pharmaceutical service criteria (Table 4.33).
Taking the mean rank, derived from the Kruskal-Wallis analysis, as an indicator of the 
perceived quality, the different service models were placed in rank order, 1 to 6 (Table 
4.33). For 11 of the criteria, hospitals with a directly-employed pharmacist or one 
contracted from an NHS hospital were ranked either 1 (best) or 2 (second best). The 
NHS-contract model did not rank below 2 for any of the 13 criteria, whereas the 
directly-employed model ranked first for 7 of the criteria and ranked third in the case 
of TPN and cytotoxics; it should be noted, however, that the Kruskal-Wallis test did 
not show significant differences between the six service models regarding the quality 
of the TPN or cytotoxics services, nor for IV-additives, secure storage or 
environmental storage. The first rank for cytotoxics was assigned to the non­
pharmacist model which, for that service criterion, was represented by only 2 
hospitals, both of which were assessed as having a ‘very good  ’ cytotoxics service. In 
the case of TPN, the best-ranked model was the self-employed-pharmacist-contracted 
model which, however, for that service criterion, was represented by only one hospital 
for which an assessment was provided. The service model that was based on a 
contract with a community pharmacist ranked third for 10 of the service criteria and 
fourth for the other criteria, except qualifications/training.
The service provider models were grouped into six groups as follows: a pharmacist 
employed directly by the hospital as "Group 1"; an NHS hospital pharmacist as 
"Group 2"; a community pharmacist as "Group 3"; a self-employed pharmacist 
"Group 4"; no pharmacist involved at all in the service provision as "Group 5" and 
the only input by a pharmacist was in supply as "Group 6".
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Table 4.33. The perceived QUALITY of pharmaceutical services using Kruskal- 
Wallis Test (Corrected for Ties)
Service Provider Model





Procurement of f0 ^ 0 3 | 
Medicines
2 1 3 4 6 5
Secure Storage 0.153,6 
of Medicines
1 2 3 6 5 4
Comprehensive OlOOQJ 
Labelling
1 2 3 5 6 4
Qualification and 0.0078 
Training of Staff
1 2 5 3 6 4
Stock Control & Q.0,062 
Record Keeping
1 2 3 5 6 4
Environmental 
Storage of Med.
1 2 3 5 6 4
Monitoring of 0.0002 
Drug Therapy
1 2 3 5 5 4
Disposal of „0^ 3Q28 
Medicines
1 2 3 6 5 4
Procedures in 0.0340 
I.V. Additives
2 1 3 6 5 4
Procedures in 0-4Q67 
Cyto-toxics
3 2 4 6 1 5
Procedures in 3 2 4 1 6 5
Drug ^).002i 
Information
2 1 3 5 6 4
Antibiotic/Cross 0 .(^ ) | 
Infection Policy
2 1 3 5 6 4
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The Least-Significant Difference test (LSD) then, was applied in an effort to identify 
where the differences in service quality lie. The results are shown in Table 4.34. The 
numbers under each service provider model indicate the other service providers) for 
which the quality assessment was significantly different. This test showed significant 
differences between the service provider models for 10 of the service criteria, notably 
when comparing the directly-employed (Group 1) or NHS-contract models (Group 2) 
with the non-pharmacist model (Groups 5 and 6), especially where no pharmacist was 
involved, even in supply (Group 6).
Because of the utilisation of many multiple-comparison procedures in our data, the 
procedures differ in how they adjust the observed significance level. The more 
stringent Bonferroni test is, therefore, useful to apply here because it adjusts the 
observed significance level based on the number of comparisons that are to be made. 
The Bonferroni Test showed significant differences between service provider models 
only in the case of the following service criteria: procurement of medicines; stock 
control of medicines; and qualification and training of staff (Table 4.34).
4.7.3. Emphasis and Assessment.
It was thought that there might be some relationship between how much emphasis the 
inspector placed on each of the 13 service criteria, during his/her inspection, and 
his/her perceived assessment of the quality of each service, in IHs with and without a 
pharmacist.
Analysis of the emphasis placed by the inspector during inspection of each service 
criterion in comparison with his/her perceived assessment of that criterion was carried 
out using cross-tabulation of the data coupled with the Pearson chi-square test. The 
cross-tabulations are shown in Appendix X, Tables X.l to X.13. The results showed a 
significant difference (p<0.05) in the relation between emphasis and assessment for 5 
of the service criteria only in hospitals with a pharmacist. Those 5 service criteria are: 
secure storage of medicines (p= 0.0207), qualification and training of staff (p= 
0.0216), monitoring of drug therapy (p= 0.0023), disposal of medicines (p= 0.0330), 
drug information (p= 0.0037).
Page 194
CHAPTER 4 Senior Pharmacists Survey
Table 4.34. Service criteria for which significant differences were identified
between the service models, us ins LSD and Bonferroni Tests:-
• •  • 1  *  JT J  s



























Secure Storage LSD 5 5 1-2
of Medicines Bonferroni - - - - - -
Comprehensive LSD 3-5-6 3-5-6 1-2 1-2- 1-2
Labelling Bonferroni - - - - - -
Qualification and LSD 5 5 1-2-6 5
Training of Staff Bonferroni 5 5 1-2
Stock Control & LSD 3-5-6 5 1 1-2 1


















Procedures in LSD - - - - - -
I.V. Additives Bonferroni - - - - - -
Procedures in LSD 5 5 1-2
Cyto-toxics Bonferroni - - - - - -
Procedures in LSD - - - - - -
TPN Bonferroni
.









Antibiotic/Cross LSD 5 5 1-2
Infection Policy Bonferroni - - - - - -
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4.8. Other criteria for inspection:-
The questionnaire asked the respondents to indicate any other service criteria which 
they considered in addition to the 13 specified in the questionnaire (question 20). Only 
40 respondents out the 111 respondents (36%) referred to additional criteria which 
they use as a basis when inspecting independent hospitals. 10 of those 40 respondents 
(25%) replied that they use the satisfaction of the medical staff with the entire 
pharmaceutical services, 9 (22.5%) stated that they focus on registration and 
inspection forms, 5 (12.5%) used quality-of-care assessment as a criterion for 
inspection, another 6 respondents used the accountability/managerial status of the 
pharmacist, 5 respondents referred to the provision of clinical pharmacy and the 
proper use of medical gases, and others referred to various other criteria including the 
availability of a 24 hour service and the provision of TTOs.
4.9. Pharmaceutical services which inspectors considered could be significantly 
improved within indevendent hospitals
4.9.1. Hospitals with pharmacists.
Overall, 40 respondents (36%) considered that several facets of pharmaceutical 
services could be significantly improved in those independent hospitals with a 
pharmacist (question 21). These included clinical pharmacy (50% of the 40 
respondents); out of hours services (25%); drug supply and stock control (15%); 
rational drug use (15%); medical gases (15%); drug information (7.5%); and aseptic 
technique (5%). The total exceeded 100% as respondents gave more than one answer.
4.9.2. Hospitals without pharmacists.
34 respondents (31%) considered that several facets of pharmaceutical services could 
be improved in those independent hospitals without a pharmacist (question 21). These 
included in-patient prescription monitoring intervention (44% of the 34 respondents); 
clinical pharmacy (32.4%); general advice (29.4%); aseptic services (14.7%); stock 
control and storage of medicines (8.8%); development of polices and formularies 
(5.9%); drug information and disposal of medicines (5.8%).
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Moreover, 23.5% of the 34 respondents expressed the view that if a pharmacist were 
present in the hospital for sufficient working hours, the service could be significantly 
improved. The total exceeded 100% as respondents gave more than one answer.
4.10. Conflict of interest with resards to inspection:-
Most of the respondents (84%) answered the question about a possible conflict of 
interest with regard to inspection if the NHS hospital employed the Senior Pharmacist 
responsible for inspection and at the same time provided pharmaceutical services to 
the independent hospital (question 22).
65 of the respondents (69.9%) agreed that there is a conflict of interest, while 28 
(30.1%) disagreed with this. 78 respondents gave further comments. Of those 78, 38 
(48.8%) of them stated that there is no conflict of interest because the responsibility 
rests with the Health Authority/Health Board and, as a result, another pharmaceutical 
inspector from a neighbouring Health Authority will inspect the relevant independent 
hospital; 21 (26%) stated that conflict is potential only and that, since inspection 
objectives do not allow room for conflict, there is no direct connection between 
providing the service and the inspection of that hospital; finally, 7 respondents(9%) 
referred to the self-audit of the inspecting pharmacist. Another 10 (12.9%) confirm 
that there is conflict of interest during inspection if the provision of a pharmaceutical 
service to the IH is comprehensive. Finally, 2 (2.6%) respondents stated that the 
detailed contract between the independent hospital and the NHS hospital would 
prevent any conflict of interest.
The job title of the person who undertakes the inspection was also considered in the 
context of this question. Table 4.34 illustrates the inspector’s job title with his/her 
response regarding the possible conflict of interest if an NHS hospital employs the 
Senior Pharmacist responsible for inspection and, at the same time, provides 
pharmaceutical services to the independent hospital. For all but one of the categories 
of job titles, the majority of inspectors considered that there was such a conflict of 
interest; the exception was in the case of the DPhO/SPMs. Otherwise, Table 4.35 
shows no significant effect of the inspectors’ job title on their views regarding a 
conflict of interest.
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Table 4.35. The relation between the inspectors job title and the response with 
resard to the conflict o f interest:-
Conflict
Yes No
gjgp DPho/SMP 8 8 16 T
‘JV' CSP 20 7 27
T Principal Pharmacist 11 5 16 O
1 i Pharmacy Manager 16 5 21
o t Pharmaceutical Advisor 8 2 10 T
b I Registration Officer 1 0 1
e Chief Pharmacist 6 3 9 A
Other 8 2 10
TOTAL 65 28 93 L
(N.B. the total based on respondents n=128)
4.11. Market forces within the NHS and the conflict o f interest in inspection of 
independent hospitals by a provider Senior Pharmacist:-
Most of the respondents (95 =86%) answered the question concerning market forces 
now operating within the NHS and the possibility of conflict of interest when the 
inspection of the independent hospitals is undertaken by a senior pharmacist employed 
by an NHS "provider" hospital (question 23). 44 (46.3%) respondents agreed that the 
situation does present a conflict of interest, while 51 (53.7%) disagreed with the 
suggestion.
77 of the respondents gave their comments with regard to this question. 43 of those 77 
(44.2%) respondents stated that there is no conflict because this responsibility is 
belongs to the Health Authority/Health Board and as a result of that, another 
pharmaceutical inspector will inspect the hospital from the neighbouring Health 
Authority/Health Board on condition that the neighbour should not be a provider to 
the Authority in question. Another 8 (10.4%) stated that the detailed contract between 
the independent hospital and the NHS hospital would prevent any conflict of interest. 
In addition, 10 (13%) stated that there is no conflict if the supply is very limited, and 
areas of competition are negligible. Finally, 25 (32.5%) referred to the fact that there 
would need to be a reliance on the professional integrity of the inspecting pharmacist.
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4.12. Acknowledgement for contribution.
The respondents were asked if they wished to be acknowledged for the contribution 
they made to the current survey. Their names can be found in Appendix XII.
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CHAPTER FIVE
INTERVIEWS WITH SOME SENIOR PHARMACISTS INVOLVED IN THE 
STATUTORY INSPECTIONS OF INDEPENDENT HOSPITALS.
5.1. INTRODUCTION.
Following the analysis of the data using the two questionnaires, it was decided that 
interviews should be conducted with all the Senior Pharmacists who, according to the 
survey results, were involved in the statutory inspection of 3 or more independent 
hospitals in England. The purpose of those interviews would be to obtain additional 
comments on:
1) problems encountered as a result of receiving some responses from the Senior 
Pharmacy Managers who stated that they were not involved in the statutory 
inspections of independent hospitals in England as discussed in Chapter 2 and,
2) certain unexpected results obtained from the analysis of the two questionnaires 
(Chapter 3 and 4) on some aspects of pharmaceutical services within independent 
hospitals,
5.2. METHODS.
' 5.2:1. Choice o f ‘method.
For the purpose of obtaining additional comments, it was decided that interviews 
should be conducted with all of the Senior Pharmacists involved in inspection of 3 or 
more independent hospitals throughout the UK.
Semi-structured face-to-face interviews were selected as the prefered method for 
collecting further information because:
(1) there were certain questions which had been included in the questionnaire, but on 
which more details were required.
(2) the Senior Pharmacists who inspected 3 hospitals or more were seen to be persons 
with considerable experience of inspection; personal interviews with them were 
expected to provide a better understanding about the situation in different 
independent hospitals, for example those with a pharmacist and those without.
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(3) the potential benefits of visiting and interviewing this small sample of experienced 
inspectors were considered to justify the cost.
5.2.2. Design o f  the interview questionnaire.
(1) Introductory letter: A letter was sent to all the Senior Pharmacists who were to 
have inspected 3 independent hospitals or more. The letter reminded the inspector 
that he/she had filled in a questionnaire in the past entitled "Pharmaceutical 
services provision in independent hospitals as perceived by pharmacists involved in 
their inspection" and explained the study and the information required. Also the 
letter gave them advance notification of the telephone call for the purpose of setting 
up a suitable time to run the interview, in case of acceptance. An assurance was 
given that the interview would not last for more than 30 minutes. A copy of the 
letter sent to these Senior Pharmacists can be found in Appendix XIII.
(2) Length of interview: In designing the semi-structured interview, care was taken to 
make the interview questions concise and straightforward, so that the length of the 
interview would not exceed 30 minutes.
(3) Time and location: Flexibility in setting the time of the interview with the 
inspectors was considered to be an important factor due to the fact that time is 
valuable for such persons.
5.2.3. Structure o f  the interview questionnaire.
The questionnaire interview was divided into 3 parts.
Part one. Questions related to the questionnaire entitled 'Pharmaceutical services in 
independent hospitals as perceived by pharmacists involved in their inspection'.
Part two. Questions related to the Questionnaire entitled 'Pharmaceutical services 
provision in independent hospitals as perceived by persons providing the service'.
Part three. General questions related to: the difficulties faced, during the study, in 
obtaining the name of the Senior Pharmacist involved in inspection of independent 
hospitals in many Health Authorities; the conflict of interest with regard to inspection; 
and the inspector’s perception regarding the level of professional co-operation 
between pharmacists in the independent hospitals and in NHS hospitals.
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5.2.3.1. Part one o f  the interview.
The first part concerned general details about the interviewee, including: name, Health 
Authority to which he/she provides inspection advice.
If the inspector was still involved in the inspection of independent hospitals, he/she 
would be asked to provide information on the current situation of pharmaceutical 
services within independent hospitals. However, even if he/she was no longer 
involved in inspection, their opinion would still be valuable especially as their 
experience related to the period of collecting the data. Therefore, the interviewer 
would ask who is currently undertaking the inspections in the relevant Health 
Authority. A question would be asked about the number of independent hospitals in 
the Health Authority and how many of those were with and/or without a pharmacist. 
Although this information was available from the questionnaire which was completed 
by the interviewee, a decision was made to include these questions in order to provide 
confirmatory information.
It was envisaged that sometimes an inspector might set out with different requirements 
for inspecting different independent hospitals according to their needs. For example, if 
the inspector had evidence (from a previous inspection visit) that a certain hospital 
received unsatisfactory service in any respect, he/she may be prepared to place more 
emphasis. on that - particular • service in- his/her next inspection visit. Also * if the' 
independent hospital had no pharmacist on site, the inspector may be prepared to set 
out a different procedure or requirements to inspect that hospital. On that basis, a 
question would be asked as to whether this was the case and if these requirements 
might differ when the objective was to inspect independent hospitals with and without 
a pharmacist.
It was recognised that the selected sample of inspectors could reflect different types of 
independent hospitals according to their high level of experience in inspection. On this 
basis, the inspectors would be asked to give their judgement of how the quality of 
pharmaceutical services in independent hospitals without a pharmacist compares, on 
average, with that in hospitals with a pharmacist present. That is to say, whether the 
quality of the services in the hospitals without a pharmacist generally is worse, or 
about the same, or better, than that in hospitals with a pharmacist.
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5.23.2. Part two o f  the interview.
Part two of the questionnaire interview would ask the inspector to comment on some 
of the results obtained from analysis of the questionnaire completed by the inspectors 
throughout the UK. For example, the analysis of the responses obtained from the 
Senior Pharmacists involved in inspection had shown that, on average, the quality of 
pharmaceutical services provision in hospitals with a pharmacist is better than that in 
hospitals without (Chapter 4). And there were significant differences in service quality 
of 9 out of 13 services specified. But for 4 of the service criteria there were no 
significant differences in quality between hospitals with and without a pharmacist; the 
relevant services were environmental storage of medicines, IV-additives, cytotoxics 
reconstitution and procedures involved in TPN. Another interesting example to be 
presented was that, the modal quality assessment for pharmacist and non-pharmacist 
were the same in cases of secure storage of medicines, drug information, IV-additives 
and antibiotic/cross infection policy, which would indicate that, on average, for those 
four service elements the services provided by the non-pharmacists were as good as 
those provided by the pharmacists.
The second part of the questionnaire interview would also ask the inspector to 
comment on the self-assessments provided by the persons actually providing the 
services in independent hospitals, some of whom obviously were pharmacists and 
others non-pharmacists. There was evidence derived from the analysis of the data in 
the questionnaire responses from independent hospitals (Chapter 3) that the service 
providers of the pharmaceutical services in independent hospitals that some, notably 
the non-pharmacists may have tended to over-estimate the quality of services they 
provide. In an effort to obtain an independent perception in this regard, the first 
question in this part of the interview would ask the inspectors, based on their 
experience in inspecting hospitals with and without a pharmacists, about whether they 
found that the service providers of pharmaceutical services tend to over-estimate the 
quality of services they provide compared with the inspector’s own estimate. And 
furthermore whether the non-pharmacists in particular, are more likely than 
pharmacists to over-estimate the quality of services they provide.
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The next question would ask the inspectors to comment on some of the analysis of 
data obtained from the questionnaire completed by pharmaceutical service providers 
in the independent hospitals. For example, the analysis showed that the modal 
assessments of service quality given by the pharmacists and the non-pharmacists were 
the same for 9 of the 12 pharmaceutical services criteria which were specified in the 
questionnaire. For the other 3 services, the non-pharmacists again gave themselves a 
modal assessment of "very good"; however, the mode for the pharmacists in those 
three cases -  drug information, expiry date checks, and IV-additives -  was less than 
"very good". So the non-pharmacists assessment of the quality of those three services 
suggested that their service quality was better than that provided by the pharmacists. 
In contrast, there were no cases for which the inspectors’ modal quality assessment of 
the 13 services ranked hospitals without a pharmacist as better than hospitals with a 
pharmacist.
5.2.3.3. Part three o f  the interview.
Part three of the questionnaire interview started by giving the inspectors an idea about 
the difficulties faced during the study when obtaining information about which Senior 
Pharmacists were involved in inspection of independent hospitals in some of the 
Health Authorities. Also it could be suggested to the inspectors that the problem 
seemed to reflect deteriorating communication among pharmacists within the NHS, 
possibly as a result of the latest NHS reorganisations. These issues had been published 
in an abstract of a poster at the 1995 British Pharmaceutical Conference held at 
Warwick 48. Based on this background, the inspectors would be asked 2 questions in 
this regard. The first question would ask the inspectors if they were aware of increased 
problems of communication or sharing of information between pharmacists within the 
NHS over the past 5 years. The second question would ask whether the inspector 
supports the conclusion that had been written in the abstract that there were problems 
of communication within the NHS as a result of the NHS reorganisation.
The next set of questions was designed to obtain the inspectors’ perception with 
regard to the possible conflict of interest associated with inspections. For example, if 
pharmaceutical services are provided from the department in which the 
pharmaceutical inspecting officer was employed, there might a possibility of a conflict 
of interest.
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Therefore, as a preparation to asking the inspector about such conflict of interest, the 
first question would ask the inspector if he/she responsible for an NHS hospital 
pharmacy. Then the next question would ask the inspector whether he/she or any one 
of the inspection staff was involved in providing pharmaceutical services in any of the 
independent hospitals which had a contract with the NHS for the provision of the 
pharmaceutical services. The answer to this question obviously would be yes or no. If 
the answer was yes, 2 further questions would be asked: 1) was the inspector involved 
in the inspection of the relevant independent hospital at the same time as providing the 
service, 2) would the inspector say that he/she inspected that hospital in as much detail 
as other hospitals which had no contract with the NHS hospitals but had their own 
pharmacist. On the other hand, if the answer was no, the inspector would be asked 
about his/her perception if that had been the case i.e. if a Senior Pharmacist was 
involved in providing the services and at the same time, was involved in the 
inspection of that hospital would a senior pharmacist in that position inspect that 
hospital in as much detail as other hospitals which have no contract with the NHS 
hospitals but had their own pharmacist. Also the inspectors would be ask if they 
consider that an independent inspection should be obligatory in such circumstances. 
The final 2 questions would ask about the inspector’s opinion of how the 
pharmaceutical services in independent hospitals compare with those in NHS hospital 
and how they would describe the level of pharmaceutical professional co-operation 
between the two sectors respectively.
5.2.4. Pre-testing o f  the questionnaire interview.
Copies of the proposed questionnaire interview pro-forma were critically examined by 
a member of the university academic staff, by an independent hospital pharmacist, and 
by a pharmaceutical inspector. They were then asked to act as an interviewee and to 
answer the questions. They were also invited to criticise any aspect of the questions, 
including question wording, question order, missing questions, inappropriate 
questions, and any other aspects they felt might be unsatisfactory or not useful. The 
comments received were mainly focused on the wording of the questions to make it 
much clearer for the interviewee. Another suggestion was to ask about the inspector’s 
job title. A copy of the final version of the interview questionnaire can be found in 
Appendix XIII.
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5.2.5. Setting the time to run the interviews.
It was decided to contact the interviewee 2 weeks after sending the introductory letter. 
Flexibility was considered an important factor for the interviewee to agree to be 
interviewed. 16 inspectors who, according to the questionnaire responses, were 
involved in inspection of 3 independent hospitals or more were chosen to be 
interviewed, each from a different Health Authority. Two weeks after sending the 
introductory letters to those 16 SPMs, telephone calls were made to arrange the time 
to run the interview. After the telephone calls, 1 inspector refused to be interviewed 
and one other had retired; this reduced the sample size to 14 inspectors who agreed to 
be interviewed. The period required to conduct all the interviews ran from mid- 
December 1996 to mid-February 1997 due to the difficulties in setting up suitable 
times to run the interviews and, in addition, the travel distances that were involved.
5.3. RESULTS.
5.3.1. General Findims:
Fourteen inspectors were interviewed. Two of them gave their comments on behalf of 
the inspection team in their Health Authority. Their responses represented eighteen 
Health Authorities throughout England.
AH of. the interviewees were .still involved in the- statutory -inspection of independent 
hospitals. Nine of them (64%), were still using NAHAT and CSP guidelines during 
their inspection, while 3 others use their own checklists in addition to NAHAT and 
CSP guidelines. Of the remaining 2, one of them uses the CSP guidelines only and the 
other uses the NAHAT guidelines only.
The number of independent hospitals inspected by each of the 14 interviewees ranged 
from 3 to 10. The total number of hospitals inspected by the group of 14 inspectors 
was 67 -  that is over one quarter (26%) of the total number of independent hospitals 
in the UK, based on our best estimate of 257.
Of those 67 independent hospitals, 48 (72%) had a pharmacist either employed or 
contracted and 19 (28%) had no pharmacist. The sample of hospitals involved 
therefore is broadly representative of those throughout the UK.
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5.3.2. Inspection requirements in hospitals with and without a pharmacist.
All but 2 of the interviewees said they did set out different requirements when they 
inspected different independent hospitals. When the same question was asked, but 
specifically in connection with independent hospitals without a pharmacist, 6 
respondents said they did not set any different requirements. The reason stated by 3 of 
the inspectors was that they had no experience of inspecting independent hospitals 
without a pharmacist; the other 3 said that they would set the same requirements but 
they explained that if a pharmacist is present, some requirements would be relaxed. 
On the other hand, 9 inspectors do set different requirements. Reasons given by those 
inspectors were as follows. Three inspectors stated that if a pharmacist is present in 
the hospital, pharmaceutical arrangements are much more prescribed, whereas if no 
pharmacist is present, the inspection requires more work and is more time-consuming. 
Two others stated that they review procedures in-depth and they described this 
procedure as "more inspection emphasis” . The 3 other inspectors gave further 
reasons. Two of them said that it would depend on the nature of the establishment as 
to whether they anticipate the need for any additional requirement, and the third stated 
that non-pharmacists are unaware of the need for pharmaceutical advice and it would 
be very risky for hospitals without a pharmacist to offer certain services.
5.3.3. Inspectors ’ quality assessment o f  hospitals with and without a pharmacist 
Inspectors were asked to place their assessment, based on their experience, on how 
they perceived, on average, the quality of pharmaceutical services in independent 
hospitals without a pharmacist. Six of the inspectors stated that the quality of 
pharmaceutical services in hospitals without a pharmacist is generally worse than in 
hospitals with a pharmacist. On the other hand, 4 of the inspectors stated that the 
quality of services in hospitals without a pharmacist are about the same as in hospitals 
with a pharmacist. Three inspectors did not answer this question because they had no 
experience in the inspection of independent hospitals without a pharmacist. One 
inspector stated that the comparison is very hard due to the different nature of services 
that are provided.
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The similarity of the quality of services provided either by the pharmacist or by a non­
pharmacist, as stated by 4 of the interviewees, was some what surprising given that 2 
of them had said in answer to the previous question that if a pharmacist was not 
present, the inspection procedure was more time-consuming and that the 
pharmaceutical supplies were less well organised. It would seem to be a cause for 
concern when the perception of persons with a high level of pharmaceutical 
experience is that quality of a pharmaceutical service may be unaffected by whether a 
pharmacist is involved in the provision of that service which a pharmacist is uniquely 
educated and trained both scientifically and professionally to provide. Although one 
possible interpretation is that the inspecting pharmacists concerned have an 
inappropriately narrow expectation of what level of pharmaceutical service is 
appropriate in an independent hospital, given their level of experience that seems 
difficult to believe.
5.3.4. Inspectors ’ comments on part o f  the analysis o f  responses obtained from 
the Senior Pharmacists involved in inspections.
The inspectors’ comments were invited on the 4 specified pharmaceutical services for 
which the analysis of responses obtained from the persons involved in inspections of 
independent hospitals. had- shown no significant • differences in quality between 
hospitals with and without a pharmacist. The specific services were environmental 
storage of medicines, IV-additives, cytotoxics reconstitution, and procedures involved 
in TPN. The comments were as follows:
• regarding environmental storage of medicines: all inspectors stated that this is a 
very simple exercise for non-pharmacists and there is no need to utilise the 
pharmacist’s knowledge just in storage of medicines. Two inspectors added that 
this service lies at the bottom line in the inspection visits and, in their experience, it 
improves every time. Two others added that this service is controlled by the NHS 
hospitals and, finally, one inspector commented that, the pharmacist’s role, these 
days, is moving towards clinical rather than traditional practice of pharmacy.
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• regarding IV-additive procedures: 10 inspectors stated that such procedures are 
nurse procedures and that there is no risk to run such a service under the leadership 
of a nurse. Of those respondents, 3 inspectors surprisingly added that, once a policy 
is defined and the intravenous additives are ready made, there is no need for a 
pharmacist to be involved in this procedure. Conversely, the remaining 4, were 
surprised with these findings and commented that there is no way that such a 
service should be available in hospitals without a pharmacist being on-site.
• regarding cytotoxics reconstitution and procedures involved in TPN: interestingly, 
6 of the inspectors were surprised with these findings and commented that such 
services should not be done without a pharmacist because the procedures require a 
very high pharmaceutical in-put. On the other hand, the remaining 8 inspectors 
more or less accepted the reporting findings of the postal survey, albeit with some 
reservations. Of those 8, 5 inspectors stated that hospitals without a pharmacist can 
buy-in this service either from an NHS hospital or from a wholesaler or a 
manufacturer able to supply ready-to-use products together with information on 
how to reconstitute the product. Of the other 3 inspectors, 2 of them referred to the 
availability of policy on such procedures within the hospital concerned. Finally, no 
comment was made by one inspector as this service is not available in any of the 
hospitals in the inspector’s area.
A number of recommendations regarding the preparation and administration of 
intravenous drug preparations have been published 21 . the training of nursing staff for 
their role in intravenous therapy was recognised as being inadequate and, regarding 
the role of the pharmacist, it was recommended that pharmacists should advise on 
pharmaceutical aspects of aseptic preparations because these aseptic procedures 
should ideally be carried out in appropriate environmental conditions under the direct 
control of a pharmacist. NAHAT and CSP guidelines 10,16 also state that: hospitals 
which do not have a pharmacist on-site, should obtain on-going advice from a 
pharmacist with experience of the type of service provided by the unit to ensure that 
appropriate arrangements are made for pharmaceutical services. Therefore, pharmacist 
involvement especially in TPN and cytotoxic services are very essential due to his 
qualification as well as training which would serve to reduce both handling and 
preparation errors.
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The comments from a number of the interviewees are extremely surprising in that they 
appear to contradict these recommendations which reflect current good hospital 
pharmaceutical practice. Despite the fact that the inspectors are all persons with 
experience and knowledge of pharmaceutical practice, the views of some of them in 
this context appeared to be at variance with that of their other colleagues.
The interviewees added further comments on the question regarding the survey 
findings of same mode in the quality assessment of secure storage of medicines, drug 
information antibiotic/cross infection policy and IV-additives services between 
hospitals with and without a pharmacist. Their comments were as follows:
• regarding secure storage of medicines: all inspectors stated that this service can be 
carried out very easily by non-pharmacists. Three of them referred to the fact that 
once a written policy for the secure storage of medicines is supplied, anybody 
should be able to comply with that properly.
• regarding drug information: 10 of the inspectors stated that such a service is 
available from the NHS hospital within the area or a hospital can buy-in this 
service. Some of the inspectors were surprised by the survey findings because they 
did not inspect this service during their inspection visits. Four other inspectors 
referred to the availability of reference books within the hospital.
• regarding antibiotic/cross infection policy: 8 of the interviewees refused to 
comment on this result because they were surprised by the survey findings. On the 
other hand, 4 inspectors stated that nurses are better than pharmacists in cross­
infection policy as this service is a ward service where the nurse is usually 
available, and they would be surprised if the pharmacists could provide this service 
better than the nurses. Two inspectors stated that this service would depend on a 
written policy and there would then be no need for pharmaceutical input.
• regarding IV-additives: the inspectors referred to their earlier comments that are 
reported above.
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Interestingly, all the interviewees again believed that there was no need for the 
pharmacist’s involvement in the secure storage of medicines thereby disregarding a 
long-standing quality assurance role in relation to medicines (e.g. the storage of fridge 
items, the special storage condition of vaccines, etc.). Also the surprising judgements 
by some inspectors with regard to drug information focused on the availability of 
reference books within the hospital rather than on the utilisation and interpretation of 
information for the benefit of other health professionals. It seems illogical to assume 
that such a service can be undertaken without the availability of a qualified expert 
such as the pharmacist, in addition to the availability of reference books.
5.3.5. Over-estimation o f  the service quality by service providers.
Six inspectors agreed that the pharmaceutical service providers tend to over-estimate 
the quality of services they provide in comparison with their actual practice. On the 
other hand, 3 inspectors did not consider that this was the case; the pharmacists in the 
area of one of the inspectors were said to be quite realistic and the other 2 stated that 
the providers were obliged to be positive, otherwise they would lose "business". Five 
inspectors said they did not know whether this was the case or not. However, when 
this same question was put regarding hospitals where the service providers were non­
pharmacists, 9 inspectors agreed that the non-pharmacists were more likely than 
pharmacists to over-estimate the quality of services they provide. Only pne inspector 
failed to agree with this assumption and the reason given was that the non-pharmacists 
were said to be trying to do their best. The other 4 inspectors did not know whether 
this was the case or not because their experience in inspections did not cover 
independent hospitals without a pharmacist.
5.3.6. Inspectors ’ comments on vart o f the analysis o f  responses obtained from 
the versons providing pharmaceutical services in independent hospitals.
The inspectors were asked to comment on results obtained from the responses 
received from the persons providing a service within independent hospitals.
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Notably the results which showed that the modal assessments given by the 
pharmacists and the non-pharmacists were the same-that is to say-"very good" for 9 
of the 12 specified pharmaceutical services criteria. For the other 3 services, the non­
pharmacists also gave themselves a modal assessment of "veiy good". In contrast, the 
mode for the pharmacists in those three cases-drug information, expiry date checks, 
and IV-additives-was less than "very good". There were none of the 12 services for 
which the inspectors’ modal assessment ranked hospitals without a pharmacist as 
better than hospitals with a pharmacist. So, the inspectors’ comments were invited on 
the contradictions obtained with regard to the non-pharmacists’ assessments of the 
quality of those three services given that the results suggested that their service quality 
was better than that provided by the pharmacists. The inspectors comments were as 
follows:
• regarding drug information: 10 inspectors believed that the pharmacists were more 
realistic and much more critical than the non-pharmacists due to their awareness of 
where the problem lies. They also referred to their previous comment that the non­
pharmacists were obliged to be positive, otherwise they would lose "business". 
Five of the inspectors believed that this service is misunderstood by non- 
pharmacists. Of the remaining 3 inspectors, 2 suggested that the non-pharmacist 
self-assessment was may be based on the fact that this service was received from 
the NHS-hospital drug-information service which was judged to be very good. One 
inspector preferred not to comment on any of the figures obtained.
• regarding expiry date checks and IV-additives: 6 inspectors specifically stated that 
the pharmacists were more realistic and much more aware of where problems exist. 
Four others stated that this service is well organised by nurses. Of the remaining 4 
inspectors, 3 stated that the non-pharmacists needed to assign themselves a very 
high score otherwise they would lose "business". Again one inspector preferred 
not to comment on any of the figures obtained.
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Thus, a number of the inspectors expressed the view that the pharmacists were more 
realistic and much more critical in assessing the services they provide, possibly due to 
their broader awareness of practice. In addition, with regard to provision of a drug 
information service, this terminology can carry two meanings, one meaning for the 
pharmacists and the other for the non-pharmacists. The non-pharmacist might 
understand the drug information service simply as the giving of basic information to 
patients with regard to their medicines. On the other hand, the pharmacists 
understanding of the drug information service would likely be the supply of up-to-date 
information about any aspect of drugs and medicines to healthcare staff as well as to 
patients. In this context, 5 inspectors referred to this possibly that the meaning of this 
service is misunderstood by the non-pharmacists as a likely explanation of the 
apparent anomalies in the self-assessment results.
5.3.7. Inspectors ’ comments with resard to the latest NHS reorganisations.
Due to the difficulties which were faced in obtaining information about which Senior 
Pharmacists were involved in the inspection of independent hospitals in the early 
stages of this current study, the inspectors were asked to comment on reasons for the 
problem and whether this problem reflects deteriorating communication among 
pharmacists within the NHS, possibly as a result of the latest NHS reorganisations.
Ten inspectors acknowledged that there were problems as a result of the latest NHS 
reorganisation. One main reason stated was that this problem originated as a result of 
the split of a Trust into two Trusts, an Acute Trust and a Community Trust. This split 
also resulted in pharmacists involved in inspection possibly not having such good 
communication with other pharmacists as before when there was only one Trust. In 
addition, the abolition of the District Pharmaceutical Officers (DPhO) and delegation 
of their down responsibilities to more NHS pharmacists with different titles increased 
the poor communications. Of those 10 inspectors, 3 added that more problems have 
arisen due to the merger of Health Authorities and the increasing number of 
independent hospitals with no money allocation for the inspection process.
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Astonishingly, and in direct contrast, the remaining 4 inspectors stated that there were 
no problems of communications, according to their knowledge, within the NHS. Two 
of those interviewed commented that the reorganisation have not affected their Health 
Authority. They also added that people in the academic institutions (i.e. Universities) 
were unaware of the rapid changes that have taken place in the NHS. Also 1 inspector 
commented that there is no need for a Senior Pharmacist or any person involved in 
inspection to know other persons who are involved in inspection in the same Health 
Authority.
Clearly, the majority of inspectors agreed that the degree of reorganisation taking 
place within the NHS places considerable demands on those affected. If those 
demands prevent adequate communication being maintained between pharmacy 
managers, that could be detrimental to future development of the profession and, in 
turn, to the provision of pharmaceutical care to patients. Of particular note is that 
some of the Senior Pharmacists interviewed would seem to be unaware of the extent 
to which some of their fellow Senior Pharmacists elsewhere in the NHS consider that 
reorganisation has led to problems of poorer communication.
5.3.8. Conflict o f  interest with resard to inspection.
Nine of the inspectors interviewed stated that they were not responsible for an NHS 
pharmacy, while the other five were responsible. Only 5 of the inspectors were 
involved in providing a pharmaceutical service to independent hospitals which have a 
contract with the NHS for the provision of those services. Of those, only one inspector 
was involved in the inspection of the relevant independent hospitals at the same time 
as providing the service. That inspector expressed the view that his involvement in 
inspection of independent hospitals which had a contract with an NHS hospital does 
not represent any conflict of interest and he would treat independent hospitals which 
had no contract in the same manner as the one with a contract.
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On the other hand, the rest of the inspectors were not involved in a dual role of that 
kind with the independent hospitals they were responsible for inspecting. Those 
inspectors were asked to comment on such situations (i.e. where a pharmacist 
provides the service to an independent hospital and at the same time is involved in its 
inspection). Their replies specifically stated that such a pharmacist should not be 
involved in the inspection of such independent hospitals due to a possible conflict of 
interest. Some of them also added that there was no point in inspecting yourself, and 
one inspector specifically added that another inspector from a far-distant Health 
Authority, not from a neighbouring Health Authority, should do the inspection 
because, sometimes, part of the service may be provided by this neighbouring Health 
Authority.
All but two of the inspectors, considered that an independent inspection should be 
obligatory. Of the two inspectors who stated that this should not be obligatory, one of 
them was involved simultaneously in service provision and also in carrying out the 
inspection of the independent hospital, but the other inspector stated that such a 
situation is indefensible.
5.3.9. Comparison o f  the quality o f pharmaceutical services in IHs with those 
in NHS hospitals, from the inspectors * point o f view.
Half of the inspectors generally believed that the quality of pharmaceutical services in 
independent hospitals are about the same or at least comparable with those in NHS 
hospitals. Of those, 3 inspectors added that, some issues cannot be achieved by the 
IHs due to lack of experience. Equally, they acknowledge that some issues also are 
very hard to achieve in the NHS such as waiting time for dispensing and lack of 
funding. On the other hand, 4 inspectors stated that the quality of service in IHs is 
better than in NHS hospitals and that was because there is no financial problem to 
employ qualified staff and to buy good quality equipment. Of the 3 other inspectors, 2 
said that the quality of service in IHs is worse than the quality in NHS hospitals and 
that this is due to a lack of internal standards and the independent hospital pharmacists 
suffering from isolation which makes them less aware of standards within NHS 
hospitals. These 2 respondents also added that, in NHS hospitals, there is more 
clinical involvement and more issues are addressed than in independent hospitals.
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One inspector made no comment in response to this question because of the unfair 
comparison between the two types of hospitals (i.e. independent and NHS hospitals).
this diversity of opinion among the 14 Senior Pharmacists was of particular interest. In 
particular, reference by some interviewees to awareness of standards in NHS hospitals 
is rather ironic given the apparent disagreement on various matters among this group 
of inspecting pharmacists.
Finally, most of the inspectors believed that the level of pharmacist professional co­
operation between the IHs and the NHS hospitals was good or even very good. They 
also added that not only was there good communication but also support was provided 
including provision of supplies in case of need. Most of them said that "pharmacists 
should help and support other pharmacists", however, 2 of the inspectors stated that, 
due to competition and market forces, sometimes when an independent hospital 
needed help from a NHS hospital they did not get it very readily.
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CHAPTER SIX
GENERAL DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS 
INCLUDING A CONSIDERATION OF THE RELEVANCE OF THE STUDY 
TO THE PHARMACEUTICAL SERVICES PROVISION IN SAUDI ARABIA
6.1. GENERAL DISCUSSION.
This investigation succeeded in achieving the aims and objectives set out in Section
1.9. The study provided information from service providers at 192 (75%) of the 
independent hospitals throughout the UK, by means of questionnaire 1, and from 138 
senior pharmacists whose inspections covered 228 (89%) of the 257 independent 
hospitals throughout the UK, using questionnaire 2. Also, a number of informative 
interviews were undertaken with senior pharmacists involved in the inspection of 
independent hospitals on behalf of Health Authorities England. Therefore, by 
surveying all Health Authorities / Health Boards in the UK and achieving high 
response rates, the study provided comprehensive information about the 
pharmaceutical service provision in independent hospitals in the UK which was 
generally representative of all hospitals.
The findings of the two questionnaires were comparable, that is to say, there was little 
variation with regard to facts for example regarding hospital details and the services 
provided. Table 6.1 illustrates some of these characteristics derived from the 
responses to the two questionnaires.
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Table 6.1. Characteristics o f the independent hospitals and the verson responsible 
for providing the pharmaceutical service. as identified usins questionnaire 1 and 2.
Service Providers 1^(Quesiidn^^^M
$  <40 beds 82 79
40 beds or more 106 92
Missing response 4 57
■Bnpf 0 32 24
1 or more 157 150
Theatres Missing response 3 54
Person §  Pharmacist 165 189
Non-pharmacist 27 38
^Responsible : Missing response 9 1
As can be seen from Table 6.1, pharmacists (either directly-employed or contracted) 
were found to be responsible for providing pharmaceutical services in 189 (83%) of 
the independent hospitals; of those 53 are known to be small hospitals with less than 
40 beds, and 86 of them are larger hospitals having up to 390 beds. The number of 
operating theatres in independent hospitals ranged from none to a maximum of 7. The 
modal value was 2 and the mean value was 1.9. The majority of big hospitals (i.e. with 
40 beds or more) are operated by limited companies, and tend to employ a pharmacist 
directly. Furthermore, for smaller hospitals (i.e. hospitals having less than 40 beds), 
the limited companies tended to rely on a contract with a NHS hospitals or a 
community pharmacy for the provision of pharmaceutical service. In general, the 
majority of hospitals without a pharmacist at all were those operated by charitable 
organisations.
Most pharmacists who were employed directly by an independent hospital offered a 
"comprehensive" service. On the other hand, "partial" pharmaceutical services 
tended to be provided mainly by a pharmacist contracted from a NHS hospital or from 
a community pharmacy. Furthermore, a pharmacist employed directly was the main 
provider for hospitals having 40 or more beds and two or more operating theatres, 
while a NHS hospital pharmacist was the main provider for hospitals of less than 40 
beds and no operating theatre.
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Wholesalers and manufacturers were the main pharmaceutical suppliers in hospitals 
with a directly-employed pharmacist, while the NHS pharmacists mainly obtained 
their pharmaceutical supplies through NHS hospitals. The main sources of 
pharmaceutical supplies to independent hospitals in emergency situations were stated 
to be NHS hospitals and community pharmacies, though pharmacists who were 
directly employed still relied heavily on wholesalers in such circumstances.
NAHAT guidelines recommend that if a hospital consists of less than 40 beds and has 
no operating theatre, the requirement is only for pharmaceutical advice to be available, 
while if the hospital consists of less than 40 beds but has an operating theatre, the 
service of a pharmaceutical department is needed and, if the hospital has 40 or more 
beds, then the services of a pharmaceutical department are needed regardless of the 
number of operating theatres.
On this basis, information obtained from the two questionnaires showed that 23 (12%) 
(questionnaire 1), and 21 (9%) (questionnaire 2) of the hospitals with less than 40 
beds or 40 or more beds and having 1 or more operating theatres were failing to 
comply with the NAHAT guidelines. The finding of the previous study in this regard 
n , showed that this number was much higher in 1991; that is to say 51 hospitals, out 
of the total of 112 which responded to that previous survey, were not complying with 
the NAHAT guideline on employment of a pharmacist. This suggests that more 
hospital directors and managers now recognise the value of services provided by the 
pharmacist and have therefore taken action to employ such services.
The NAHAT guidelines recommend that, where a pharmacist is employed in an 
independent hospital, the statutory minimum of two inspections per year should be 
carried out. However, where no pharmacist is employed, it is recommended that 
inspections be undertaken quarterly. From the information obtained using 
Questionnaire 1, 57 of the hospitals with a pharmacist and 9 of the hospitals without a 
pharmacist received only one inspection visit per year and, in total, 21 hospitals 
without a pharmacist received fewer than the number of visits recommended by 
NAHAT.
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On the other hand, information obtained from Questionnaire 2 showed that 2 
hospitals, one with and one without a pharmacist, received no inspection visits at all. 
In addition, 38 hospitals with a pharmacist received only one inspection visit per year, 
which is below the figure of two recommended by NAHAT and required by statute. 
Although 26 hospitals without a pharmacist, received at least one and up to three 
inspection visits during the year, that was still below the figure of four recommended 
by NAHAT.
Analysis of the responses obtained from the senior pharmacists involved in inspection 
(Questionnaire 2) showed that, on average, the quality of pharmaceutical service 
provision in independent hospitals with a pharmacist is better than in hospitals 
without (Table 4.31). A surprising range of opinion was obtained from a number of 
the inspectors when they were interviewed with regard to the four service criteria for 
which the analysis had shown no significant differences between hospitals with and 
without a pharmacist.
Despite the fact that the inspectors are all persons with experience and knowledge of 
pharmaceutical practice, the views of some of them in this context appeared to be at 
variance with that of their other colleagues for example, 4 inspectors stated that the 
IV-additives are nurse procedures and 5 others stated that the cytotoxics can be 
reconstituted by information supplied from the manufacturer. On the other hand, 
analysis of the quality assessments, made by the persons providing pharmaceutical 
services (Questionnaire 1) showed that the modal assessments given by the 
pharmacists and the non-pharmacists were the same — that is to say, “very good” in 
each case — for 9 of the 12 pharmaceutical services criteria (Table 3.43). The non- 
pharmacists’ assessment of the quality of those services suggested that their service 
quality was better than that provided by the pharmacists. In contrast, there were none 
of the 13 services for which the inspectors’ modal assessment ranked hospitals 
without a pharmacist as better than hospitals with a pharmacist. A number of the 
inspectors who were later interviewed expressed the view that the pharmacists were 
more realistic and much more critical in assessing the services they provide, possibly 
due to their broader awareness of practice.
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A comparison of Table 3.45 derived from the results of Questionnaire 1 and Table 4. 
32 from Questionnaire 2 shows that the mean rank obtained from self-assessment of 
the service quality was rarely in accordance with that of the inspecting pharmacists’ 
responses. Although in 11 cases of self-assessment by non-pharmacists, their service 
provision ranked as either best (1), second best (2) or third best (3), the inspecting 
pharmacists’ responses resulted in only a single case which gave a mean rank in this 
range of 1-3. This apparent tendency for non-pharmacists to be less critical than 
pharmacists, when assessing the quality of service provision, is emphasised by a 
comparison of the modal values for the quality assessments by the pharmacists and 
non-pharmacists in Tables 3.45 and 4.31.
Both groups of respondents — providers and inspectors — suggested several aspects of 
pharmaceutical services that could be significantly improved in independent hospitals. 
Of the replies to this question in Questionnaire 1,13 respondents stated the need for 
an "on-site pharmacy", these responses indicated that some independent hospitals 
suffer from a lack of pharmaceutical input despite these hospitals being served by 
either a NHS or a community pharmacist. This may be due to the fact that the 
contracted pharmacists (i.e. NHS or community) were not available in the hospital at 
all times while the directly employed pharmacist is available and can also provide 
"out of hours" service. Also if the community pharmacist lacks hospital experience, 
that may prove to be a disadvantage.
Of the respondents to Questionnaire 1, 60 (33%) stated that there were aspects of 
pharmaceutical legislation which could create difficulties. Half of those respondents 
stated the need for specific legislation for independent hospitals. This need for specific 
legislation, relating specifically to acute independent hospitals as distinct from nursing 
homes, seems entirely logical. Such legislation could be of potential benefit, as 
NAHAT and CSP guidelines are only in the form of recommendations and have no 
power. Therefore, legislation could be implemented with regard to the provision of a 
quality pharmaceutical service in those establishments where the nature of the number 
of beds and the presence of operating theatres requires that a pharmacist is responsible 
for ensuring such provision.
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Once legislation is enacted to establish a pharmacy department within independent 
hospitals, the standards of services provided could be significantly improved under the 
control of the pharmacist. The provision of specific legislation could also solve the 
evident difficulties presently associated with the Controlled Drugs Licensing, ideally 
with the pharmacist taking full responsibility for such CDs, as the community 
pharmacist does.
Looking at hospitals without a pharmacist, it can be seen that they do offer various 
support and specialist services such as hydrotherapy and health-screening. What is 
surprising is that some of these hospitals offered paediatric and chemotherapy services 
but possessed no pharmacy department. In these two areas, in particular, where doses 
are critical and often depend on body-weight or surface area, the available advice of 
pharmaceutically qualified staff would seem of prime importance. Indeed, in many 
other instances pharmacy staff are involved in preparing medicines in these two 
speciality fields, to help avoid problems with dilution and calculation at ward level. 
For example, cytotoxic reconstitution services and intravenous additives (IV- 
additives) services or pre-filled syringes for paediatrics.
The purchasing policy and drug utilisation varies between those independent hospitals 
with and without a pharmacist. It was also noted that over half of the independent 
hospitals without a pharmacist had no hospital formulary in use. The use of such a 
formulary where no pharmacist is available to give advice on medicines, would appear 
to be essential.
In an epidemiological context, the importance of an antibiotic policy to reduce the risk 
of appearance of resistant micro-organisms, is as important for patients being treated 
in an independent hospital as for those in the NHS. However, only seven of the 
independent hospitals without a pharmacist had established an antibiotic policy.
A certain number of hospitals without a pharmacist stated that their procurement of 
generic products depended on the preference of the consultant or was decided on the 
basis of cost and availability. From these responses, it was not possible to ascertain 
whether the respondents felt that the quality of the product was an important factor.
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Thus, only 11 responses indicated that the quality of the product was a consideration. 
If the hospital had a pharmacist, who was responsible for purchasing medicines, 
he/she might be expected to be more concerned with quality and to be more aware of 
the potential problems of lack of bio-equivalence between generic and brand-named 
products and between different generic manufacturers.
With regard to the continuing professional development of pharmacists, Principal Five 
of the Code of Ethics of the Royal Pharmaceutical Society of Great Britain7 states that 
the pharmacist must keep abreast of the progress of pharmaceutical knowledge in 
order to maintain a high standard of professional competence relative to his sphere of 
activity. The schools of pharmacy also play a key part in continuing education. The 
apparent complete absence of continuing education reported by a large number of 
pharmacists involved in the provision of pharmaceutical services in independent 
hospitals must therefore be of prime concern. If the respondents have not taken the 
opportunities for training and continuing education that available to them, then it 
would seem that the inspecting pharmacist has a duty to consider whether that person 
is suitable or not to practise in an independent hospital.
It is appreciated that most pharmacies in acute independent hospitals could not be 
expected to provide the same full range of services that a large NHS pharmacy within 
a general hospital can provide. If specialist knowledge and expertise of the pharmacist 
is needed to be utilised, for example, in the production of TPN, cytotoxic 
reconstitution, aseptic dispensing and IV-additives, it would seem to be the duty of the 
inspecting pharmacist to provide a clear picture to the Health Authority as well as the 
Director of the independent hospital, of how pharmaceutical services should be 
provided in the acute independent hospitals where no pharmacist is present. The same 
duty of the inspecting pharmacist would apply to hospitals with a pharmacist if any 
deficiency is identified in important areas of service provision such as those 
mentioned above.
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A large majority of inspectors agreed that there is a conflict of interest with regard to 
inspection if the senior pharmacist responsible for inspection is, at the same time, 
employed by an NHS hospital that is providing pharmaceutical services to the 
independent hospital concerned. The inspectors who agreed included 70% of those 
who responded to Questionnaire 2 and all but one of the senior pharmacists who were 
interviewed. The majority view, therefore, was that inspection in such cases should be 
undertaken independently. It would seem appropriate for this requirement to be made 
obligatory by all Health Authorities or for the matter to be written in to new legislation 
relating to independent hospitals.
6.2. CONCLUSIONS.
• Pharmaceutical services in independent hospitals in the UK were judged, on 
average, to be better when the services were provided by pharmacists who were 
directly-employed or contracted from the NHS, according to the responses 
obtained from the inspecting pharmacist.
• According to the responses obtained from the senior pharmacists involved in 
inspections, there were some services provided by some pharmacists which were 
assessed as "poor" or even "very poor". But a disproportionate number of 
services provided by non-pharmacists were rated as "poor" or "very poor".
. •. The close similarity in emphasis, .placed on-the inspection o f services provided by ■ 
pharmacists and by non-pharmacists, indicated a lack of bias by the inspecting 
pharmacists.
• The results confirmed the findings of a previous study that there is poor 
compliance with NAHAT guidelines on inspection of pharmaceutical services in 
independent hospitals.
• The assessments of service quality provided by pharmacists involved in service 
provision were most likely to be in accordance with those of the senior 
pharmacists involved in inspection.
• The perceived quality assessments received from non-pharmacists regarding 
services provided by a non-pharmacist tended to over-estimate the quality of those 
services when compared with the perceived quality assessment made by the 
inspecting pharmacist.
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• The results provide evidence of potential advantages if pharmacists are employed 
to provide pharmaceutical services in independent hospitals; their more critical 
assessment of service provision may be attributed to their specialist expertise and 
in-depth knowledge of pharmaceutical science and practice.
• This comparative study provided evidence that the judgement of non-pharmacists 
as to the quality and sufficiency of pharmaceutical services may be unreliable.
6.3. PHARMACEUTICAL SERVICES IN SAUDI ARABIA.
In order to appreciate the relevance of how some of the findings in this thesis relate to 
the provision of pharmaceutical services in the Kingdom of Saudi Arabia, it is 
necessary first to outline the nature of the health service and associated 
pharmaceutical services in the Kingdom of Saudi Arabia.
The primary care system has been found successful in tackling the basic health 
problems in the Kingdom of Saudi Arabia, for example, environmental hygiene, water 
supply and transmittable diseases. It has been a useful strategy for implementing the 
Government’s health policy.
The Government’s pharmaceutical policy gives priority to ensuring a regular supply of 
drugs of proven safety, quality and efficacy and to rationalising the use of drugs.
The Saudi Arabian Ministry of Health (MOH) formulates the main points of the 
Governmental health policy. Several Government Ministries in addition to the MOH 
have their own health facilities and Medical Services Directorate. In addition there is a 
private health sector. All medical services directorates as well as private health sector 
should follow the following basic guidelines:-
1. No drug is to be allowed into the Saudi market without registration. A 
sample of the drug must be supplied to the Government Quality Assurance 
Laboratory and the manufacturer is also required to submit a document 
attesting to the safe use of the product in its original country of origin;
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2. A National Drug Formulary (Drug Directory) must be established with a list 
of all the registered drugs. Hospitals and vendors are only allowed to import 
drugs included in the list;
3. Local manufacturing of essential drugs must be encouraged to obtain good 
quality products and a continuous supply;
4. A specialised hospital must be set up in each region of the country as a 
centre for receiving referred patients and for monitoring the supply of drugs 
to the Community Health Clinics within the region. This aims to rationalise 
the use of drugs.;
5. Primary Care Clinics must be established in each quarter of the cities and in 
villages in order to minimise the patient pressure on the central hospitals. 
These clinics should refer the patients to the hospitals for further medical 
care if necessary;
6. Highly qualified people are to be employed to supervise the implementation 
of the health care system.
Against this background, the following structure of the current management system 
should becomes clear and the pharmaceutical services policy should be 
understandable.
6.3.1. Health Policy.
Health care is provided by the public sector as well as by the private sector. They are 
both supervised mainly by the Ministry of Health according to the following 
principles:-
a) Members of the community should be involved in private sector health activities;
b) Primary Health Care Clinics should be established by the Government;
c) Regional integration is required of special health programmes and specialised 
health centres;
d) Development of programmes training for health care professionals to improve their 
expertise in management and health provision;
e) Control of drugs of abuse and treatment of addiction.
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The Primary Care Clinics in Saudi Arabia serve a similar purpose of General 
Practitioners (GPs) surgeries in the UK as they serve all the people living in the 
community but do not provide facilities for hospitalising patients. Patients requiring 
hospitalisation are referred to the central hospitals if necessary. There are some 
specialised centres which offer special hospital treatment to patients, for example, the 
Heart Centres and Eye Hospital.
6.3.1.1. Pharmaceutical Policy and its implementation.
The pharmaceutical policy concentrates on ensuring the availability of drugs and other 
medical supplies to the patient. By giving priority to pharmaceutical services in the 
Primary Care Clinics the pressure on the pharmacies in the central hospitals is 
reduced. These elements from the basis of the pharmaceutical policy in the health care 
system in Saudi Arabia and the following summarises the present procedures which 
implement the policy:-
1) DRUG AND DOSAGE FORM SELECTION 
A scientific committee of experts prepares the Drug Directory for Saudi Arabia. They 
consult specialists in all fields of health care from different hospitals and end up with 
a formulary for the drugs which should be available throughout the country.
• ' ' 2) DRUG QUANTITIES..........................................................................
The quantities of the individual drugs needed are determined by the pharmacy 
department of each hospital and an order is sent to the Medical Supply Department 
(MSD). The Medical Supply Department then negotiates the quantity to be supplied to 
the hospital according to the hospital’s use in the previous year and the quantity may 
either be reduced or stay the same. The Medical Supply Department always purchases 
about 10-20% more than the total quantity ordered, to overcome any shortages that 
may develop. However, supply is not direct from the Medical Supply Department -  
but occurs from the Regional Supply Department.
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3) DRUG PROCUREMENT.
The regional supply departments therefore must submit their own tenders to the 
Medical Supply Department of the Ministry of Health where they are reviewed, 
checked and approved. The Regional Tenders are based on the individual quantities 
required by individual hospitals and Primary Care Clinics in that region. The regional 
supply departments then receive their supplies direct from the vendors. The Ministry 
of Health, based on the quantities requested by the regional stores, also makes its own 
tender which represents 20% above the total regional demand. This 20% is kept in a 
central Government store and is used to overcome any emergencies which may arise.
The drugs which are not available locally can be imported from abroad. Importation 
needs a recommendation letter from a specialised health centre where the drug is 
going to be used. Private hospitals cannot import any drug that is not registered. 
Patients who require such drugs therefore must be referred to a specialised health 
centre for further treatment. Government Hospitals can obtain approval to import non­
registered drugs for use in named patients.
4) QUALITY ASSURANCE.
Random samples of drugs imported into Saudi Arabia are taken and tested at the time 
of importation. These are sent to the Central Quality Assurance Laboratory in Riyadh 
belonging to the Ministry of Health where they are tested and approved. This 
laboratory is managed by the Ministry of Commerce.
5) STORAGE AND DISTRIBUTION.
The Medical Supply Department of the Ministry of Health requires the local agents or 
the pharmaceutical companies to deliver their merchandise direct to the regional 
stores. Each region has a large central store built according to international standards 
which then organises the distribution of drug supplies within that region and sends to 
each hospital and Primary Care Clinic the quantity required according to their needs.
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6) REGULATORY CONTROL
The General Directorate responsible for Medical and Pharmaceutical Licenses in the 
Ministry of Health develops and enforces the legislation. It accomplishes this purpose 
through the following divisions:-
• Division of Licensing and Registration of Professionals;
• Division of Drug Registration;
• Narcotic and Psychotropic Substances Central Division;
• Division of Pharmacies Inspection; and,
• Department of Pricing and Marketing.
These divisions carry out their duties based on the following current legislation which 
governs the pharmaceutical services
i) Pharmacy Practices Act;
ii) Policy and procedure for Narcotics; and,
iii) Medical Practices Act.
7) RATIONAL DRUG USE.
Experience from field work has shown that irrational use of drugs may occur due to 
the absence of a standard treatment schedule and the lack of knowledge about drug 
use on the part of health workers. The use of narcotics and psychotropic drugs and 
more recently, the antibiotics, is now more tightly controlled and procedurised.
8) MONITORING OF THE DRUG USE
There are no effective monitoring systems for checking the range in which drugs are 
used. Instead, it depends on the individual efforts of hospitals and supply departments. 
Only the narcotics and psychotropics are monitored by the Ministry of Health. The 
lack of such systems for monitoring has led to excessive drug consumption.
9) DRUG INFORMATION
Every hospital has its own drug information unit which serves that hospital’s 
professionals. There is a regional drug information centre in each specialised health 
centre which serves the professionals in that region (e.g. Teaching Hospitals, 
Specialist Eye Hospital, Military Hospital ...etc.).
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10) TRAINING AND CONTINUING EDUCATION 
There is no formal continuing education programme at present to develop the skills of 
health professionals. The newly-formed Saudi Pharmaceutical Society is planning to 
begin some programmes to educate the pharmacists and they have already started 
organising some professional symposia related to appropriate drug utilisation.
6.4 . RECOMMENDATIONS FOR PRACTICE.
Based on the findings of this study and taking in into account knowledge of the 
present health care situation in the UK and the situation in Saudi Arabia, summarised 
in Sections 6.1 and 6.1.1, recommendations for the future development of provision of 
pharmaceutical services in acute independent hospitals in the UK and in Saudi Arabia 
are listed below:-
6.4.1. Recommendations for the UK and Saudi Arabia.
1) Formularies should be created based on independent, critical judgement aimed at 
promoting rational drug use for example through generic prescribing, when 
appropriate, as well as other measures. The production of such formularies can be 
done by an expert committee. Each independent hospital may also develop their 
own formulary based on the national formulary.
2) As a result of increased drug complexity, potency and availability of a wide range 
of medicines, practising pharmacists should receive adequate in-service training to 
broaden their concept of the new roles of the profession especially in medicines 
management and in the provision of aseptic techniques. The responses from the 
inspecting pharmacists in the UK suggested that more emphasis should be placed 
on aseptic preparation in independent hospitals.
3) More emphasis should be placed on the involvement of the pharmacist in the 
provision of drug information for fellow health workers, for example, formularies, 
standard treatment schedules etc. The interdisciplinary involvement of pharmacists, 
doctors, nurses and others in drug and therapeutic committees is to be promoted.
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4) More emphasis should be placed on the provision of clinical pharmacy services 
Clinical pharmacy should be practised in all hospitals and in primary care. 
Pharmacist should be involved in the reporting of suspected drug adverse reactions 
and more involved in patient counselling. Pharmacists need to be enabled to 
contribute their professional knowledge and expertise by becoming more fully 
integrated as members of the health care team. This can lead to more involvement 
in the choice of medication regimen and alternative drug therapy and other clinical 
aspects in collaboration with and while respecting the role of other health care 
professionals.
5) Isolation of pharmacists working in different sectors of health care needs to be 
resolved. Joint meetings focused on topics such as medicines management, 
pharmaceutical care and case studies would be beneficial.
6.4.2. Recommendations for the UK.
1) Communication with other health care professionals needs to be improved. 
Alternative methods of communication, such as computer networks, must be 
considered.
2) Pharmacists should ensure that the patient, on discharge, is counselled on their 
medications. For example, patients need to be aware about the changes in brands of 
medication to avoid confusion, patients need to be aware about how to obtain
• • • further supply and, patients need- to be- aware about whether the' medication needs 
to be continued after the supply has run out.
3) Effective communication channels between the pharmaceutical service provider in 
a hospital should be in place with all hospital professionals.
6.4.3. Recommendations for Saudi Arabia.
1) Pharmacists need to be fully involved in Quality Assurance of medicines, based on 
their understanding of drug stability under varying storage conditions and in order 
to control the movement of fake and counterfeit drugs.
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2) An effective information system is indispensable for efficient implementation of 
the various functions of drug supply management. Good communication information 
exchange and co-operation between different Ministries and with others involved in 
health care provision is crucial for the success of effective drug supply management.
6.5. RECOMMENDATIONS FOR FUTURE WORK.
The work described in this thesis has stimulated a number of ideas for future 
research:-
1) According to the evidence that there is a need for improvement in some 
pharmaceutical services in some independent hospitals, it would be appropriate to 
evaluate how that compares with the situation in NHS hospitals.
2) Studies are also required to investigate in greater depth the reasons why some 
services provided by some pharmacists were assessed by the inspecting 
pharmacists as "poor" or "very poor". The aim would be to identify solutions to 
any problems faced by those pharmacists in independent hospitals.
3) Large numbers of NHS hospitals have well-developed clinical pharmacy services, 
these days. Studies are required to investigate the extent to which clinical pharmacy 
has developed in independent hospitals and to identify any possible obstacles to its 
development.
4) There is a need to undertake a comprehensive survey of the future practice of 
pharmacy in the kingdom of Saudi Arabia. Certain aspects require detailed study, 
for example stock control and aseptic dispensing as this has not been done already. 
That could provide the basis for establishing an appropriate up-to-date policy for 
the practice of pharmacy in Saudi Arabia. In addition, the need for in-service 
training for Saudi pharmacists needs to be carefully examined and means for 
providing such further training need to be identified.
5) Comparative studies are required of the range and extent of pharmaceutical 
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At present I am a post-graduate student in the School of Pharmacy and 
Pharmacology at the University of Bath . I am working on a project under the 
supervision of Professor J E Rees . The aim of this project is to obtain and evaluate 
information concerning the pharmaceutical services provision in independent (private) 
hospitals throughout the U K .
As part of this study we have designed two questionnaires. One 
of these will be sent out to pharmacists working in the private health care sector .The 
second questionnaire will be used to obtain the opinions of senior pharmacists who 
participate in Health Authority inspections of independent hospitals .
You will be aware that two earlier studies were undertaken by 
Professor Rees in conjunction with Karen Harrowing, Joanne Peart, Calvin Rendle 
and Hannah Rees . The aim of the present study is to obtain additional information on 
the present state of provision of pharmaceutical services, and to examine factors 
which may influence the quality of service provision.
Initially, we are sending the two questionnaires to a small 
selected group of colleagues asking for your opinion. I therefore would be grateful if 
you could kindly spend a few minutes of your valuable time to review critically the 
content of each questionnaire, its structure, continuity and ease of completion . In 
particular I would welcome any opinions you may have on unnecessary questions or 
any additional information that you feel might be appropriate to gather . I realise that 
we have not included any questions relating to the registration of pharmacies in 
independent hospitals with the Royal Pharmaceutical Society . Do you feel that such 
developments are worthy of investigation from any stand point.
I would be most grateful if you could please give me your 
opinion within two weeks using the enclosed pre-paid envelope . As soon as I receive 
replies to this letter, I am planning to circulate this questionnaire to all independent 
hospitals in England, Scotland, Wales and Northern Ireland .
Once again thank you for your co-operation and for your time 
taken in commenting on these questionnaires .
Sincerely yours,
Yasir A. Turkistani N.B. If you have any queries please contact:
Mr. Yasir A. Turkistani 
c/o Prof. J E Rees
School of Pharmacy & Pharmacology
University of Bath
Claverton Down
Bath Avon BA2 7AY
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PHARMACEUTICAL SERVICES IN ACUTE INDEPENDENT HOSPITALS* 
Please tick [V] box(es) where appropriate
1) Please give the name and address of your independent hospital
----------------------------------------------  Post code
2) Year when first opened? 19....
3) Please indicate whether the ownership of your hospital is by :
N]
• Private individual □
• Limited company □
• Charity d
• Other □  Please specify.................
Please give name of group / individual / charity etc.
4) Number of beds ?
5) What is the total number of operating theatres ?
6) Which of the following support services are provided within the hospital ?
• Pharmacy d  Since(year).........................
• X-ray (Radiography) d
• Physiotherapy d
• Pathology □
• Other(s) {Please specify} □
7) What specialist services are offered by the hospital?
• Acute Psychiatric □  • Cardio-thoracic surgery □
• In-vitro fertilisation d  • Paediatrics □
• Other(s) {Please specify} □ -----------------------------------------
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8) Is there a Resident Medical Officer! Yes O  No □
If YES, is the cover provided during :
Day □  Night □  (Tick both if 24 hours)
IF  THERE IS  A PHARMACIST EMPLOYED (OR CONTRACTED TO WORK) 
WITHIN THE HOSPITAL PLEASE CONTINUE BELOW A T  QUESTION 9.
IF  NOT, GO TO QUESTION 15.
9) Is the pharmacist:-
• Employed by the hospital Y esO  N oO
• Contracted to work in the hospital Y esO  N < 0
• Other (Please state) ------------------------




11) To whom does the pharmacist report, managerially ?
(e.g. Hospital director, Matron, etc.) .
Job title-----------------------------
12) Between what hours is the Pharmacist on site ?
• Weekdays from------------- to -------------
• Saturday from -------------- to -------------
• Sunday from --------------- to ------------
How are pharmaceutical services provided outside these hours?
• An "on call" pharmacist can be contacted: by telephone O  by pager O
• Other,(please state) O
13) How many staff are employed in the Pharmacy department ?
Total No. o f staff Full time equivalent (approx.)
•Pharmacists ........  .......
•Technicians ........  .......
•Assistants ........
•Others (Please state) .........  .......
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14) The Association of Private Hospital Pharmacists(APHP)holds meetings four times 
a year, to discuss new developments and topics of mutual interest.
Are you a member of APHP ? Y esO  N cO
Do you attend these meetings whenever possible ? Y esO  N < 0
If NO is that because o f :
• Lack of time
• Lack of resources
• Lack of interest in the programme
• Travel distances involved
• A preference for other meetings
• No comment
• Other (Please specify)
(Please tick all appropriate boxes) □□□□□□□
PLEASE GO TO QUESTION 20




16) To whom does this person report, managerially ?
Name:-----------------------------------  Job title:------------------------------
17) Apart from inspections, is the hospital visited on a regular basis by a pharmacist 
providing pharmaceutical advice or other services ?
Y esO  N < 0
If YES, please indicate who does this, and how frequently
No. o f visits 
per week Total hours per week
Min. Max. (Average)
• Community pharmacist (Chemist) □  ......................................
• NHS Hospital pharmacist □  ......................................
• Group pharmacy advisor O  ................
• Other(s) {Please specify} □  ......................................
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18) Does the person(s) referred to in Question 17 provide an 'on-call' advisory service ?
Y esO  N c O
If NO, who can be contacted about a problem or query concerning the 
medication for a particular patient ?
19) Who is available to advise nursing and medical staff on a 'day-to-day' basis on 
drugs and medicines (for example, drug interactions, dosage, side effects, 
alternative products, cost effectiveness etc.) ?
20) Who normally provides pharmaceutical supplies to the hospital ?
• Local Pharmacy (Chemist). O
• Local NHS Hospital Pharmacy O
• Pharmaceutical wholesaler O
• Pharmaceutical manufacturers O
• Health centre 0
• Others (please specify) O  ------------------------
21) In an emergency, where can medicines be obtained, if not available in the 
hospital?
• Local Pharmacy (Chemist) C3
• Local NHS Hospital Pharmacy O
• Other Private Hospital O
• Pharmaceutical Wholesaler O
• Other(s) (Please specify) O  ------------------------------
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22) a] How are patients issued with medicines to take home (TTOs) ?
• During the day---------------------------------------------------
• At night/weekend------------------------------------------------
b] Is the supply limited in any way ? (Please give details)
c] Who advises the patient concerning their use of TTO medication?
23) How many out-patient prescriptions are dispensed per month, on average ?
24) Who is the person named on the Home Office Licence for Schedule 2 controlled 
drugs?
Name:-------------------------------  Job title:------------------------------
Not applicable □  If so, please give reason:-----------------
25) Is the Hospital Pharmacy registered with the Royal Pharmaceutical Society of 
Great Britain ?
YesO N oO  
If NO, please state the reasons :----------------------------------------------------
Page 243
Appendices
26) Is there a hospital Formulary in use ?
YesCJ N oO
If YES from where does the Formulary originate ? (Please specify the source)
• Local Health Authority
• Other Health Authority
• Your hospital
• Another hospital
• Group / Company 
« Other(s)
27) Does the hospital have a policy on the prescribing of antibiotics ?
YesO F k O
If YES, please outline the procedure adopted when an antibiotic is to be 
prescribed.
□□□□□□
28) Do you normally user-
Brand-name products YesO NoO Don't KnowO
Generic-name products YesO NcO Don’t KnowO
Both (Brand + Generic) YesO NcO Don’t KnowO




30) Would you consider using parallel-imported medicines?
YesO NcO Don't knowd
If YES, what procedure would you adopt to avoid counterfeit and/or 
substandard products?
31) Does the hospital calculate precisely the cost of medicines administered to 
individual patients?
YesO NoO Don't knowO
If YES, please indicate if this information is used for any additional cost 
analysis, for example, to cost the procedures carried out by different 
consultants.
If NO, how are medicines charged to patients in the hospital ?
32) Do you receive notices issued by the Department of Health and by pharmaceutical 
manufacturers concerning product recalls and medicines warnings?
YesO  N oO  Don't knowO
If YES, please indicate :
a} From whom you receive notification:---------------------------------------------
b} Who co-ordinates action in the hospital, in response to these notices:
Name:--------------------------------------  Job title:--------------------
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33) Who has carried out an official inspection of the pharmaceutical facilities and 
procedures within your hospital during the past 12 months, and how often ?
No. o f visits in the last 
12 months□□□□□
* (or the equivalent Senior Pharmacy Manager).
34) Do you regard inspections by the DPhO/CSP as :
• Advisory. □
• An enforcement of standards . O
• Other(Please specify) □
[V]
• District Pharmaceutical Officer (DPhO)* O
• Community Services Pharmacist(CSP) O
• Royal Pharmaceutical Society Inspector O
• Home Office Inspector □
• Other(s) (Please specify) □
35) Does the person in charge of pharmaceutical services undertake any training or 
continuing education ?
YesO N oO  
If YES , how many hours (approximately) of training or continuing education 
have they undertaken on the following topics during the past 12 months ?
No. of hours
• Pharmacy practice /Clinical pharmacy ..............................
• Management. .....
• Financial management. .....
• Safety. .....
• Legislation. .....
• Other (Please specify). .....
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36) With regard to the provision of pharmaceutical services in the hospital, please select 
the 5 key qualities of the person(s) responsible, and rank those qualities ffom:- 
O (least important) to © (most important)
• Purchasing skills d
• Knowledge of clinical uses of drugs & medicines d
• Networks of pharmaceutical contacts □
• Ability to interact with other people d
• Knowledge of safe handling of parenteral / 
cytotoxic drugs, etc.... d
• Knowledge of pharmaceutical legislation d
• Accurate & efficient dispensing d
• Good organisational skills d




37) Is there frequent contact between individual consultants in your hospital and the 
person(s) providing pharmaceutical services?
Y esO  NcO Don't knowd
a} If YES, approximately how often ? — times per week  per month .
b} What kinds of topics are most usually discussed ?
• Drug expenditure □
• Drug therapy d
• Others (Please state) d
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38) Listed below are a number of pharmaceutical services. Please indicate [V] which 
of
these are available in your hospital.
In the PROVIDER column please use one or more of these abbreviations to 
indicate who provides the relevant service
in-house Pharmacist (PH), a Community Pharmacist (CP), NHS Hospital 
Pharmacist (NHS), Group Pharmaceutical Advisor (GPA), Technician(T), 
wholesaler(WS), Other (please specify).
In the right hand column, please give your assessment of the QUALITY of
that service:
1: Very poor 2: Poor 3: Satisfactory 4: Good 
5: Very good.
Available Provider Quality 
[Vl (1-5)
• Stock control of drugs/medicines. □    □
• Expiry date checks . □    □
• Ward visits to advise patients. O  -------------  O
• Patient medication chart review. □    □
• Reconstitution of IV preparations . □    □
• Cytotoxic reconstitution. □    □
• Specialised production of medicines 
for this hospital. □   □
• Labelling of medicines . □    □
•Secure storage of medicines . □    □
• Environmental control of 
storage conditions □    □
• Disposal of medicines □    □
• Drug information. O  -------------  C3
• Other services (Please specify below) □    □
  □    □  
.   □    □  
  □    □  
.   □    □
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39) Could any aspects of the pharmaceutical services in your hospital be significantly 
improved ?
Y esO  N < 0  Don't knowO
If YES, please explain what aspects-------------------------------------------------
40) Are there any aspects of pharmaceutical legislation which create particular 
difficulties
in Independent Hospitals?
Y esO  N c O  Don't knowO
If YES, please give details---------------------------------------------------------------
41) Are there any specific reasons why those providing a pharmaceutical service 
might
find the opportunities available in an Independent Hospital more attractive than in 
a NHS hospital ?
42) Are there any disadvantages associated with the provision of pharmaceutical 
services in an Independent Hospital?
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43) No specific information from this survey will be attributed to an individual or a 
hospital, nor will such information be disclosed to a third party . Please indicate, 
however, if we are authorised to acknowledge in any future report that a response 
was received from your hospital.
YesO NoO 
If YES , please indicate which of the following can be acknowledged .
Name of the hospital O
Your own name O
You do not have to complete the following, if you prefer. However, we would 
appreciate receiving this information as it will enable us to send you a copy of the 
results in due course.
Name------------------------------ Qualifications------------------
Signature:----------------------
Thank you for completing this questionnaire .Please give (overleaf) any additional 
information that you feel may be relevant. You are invited to use the pre-paid 
envelope to return the questionnaire to :
Mr. Yasir A. Turkistani
c/o Professor John E Rees
School of Pharmacy and Pharmacology
University of Bath
Claverton Down







COPY OF THE LETTER WHICH WAS SENT TO THE UK HOSPITALS- 
GROUP OWNERS AND APHP.
Date: March 1994
Dear Sir/Madam,
At present I am a post-graduate student in the School of Pharmacy and 
Pharmacology at the University of Bath. I am working under the supervision of 
Professor J E Rees.
Currently, I am undertaking a national survey of pharmaceutical services in 
independent hospitals in the UK and it would be most helpful if you could assist me in 
the following way.
I wish to contact the Senior Pharmacist working in each independent hospital which 
has a pharmacy department. If you could please supply me with the name and address 
of the pharmacist concerned at each of the hospitals within your group, I therefore 
would be most grateful.
Thank you in advance for your help in this matter.
Yours faithfully




QUESTIONNAIRE AND COVERING LETTER SENT TO PERSON IN­
CHARGE OF PHARMACEUTICAL SERVICES IN INDEPENDENT 
HOSPITALS FOR NATIONAL SURVEY.
June 1994
Dear Mr/Mrs/ Ms/Dr,
At present I am a post-graduate research student at the School of 
Pharmacy and Pharmacology, University of Bath, working on a project under the 
supervision of Professor John E Rees .
The aim of the project is to investigate the provision of pharmaceutical 
services in independent hospitals throughout the UK. We realise that, within the 
independent sector, a number of different organisational approaches are used to 
provide hospital pharmaceutical services.
We would be most grateful if you could spend a few moments in 
completing this Questionnaire which is being sent to all independent hospitals in 
England, Scotland, Wales, and Northern Ireland. After the replies have been analysed, 
we intend to publish the results of this survey. Your opinions and information will 
help to ensure that the data we collect are comprehensive and representative of 
independent hospital practice. May we assure you, however, as emphasised on the last 
page of the Questionnaire that any information you supply will be treated in strict 
confidence and will not be disclosed as such to a third party .
A prompt reply would be very much appreciated. A Free post envelope 
is provided for your convenience.
We thank you in advance for your co-operation and for your time taken 








At present I am a post-graduate research student at the School of 
Pharmacy and Pharmacology, University of Bath, working on a project under the 
supervision of Professor John E Rees .
The aim of the project is to investigate the provision of the 
pharmaceutical services in independent hospitals throughout UK.
We realise that, within the independent sector, a number of different 
organisational approaches are used to provide hospital pharmaceutical services.
We would be most grateful if you could please arrange for completion 
of the enclosed questionnaire which is being sent to all independent hospitals in 
England, Scotland, Wales, and the Northern Ireland. From our various reference 
sources, we do not know whether your hospital has a pharmacy department. May I 
therefore suggest that you pass the questionnaire to the person responsible for 
pharmaceutical services.
After the replies have been analysed we intend to publish the results of 
this survey. Your opinions and information will help to ensure that the data we collect 
are comprehensive and representative of independent hospital practice. May we assure 
you, however, that any information supplied by you will be treated as strictly 
confidential and will not be disclosed to a third party.
A prompt reply questionnaire would be very much appreciated. A Free 
post envelope is provided for your convenience.
We thank you in advance for your co-operation and for your time taken 
in completing this questionnaire .
If you have any queries, please contact:
Mr. Yasir A. Turkistani
c/o Prof. John E. Rees
School of Pharmacy and Pharmacology
University of Bath





PHARMACEUTICAL SERVICES IN ACUTE INDEPENDENT HOSPITALS* 
Please tick[yl]box(es) where appropriate
1) Please give the name and address of your independent hospital
----------------------------------------------  Post code
2) Year when first opened? 19....





•Other □  Please specify..............................
Please give name of group / individual / charity etc.
4) Number of beds ?
5) What is the total number of operating theatres ?
6) Which of the following support services are provided within the hospital ?
• Pharmacy □ ....................Since(year)........................
• X-ray (Radiography) O
• Physiotherapy O
• Pathology □
• Other(s) {Please specify} □
*In this survey, an Acute Independent Hospital includes any premises which are used 
for the provision of acute psychiatric services and/or any of the following services:- 
the carrying out of surgical procedures under anaesthesia; the termination of 




7) What specialist services are offered by the hospital?
• Acute Psychiatric G • Cardio-thoracic surgery G
• Oncology G • Paediatrics G
• Other(s) {Please specify} G
8) Is there a Resident Medical Officer? YesG N od
If YES, is the cover provided during : DayG NightG (Tick both if 24 hours)
IF THERE IS A PHARMACIST EMPLOYED (OR CONTRACTED TO WORK) 
WITHIN THE HOSPITAL PLEASE CONTINUE BELOW AT QUESTION 9. 
IF NOT, GO TO QUESTION 15.
9) Is the pharmacist:- • Employed by the hospital YesG NoG
• Contracted to work in the hospital YesG N od
• Other (Please state)




11) To whom does the pharmacist report, managerially ?
(e.g. Hospital director, Matron, etc.) .
Job title-----------------------------
12) Between what hours is the Pharmacist on site ?
• Weekdays from-------------- to ------------
• Saturday from -------------- to -------------
• Sunday from -------------- to -------------
How are pharmaceutical services provided outside these hours?
• An "on call" pharmacist can be contacted : by telephone G by pager G
• Authorised persons have access to the pharmacy G
(Please explain)---------------------------------------------------------
• Authorised persons have access to an emergency supply cupboard G
(Please explain)---------------------------------------------------------
• Other,(please state) G
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13) How many staff are employed in the Pharmacy department ?
Total No. o f staff Full time equivalent (approx.)
•Pharmacists ........  .......
•Technicians ........  .......
•Assistants ........
•Others (Please state) .........  .......
14) The Association of Private Hospital Pharmacists(APHP)holds meetings four times 
a year, to discuss new developments and topics of mutual interest.
Are you a member of APHP ? YesG NoG
Do you attend these meetings whenever possible ? YesG NoG
If NO is that because o f : (Please tick all appropriate boxes)
• Lack of time G
• Lack of resources G
• Lack of interest in the programme G
• Travel distances involved o
• A preference for other meetings G
• No comment G
• Other (Please specify) G
PLEASE GO TO QUESTION 20




16) To whom does this person report, managerially ?
Name:  Job title:
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17) Apart from inspections, is the hospital visited on a regular basis by a pharmacist 
providing pharmaceutical advice or other services ?
YesG NoG
If YES, please indicate who does this, and how frequently
No. of visits 
per week Total hours per week 
Min. Max. (Average)
• Community pharmacist (Chemist) G ......................... ..........
• NHS Hospital pharmacist G ....................... .........
• Group pharmacy advisor G ....................... .........
• Other(s) {Please specify} G ....................... .........
18) Does the person(s) referred to in Question 17 provide an 'on-call' advisory service ? 
YesG NoG
If NO, who can be contacted about a problem or query concerning the 
medication for a particular patient ?
19) Who is available to advise nursing and medical staff on a 'day-to-day' basis on 
drugs and medicines (for example, drug interactions, dosage, side effects, 
alternative products, cost effectiveness etc.) ?
20) Who normally provides pharmaceutical supplies to the hospital ?
• Local Pharmacy (Chemist) . G
• Local NHS Hospital Pharmacy G
• Pharmaceutical wholesaler G
• Pharmaceutical manufacturers G
• Health centre G
• Others (please specify) G
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21) In an emergency, where can medicines be obtained, if not available in the hospital?
• Local Pharmacy (Chemist) □
• Local NHS Hospital Pharmacy CJ
• Other Private Hospital O
• Pharmaceutical Wholesaler □
• Other(s) (Please specify) □  --------------------------------
22) a] How are patients issued with medicines to take home (TTOs) ?
• During the day  ----- -— ———  ----------------------------------
• At night/weekend------------------------------------------------------------
b] Is the supply limited in any way ? (Please give details)
c] Who advises the patient concerning their use of TTO medication?
23) How many out-patient prescriptions are dispensed per month, on average ?
24) Who is the person named on the Home Office Licence for Schedule 2 controlled 
drugs?
Name:-------------------------------  Job title:-------------------
Not applicable □  If so, please give reason:-
25) Is the Hospital Pharmacy registered with the Royal Pharmaceutical Society of 
Great Britain ?
Y esd N od
If NO , please state the reasons :---------------------------------------------------
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26) Is there a hospital Formulary in use ?
YesO NoO
If YES from where does the Formulary originate ? (Please specify the source)
• Local Health Authority O ----------------
• Other Health Authority O ----------------
• Your hospital O
• Another hospital O ----------------
• Group / Company O ----------------
• Other(s) O ----------------
27) Does the hospital have a policy on the prescribing of antibiotics ?
YesO NoG
If YES, please outline the procedure adopted when an antibiotic is to be 
prescribed.
28) Do you normally use:-
• Brand-name products YesO NoG Don't knowO
• Generic products YesG NoG Don't knowO
• Both (Brand + Generic) YesO NoG Don't knowO
29) If you use generic pharmaceutical products, please indicate how you decide which 
ones to use ?
30) Would you consider using parallel-imported medicines?
YesG NoG  Don’t knowG




31) Does the hospital calculate precisely the cost of medicines administered to 
individual patients?
YesO NoO Don't knowO
If YES, please indicate if this information is used for any additional cost 
analysis, for example, to cost the procedures carried out by different 
consultants.
If NO, how are medicines charged to patients in the hospital ?
32) Do you receive notices issued by the Department of Health and by pharmaceutical 
manufacturers concerning product recalls and medicines warnings?
YesO NoO Don't knowO
If YES, please indicate :
a} From whom you receive notification:---------------------------------------------
b} Who co-ordinates action in the hospital, in response to these notices: 
Name:------------------------------- Job title:----------------------
33) Who has carried out an official inspection of the pharmaceutical facilities and 
procedures within your hospital during the past 12 months , and how often ?
No. of visits in the last 
[V] 12 months
District Pharmaceutical Officer (DPhO)* O  □
Community Services Pharmacist(CSP) □  □
Royal Pharmaceutical Society Inspector CJ □
Home Office Inspector O  O
Other(s): (Please specify) □  □
(or the equivalent Senior Pharmacy Manager)
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34) Do you regard inspections by the DPhO/CSP as :
• Advisory. □
• An enforcement of standards . O
• Other(Please specify) □
35) Does the person in charge of pharmaceutical services undertake any training or 
continuing education ?
YesO NoO 
If YES , how many hours (approximately) of training or continuing education 
have they undertaken on the following topics during the past 12 months ?
No. of hours
• Pharmacy practice /Clinical pharmacy. .....
• Management........................................................... .....
• Financial management. .....
• Safety. .....
• Legislation. .....
• Other (Please specify). .....
36) With regard to the provision of pharmaceutical services in the hospital, please 
select the 5 key qualities of the person(s) responsible , and rank those qualities 
from:-
O (least important) to 0  (most important)
• Purchasing skills O
• Knowledge of clinical uses of drugs & medicines □
• Networks of pharmaceutical contacts O
• Ability to interact with other people O
• Knowledge of safe handling of parenteral / 
cytotoxic drugs, etc.... □
• Knowledge of pharmaceutical legislation O
• Accurate & efficient dispensing O
• Good organisational skills O
• Other(s) (Please specify)
 •   □
.   □.  □.  □
Page 262
Appendices
37) Is there frequent contact between individual consultants in your hospital and the 
person(s) providing pharmaceutical services?
YesO NoO Don't knowO
a} If YES, approximately how often ?
 times per week ------- per month .
b} What kinds of topics are most usually discussed ?
• Drug expenditure O
• Drug therapy O
• Others (Please state) O
38) Listed below are a number of pharmaceutical services. Please indicate [V] which 
of
these are available in your hospital.
In the PROVIDER column please use one or more of these abbreviations to 
indicate who provides the relevant servicer- 
in-house Pharmacist (PH), a Community Pharmacist (CP), NHS Hospital Pharmacist 
(NHS), a Nurse (N), Technician(T), wholesaler(WS), Other (please specify).
In the right hand column, please give your assessment of the QUALITY of
that service:
1: Very poor 2: Poor 3: Satisfactory 4: Good 5: Very good.
Available Provider Quality
[Vl d -5 )
• Stock control of drugs/medicines. G   G
• Expiry date checks. G   G
• Ward visits to advise patients . G   G
• Patient medication chart review . G   G
• Reconstitution of IV preparations . G   G
• Cytotoxic reconstitution. G   G
• Specialised production of medicines
for this hospital. G   G
• Labelling of medicines. G   G
•Secure storage of medicines . G   G
• Environmental control of
storage conditions G   G
• Disposal of medicines G   G
• Drug information. G   G
• Other services (Please specify below) G   G
.   □    □.  □   □
 •   □    □.  □   □
Page 263
Appendices
39) Could any aspects of the pharmaceutical services in your hospital be significantly 
improved ?
YesO NoO Don't knowO
If YES , please explain what aspects------------------------------------------------
40) Are there any aspects of pharmaceutical legislation which create particular 
difficulties in Independent Hospitals?
YesO NoO Don't knowO
If YES, please give details-----------------------------------------------------
41) Are there any specific reasons why those providing a pharmaceutical service 
might
find the opportunities available in an Independent Hospital more attractive than in 
a NHS hospital ?
42) Are there any disadvantages associated with the provision of pharmaceutical 
services in an Independent Hospital?
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43) No specific information from this survey will be attributed to an individual or a 
hospital, nor will such information be disclosed to a third party. Please indicate, 
however, if we are authorised to acknowledge in any future report that a response 
was received from your hospital.
YesO NoO 
If YES, please indicate which of the following can be acknowledged .
Name of the hospital O
Your own name O
You do not have to complete the following , if you prefer . However, we would 
appreciate receiving this information as it will enable us to send you a copy of the 
results in due course.
Name-----------------------------  Qualifications--------------------
Signature:------------------------
Thank you for completing this questionnaire .Please give (overleaf) any additional 
information that you feel may be relevant. You are invited to use the pre-paid 
envelope to return the questionnaire to :
Mr. Yasir A. Turkistani
c/o Professor John E Rees
School of Pharmacy and Pharmacology
University of Bath
Claverton Down







COPY OF QUESTIONNAIRE # 2 AND COVERING LETTER USED FOR 
FURTHER PRE-TESTING.
Date : 1 April 1994
Regional Pharmaceutical Officers
Dear Mr/Mrs/Ms/Dr,
At present I am a post-graduate student in the School of Pharmacy and 
Pharmacology at the University of Bath . I am working on a project under the 
supervision of Professor John E Rees , the aim of this project being to obtain and 
evaluate information concerning the pharmaceutical services provision in independent 
(private) hospitals throughout the U K .
As part of this study we have designed a questionnaire which we intend 
to send out to Senior Pharmacy Managers who participate in the statutory inspection 
of private hospitals by Health Authorities .
Initially , I am sending this questionnaire to a selected group of 
pharmacists whose names have been suggested to me by Professor Rees, asking for 
their critical comments. I therefore would be most grateful if you could kindly spend 
a few minutes of your valuable time to give me your views on the content of the 
questionnaire, its structure, continuity and ease of completion . I would also be 
pleased to receive suggestions on any deletions or additions which you feel might 
usefully be made.
I would be especially grateful to receive your opinion as soon as 
possible, ideally within two weeks, using the pre-paid envelope . As soon as I receive 
the replies to this letter I am planning to circulate the questionnaire to all the relevant 
Senior Pharmacists in England, Scotland, Wales and Northern Ireland .
Could I also ask one further favour of you. Would it please be possible 
for you to send me a complete list of the names, job title and addresses of the Senior 
Pharmacy Manager, in each District within your Region, who is involved in the 
inspection of independent hospitals. I realise that, in the past , this inspection role 
would have been the responsibility of DPhOs. However, given recent reorganisations, 
I suspect that your office may be the most reliable source of the information I require .
May I thank you most sincerely for your co-operation and for the time 
taken in commenting on this questionnaire .
Sincerely yours,
Yasir A. Turkistani N.B. If you have any queries please contact:
Mr. Yasir A. Turkistani
C/O Prof. JE  Rees
School of Pharmacy & Pharmacology
University of Bath
Claverton Down
Bath Avon BA2 7AY
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PHARMACEUTICAL SERVICES IN ACUTE INDEPENDENT HOSPITALS* 
Please tick [V] box(es) where appropriate
1) Are you, or persons under your direction, involved in the inspection of 
pharmaceutical services provided in Independent/Private Hospitals ?
YesO NoO
2) Who undertakes the inspection of those Independent Hospitals ? Please state 
the person’s job title and type of establishment where employed .
(e.g. Trust Hospital, Health Authority etc. ).
• District Pharmaceutical Officer/ Senior Pharmacy Manager O
Title------------------  Employer-------------------




3) How many Independent Hospitals are there within your area of responsibility ?
4) Have all those Independent Hospitals previously been inspected at sometime?
YesO NoO Don't knowO
5) Do you regard inspection as :
• Advisory ? O
• An enforcement of standards ? O
• An administrative necessity ? O
• Other ? (Please specify) O
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6) Are some of the hospitals inspected less frequently than recommended by the 1994 
NAHAT guidelines ?
YesO NoO
7) If YES (for Question 6), is this because you have :
Hospital Number *(See footnote) 
1 2 3 4 5 6
• Confidence in the services
provided by the Pharmacist ? O O O O O O
• Confidence in the pharmaceutical
services provided by others ? O O O O O O
• Lack of staff for inspections ? O
• Lack of time for inspections ? O
• Other higher priority 
commitments within the NHS ? O
Other reason(s) (Please specify) O
* Footnote
Please allocate each of the Independent Hospitals an (anonymous) 
identifying number, and use the same identifying number when answering 
Questions 8 , 9 and 19 .
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8) Please indicate which of the following describes how the Pharmaceutical Service is 
provided in each Independent Hospital, by writing the letter “C” (to represent a 
comprehensive service) or “P” (a partial service) in the box provided.
Hospital number 
1 2 3 4 5 6
• By a Pharmacist(s) employed directly
by the hospital O O O O O O
• By a Pharmacist(s) contracted from an
NHS hospital O O O O O O
• By a Community Pharmacists) O O O O O O
• By an independent (self employed) pharmacist O O O O O O
• By non-pharmacist(s). Please state by whom : O O □  □  O O
• The only provision by a Pharmacist is a supply 
function^]. Please state from where: O O O O O O
There is  no Pharmacist involved at all [V] O O O O O O
9) How many hours of pharmaceutical services usually are provided at each 
Independent Hospital per week? Please tick [V]
(Please note that further details are requested later at Question 19)
Hospital Number 
1 2 3 4 5 6
0 hours O O O O O O
<5 □ □ □ □ □ □
5 to <15 O O O O O O
15 to <30 O O O 0  O O
30 to <40 O O O O O O
40 +(in which case, please state O O O O O O
the approx. hours here) ................................





11) If NO (for Question 10) , please state what criteria you would use to determine 
whether the services of a Pharmacist are required ?
12) Should the requirement to employ the services of a pharmacist be enabled by :
• Legislation? YesO NoO
• A requirement of the inspecting Health Authority ? YesO NoO
• Other means ? (Please specify) YesO
13) Where a hospital has NO PHARMACIST PRESENT are there reasons for 
inspecting that hospital:
More frequently YesO NoO
Less frequently YesO NoO
than a hospital which has a PHARMACIST PRESENT ?
Please give your reason(s)--------------------------------------------------------
14) Do you consider the NAHAT guidelines on inspection to be appropriate ? 
YesO NoO
If NO , please comment:------------------------------------------------------




16) Does your local Health Authority have a documented procedure for the inspection 
of pharmaceutical services in Independent Hospitals ?
YesO NoO
If YES , please attach a copy.
If NO , on what basis do you set the standards for inspection ?
17) Following a visit, is a written report submitted to the hospital? 
YesO NoO
18) Is a follow-up inspection undertaken, when quality deficiencies have been 
identified ?
YesO NoO
19) The Table overleaf calls for specific information on each of the Independent 
Hospitals in your District. If you have more than 6 Hospitals, please first make an 
extra copy of the blank table .
We list a number of criteria which you may well be using as a basis for your 
inspections.
Please would you rank these in two ways, as follows :
EMPHASIS:- What emphasis do you place on each criterion during inspection ? 
[1] Unimportant [2] Quite important [3] Very important
ASSESSMENT:- What in your opinion was the standard of each service 
criterion at the hospital concerned, at the time of your last inspection ?
[A] [B] [C] [D] [E]
Very Good Good Satisfactory Poor Very Poor
[Note :-If your emphasis on a particular criterion is always the same, regardless 
of hospital, please complete this once only for hospital number 1 ]
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□ □ □ □ □ □ □ □ □ □ □ □ Emphasis
□ □ □ □ □ □ □ □ □ □ □ □ Assessment
Two
n n n □ □ □ □ □ □ □ □ □ n □ □ Emphasis
U U L I □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Three
n n n □ □ □ □ □ □ □ □ □ □ □ □
Emphasis
U U U □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Four
□ □ □
□ □ □ □ □ □ □ □ □ □ □ □ Emphasis
□ □ □ □ □ □ □ □ □ □ □ □ Assessment
Five
n n n □ □ □ □ □ □ □ □ □ □ □ □
Emphasis
U U U □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Six
□
n n □ □ □ □ □ □ □ □ □ □ □ □
Emphasis
U U □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Emphasis: [1] Unimportant [2] Quite important [3] Very important
Assessment: [A] [B] [C] [D] [E]
Very Good Good Satisfactory Poor Very Poor
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20) Are there any other criteria which you use when inspecting the quality of 
pharmaceutical services provision in Independent Hospitals ?
If so please state:-
21) Which pharmaceutical services could be significantly improved in Independent 
Hospitals in your District ?
a} Those with a Pharmacist present:-----------------------------------------------
b) Those with NO pharmacist present:
22) If a NHS Hospital which employs the Senior Pharmacist, responsible for inspection, 
also provides a pharmaceutical service to an Independent Hospital in the same Health 
Authority, is there a conflict of interest as regards the responsibility for the inspection 





23) Given that market forces now operate within the NHS, is there any conflict of 
interest when the inspection of an Independent Hospital is undertaken by a senior 
pharmacist employed by a NHS "provider" hospital ?
YesO NoO
Please comment:----------------------------------------------------------------------
24) You are under no obligation to give your name and address below. However, 





Thank you for completing this questionnaire. You are invited to add, overleaf, any 
additional comments that you feel may be relevant.
When a report is prepared on this study, no specific information will be attributed to 
an individual or Hospital or District, nor will that information be disclosed to a third 
party.
If you wish to authorise us to acknowledge your contribution to this study, please tick 
this box □
Please return the questionnaire to the address below, using the FREE POST envelope. 
Mr Yasir Turkistani 
c/o Professor John E Rees 
School of Pharmacy & Pharmacology 













At present I am a post-graduate student in the School of Pharmacy and 
Pharmacology at the University of Bath, working on a project under the supervision of 
Professor John E. Rees. The aim of this project is to obtain information on the quality 
of pharmaceutical services available in independent hospitals throughout the U K .
According to our information, we understand that you, or persons 
under your direction, are involved in the inspection of pharmaceutical services in 
independent hospitals. Consequently, we recognise that you are in an excellent 
position to provide the information we require .
I would therefore be most grateful if you could take a few minutes of 
your valuable time to complete the enclosed Questionnaire and return it to me using 
the pre-paid envelope provided, in the next four weeks.
We intend to publish the results of this study. Your opinions and 
information will be invaluable to us in achieving a comprehensive coverage of 
independent hospitals. We wish to assure you that any information supplied by you 
will be treated strictly in confidence and that no details will be disclosed to a third 
party which might enable a particular person, district, or hospital to be identified .
May we thank you in advance for your co-operation and for the time 
taken in completing this Questionnaire .
Sincerely yours
Yasir A. Turkistani
PS If our information is not correct, and you are not involved in inspection of 
independent hospitals, could I please ask you to return the blank Questionnaire to us 
in the Free-post envelope. If possible could you, at the same time, give us the name 
and address of the pharmacist to whom we should send this Questionnaire.
PPS If you have any queries please contact:
Mr. Yasir A. Turkistani c/o Prof. J.E.Rees 
School of Pharmacy & Pharmacology 
University of Bath Claverton Down
Bath Avon BA2 7A Y
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PHARMACEUTICAL SERVICES IN ACUTE INDEPENDENT HOSPITALS* 
Please tick [V] box(es) where appropriate
1) Are you, or persons under your direction, involved in the inspection of 
pharmaceutical services provided in Independent/Private Hospitals ?
Y qsD  N o G
2) Who undertakes the inspection of those Independent Hospitals ? Please state 
the person's job title and type of establishment where employed .
(e.g. Trust Hospital, Health Authority etc. ).
• District Pharmaceutical Officer/ Senior Pharmacy Manager □
Title------------------  Employer-------------------




3) How many Independent Hospitals are there within your area of responsibility ?
4) Have all those Independent Hospitals previously been inspected at sometime? 
YesE NoO Don't knowO
• In this survey, an Acute Independent Hospital includes any premises which are 
usedfor the provision o f acute psychiatric services and/or any o f  the following 
services> the carrying out o f  surgical procedures under anaesthesia; the 
termination o f  pregnancies; endoscopy; haemodialysis or peritoneal dialysis; 
treatment by specially controlled techniques.
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8) Please indicate which of the following describes how the Pharmaceutical Service is 
provided in each Independent Hospital, by writing the letter “CM (to represent a 
comprehensive service) or “P” (a partial service) in the box provided.
Hospital number 
1 2 3 4 5 6
By a Pharmacist(s) employed directly
by the hospital □ □ □ □ □ □
By a Pharmacist(s) contractedfrom an
NHS hospital □ □ □ □ □ □
By a. Community Pharmacists) □ □ □ □ □ □
By an independent (self employed) pharmacist □ □ □ □ □ □
By non-pharmacist(s). Please state by whom : □ □ □ □ □ □
• The only provision by a Pharmacist is a supply 
functional]. Please state from where: □ □ □ □ □ □
There is no Pharmacist involved at all [V] □ □ □ □ □ □
9) How many hours of pharmaceutical services usually are provided at each 
Independent Hospital per week? Please tick [V]
(Please note that further details are requested later at Question 19)
Hospital Number 
1 2 3 4 5 6
0 hours □ □ □ □ □ □
<5 □ □ □ □ □ □
5 to <15 □ □ □ □ □ □
15 to <30 □ □ □ □ □ □
30 to <40 □ □ □ □ □ □
40 +(in which case, please state □ □ □ □ □ □
the approx. hours here) ................................
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10) In your opinion, should all the Independent Hospitals employ the services of a 
Pharmacist ?
YesO NoO
11) If NO (for Question 10), please state what criteria you would use to determine 
whether the services of a Pharmacist are required ?
12) Should the requirement to employ the services of a pharmacist be enabled by :
• Legislation? YesO NoO
• A requirement of the inspecting Health Authority ? YesO NoO
• Other means ? (Please specify) YesO
13) Where a hospital has NO PHARMACIST PRESENT are there reasons for 
inspecting that hospital:
More frequently YesO NoO
Less frequently YesO NoO
than a hospital which has a PHARMACIST PRESENT ?
Please give your reason(s)--------------------------------------------------------
14) Do you consider the NAHAT guidelines on inspection to be appropriate ? 
YesO NoO
If NO , please comment:------------------------------------------------------




16) Does your local Health Authority have a documented procedure for the inspection 
of pharmaceutical services in Independent Hospitals ?
YesO NoO
If YES , please attach a copy .
If NO, on what basis do you set the standards for inspection ?
17) Following a visit, is a written report submitted to the hospital? 
YesO NoO
18) Is a follow-up inspection undertaken, when quality deficiencies have been 
identified ?
YesO NoO
19) The Table overleaf calls for specific information on each of the Independent 
Hospitals in your District. If you have more than 6 Hospitals, please first make an 
extra copy of the blank table .
We list a number of criteria which you may well be using as a basis for your 
inspections.
Please would you rank these in two ways, as follows :
EMPHASIS:- What emphasis do you place on each criterion during inspection ? 
[1] Unimportant [2] Quite important [3] Very important
ASSESSMENT:- What in your opinion was the standard of each service 
criterion at the hospital concerned, at the time of your last inspection ?
[A] [B] [C] [D] [E]
Very Good Good Satisfactory Poor Very Poor
[Note :-If your emphasis on a particular criterion is always the same, regardless 









































































n □ □ □ □ □ □ □ □ □ □ □ □ □
Emphasis
U U □ □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Two
n n n □ □ □ □ □ □ □ □ □ □ □ □ □
Emphasis
U U U □ □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Three
□ □
n □ □ □ □ □ □ □ □ □ □ □ □ □
Emphasis
U □ □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Four
□ □ □
□ □ □ □ □ □ □ □ □ □ □ n □ Emphasis
□ □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Five
□ □ □
□ □ □ □ n □ □ □ □ □ □ □ □ Emphasis
□ □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Six
□ □ □
□ □ □ □ □ □ □ □ □ □ □ □ □ Emphasis
□ □ □ □ □ □ □ □ □ □ □ □ □ Assessment
Emphasis: [1] Unimportant [2] Quite important [3] Very important
Assessment: [A] [B] [C] [D] [E]
Very Good Good Satisfactory Poor Very Poor
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20) Are there any other criteria which you use when inspecting the quality of 
pharmaceutical services provision in Independent Hospitals ?
If so please state:-
21) Which pharmaceutical services could be significantly improved in Independent 
Hospitals in your District ?
a} Those with a Pharmacist present:-----------------------------------------------
b) Those with NO pharmacist present:
22) If a NHS Hospital which employs the Senior Pharmacist, responsible for inspection, 
also provides a pharmaceutical service to an Independent Hospital in the same 
Health
Authority, is there a conflict of interest as regards the responsibility for the inspection 





23) Given that market forces now operate within the NHS, is there any conflict of 
interest when the inspection of an Independent Hospital is undertaken by a senior 
pharmacist employed by a NHS "provider" hospital ?
YesO NoO
Please comment:----------------------------------------------------------------------
24) You are under no obligation to give your name and address below. However, 





Thank you for completing this questionnaire. You are invited to add, overleaf, any 
additional comments that you feel may be relevant.
When a report is prepared on this study, no specific information will be attributed to 
an individual or Hospital or District, nor will that information be disclosed to a third 
party.
If you wish to authorise us to acknowledge your contribution to this study, please tick 
this box □
Please return the questionnaire to the address below, using the FREE POST envelope. 
Mr Yasir Turkistani 
c/o Professor John E Rees 
School of Pharmacy & Pharmacology 









COPY OF THE REMINDER LETTERS SENT TO BOTH RESPONDENTS 
(QUESTIONNAIRES # 1 AND # 2.
Date:- August 1994
Re. A Survey on Pharmaceutical Services In Acute Independent Hospitals .
Dear Sir/Madam,
I wrote recently asking you to complete a Questionnaire on the subject 
of the above survey . We have obtained a very good response to that first mailing. 
However, we have no record of a reply from you.
In order to ensure that our data are comprehensive and representative 
,your response is extremely important to our study. Therefore we would be most 
grateful if you could please return the completed Questionnaire to me, if at all possible 
by 15 August 1994 .
If you have mislaid your original copy of the blank Questionnaire, 
please let me know as soon as possible using the tear-off slip below to indicate your 
requirements.
A number of responses received already have been completed 
anonymously. If your response was among those, it would be most helpful if you could 
please inform me using the tear-off slip below. That will avoid me sending you a 
further reminder.
Thank you for your co-operation
Sincerely Yours, Please return the tear-off slip below to:
Pharmacy Practice Research Unit 
School of Pharmacy & Pharmacology 
FREEPOST (SN1548)
Yasir A. Turkistani University of Bath
Bath Avon BA2 7LZ
X ----------------------------------------------------------------------
I’ve already returned the Questionnaire to you 
Please send me a second copy of the Questionnaire 











Re. A Survey on Pharmaceutical Services Provision As Perceived By Pharmacists 
Involved In Inspection.
Dear Mr/Mrs/Ms/Dr,
I wrote recently asking you to complete a Questionnaire on the subject 
of the above survey . We have obtained a very good response to that first mailing. 
However, we have no record of a reply from you.
In order to ensure that our data are comprehensive and representative 
,your response is extremely important to our study. Therefore we would be most 
grateful if you could please return the completed Questionnaire to me, if at all possible 
by 15 August 1994 .
If you have mislaid your original copy of the blank Questionnaire, 
please let me know as soon as possible using the tear-off slip below to indicate your 
requirements.
A number of responses received already have been completed 
anonymously. If your response was among those, it would be most helpful if you could 
please inform me using the tear-off slip below. That will avoid me sending you a 
further reminder.
Thank you for your co-operation
Sincerely Yours, Please return the tear-off slip below to:
Pharmacy Practice Research Unit 
School of Pharmacy & Pharmacology 
FREEPOST (SN1548)
Yasir A. Turkistani University of Bath
Bath Avon BA2 7LZ
X ----------------------------------------------------------
I’ve already returned the Questionnaire to you 
Please send me a second copy of the Questionnaire 











COPY OF THE LETTER SENT TO THE REGIONAL PHARMACEUTICAL 




Thank you for your letter dated 15 April 1994 responding to my 
letter dated 1 April 1994 concerning my queries about the names and addresses 
of the Senior Pharmacy Managers who are involved in inspection of 
pharmaceutical services in Independent Hospitals .
My record show that I have received replies from :-
but unfortunately Mr , Mrs , Ms and Dr had returned to
me the blank Questionnaire and told me that they are not involved in 
inspection of Independent Hospitals but they are unable to inform me of the 
names of pharmacists responsible for inspection in there district.
I wonder if you would be able to give me the names and
addresses of the Senior Pharmacy Managers responsible in Mr ’s,
Mrs ’s , Ms ’s and Dr ’s district.









I am writing to you in your capacity as Chair of the Community 
Services Pharmacists’ Group, following a recommendation made by Mrs. Beth Taylor 
in a conversation between her and Professor John Rees at British Pharmaceutical 
conference 94 in London.
As may recall that I am a post-graduate research student in the School 
of Pharmacy and Pharmacology at the University of Bath, working on a project under 
the supervision of Professor Rees. The aim of this study is to obtain and evaluate 
information concerning the pharmaceutical services provision in independent (private) 
hospitals throughout the UK. You were kind enough to complete a Questionnaire 
which was sent to Norwich, and we are most grateful to you.
As you know, as a part of this study we designed a Questionnaire 
which was sent out to Senior Pharmacy Managers who participate in the statutory 
inspection of private hospitals by Health Authorities .The names and addresses were 
obtained from the Regional Pharmaceutical Officers whom we asked for that 
information.
Unfortunately, from the replies of the Senior Pharmacy Managers , we 
find that some of them are not involved in inspection nor are they aware of the person 
responsible for inspection in their Districts. One of the lists attached to this letter 
(no.l) shows the names and the districts of all the Senior Pharmacy Managers from 
whom I have received completed Questionnaire. You will see, however, from that list 
that I have been unable to obtain the required information from several Districts.
Given recent reorganisation, I suspect that your group may be the most 
reliable source of the information I require. So, I would be especially grateful, and it 
would be most helpful, if you could assist me in the following way. I wish to contact 
the CSP’s involved in the inspection of Independent Hospitals in those Districts for 
which I do not have a completed Questionnaire. Would it please be possible for you to 
supply me with a complete list of the names, job title and addresses of the CSPs 
concerned, either by filling in the attached list (no2) or by putting the name and 
address in the empty space of each district in list (nol). If you are not able to give us 
this information, would you please let us know who might be able to help in this 
matter.
May we thank you in advance for your cooperation in this matter.
Your sincerely,
Yasir A. Turkistani
N.B. If you have any queries please contact me or 




COPY OF THE LETTER SENT TO NURSING HOMES REGISTRATION 
OFFICERS (NHRO).
Dear Sir/Madam,
One of my post-graduate students Mr. Yasir A. Turkistani is 
undertaking a national survey of the pharmaceutical services provision in acute 
Independent (private) Hospitals throughout the UK.
As a part of his study he wishes to contact those pharmacists who 
participate in the statutory inspection of private hospitals by Health Authorities.
Given recent reorganisation, it has proved difficult to ascertain the 
name of the pharmacist concerned in certain parts of the UK including your own 
Health Authority. I therefore would be most grateful, if you could assist us by 
providing the necessary information. You may find it convenient simply to fill in the 
section below and return it to me using the enclosed free-post address sticker. If you 
are not able to supply this information, perhaps you could let me know who might be 
able to help in this matter.
Date:- January 1995
May I thank you in advance for your assistance.
With kind regards
Professor John E.Rees 
Head of Pharmacy Practice
X
(Please tick [S] where appropriate)
♦There are no Independent Hospitals in the area covered by this
Health Authority □
♦The name of the pharmacist usually involved in inspection is given
below □
*The inspection team does not normally include a pharmacist
the person responsible for inspecting the pharmaceutical services is
named below □
Name:--------------------------------------




* Additional comments: 




Table X .l. Emphasis placed by the inspector on the PROCUREMENT OF MEDICINESt compared with their perceived assessment in
hospitals with and without a vharmacist:-









Table X.2. Emphasis placed by the inspector on the SECURE STORAGE OF MEDICINES, compared with their perceived assessment in







Table X.3. Emphasis placed by the inspector on the COMPREHENSIVE LABELLING OF MEDICINES. compared their perceived
assessment in hospitals mill and without a pharmacist:-
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TableX.4. Emphasis placed by the inspector on the QUALIFICATION AND TRAINING OF STAFF, compared with their perceived
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Table X.5. Emphasis placed by the inspector on the STOCK CONTROL AND RECORD KEEPING, compared with their perceived
assessment in hospitals with and without a pharmacist:-
Very Good Satis- 
Good factory








Table X.6. Emphasis placed by the inspector on the ENVIRONMENTAL STORAGE CONDITIONS OF MEDICINES, compared with their


















Table X.7. Emphasis placed by the inspector on the MONITORING/INTERVENTION OF IN-PATIENT DRUG THERAPY, compared with














Table X.8. Emphasis placed by the inspector on the DISPOSAL OF MEDICINES, compared with their perceived assessment in hospitals








Table X.9. Emphasis placed by the inspector on the PROCEDURES INVOLVING IN  IV  ADDITIVES. compared with their perceived
assessment in hospitals with and without a pharmacist:-
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Table X10.Emphasis placed by the inspector on the PROCEDURES CYTOTOXICS PREPARA TIONS. compared




















Table X J L  Emphasis placed bv the inspector on the PROCEDURES INVOLVING PREPARATIONS, compared
perceived assessment in hospitals with anil without a pharmacists










Table X.12. Emphasis placed by the inspector on the DRUG INFORMATION SERVICES. compared with their perceived assessment in
hospitals with and without a pharmacist:-
Good Satis­
factory
Very Good Satis- Poor Very
Good factory PoorGood
important
mM M  Quite- 




Table X.13. Emphasis placed by the inspector on the ADVICE ON ANTIBIOTIC/CROSS INFECTION POLICY. compared with their

























LIST OF THE SERVICE PROVIDERS AND THEIR HOSPITALS WHO 
WISHED TO BE ACKNOWLEDGED.
Hospital Name Respondent Name
Stuart House Clinic
AMI Ross Hall Hospital Ms. A. Beach
Cheadle Royal Hospital Mrs. Jean Layton
BUPA Hospital Cardiff Mrs. Ann Johns
The Garden Hospital
The convent Hospital Mrs. Elsmeth Pimlott
PUPA Hospital Portsmouth Ms. Denise Lumb
Hampshire Clinic
St. Mary’s Hospital Ms. Ann Heath
Manor Hospital Mrs. Lucy A. Linton-Willoughby
Lourdes Hospital Miss. Janet Rainford
Farm Place
AMI Princess Margaret Hospital Mrs. Kath Fullerton
AMI Chaucer Hospital Mrs. Mary Me Gillie
The Bath Clinic
Woodboume Clinic Mrs. Celia Feetam
BUPA Hospital Manchester Mrs. Rosemarie Taylor
Calthorpe Nursing Home
IBH King’s Park Hospital
AMI Priory Hospital Mrs. Lesley Ryan
New Victoria Hospital Mrs. E.J. Nix
Sussex Private Clinic




New Hall Hospital Ms. V. M. Seymour Farr
IBH Abbey Park Hospital
Ms. Maynard S. Newman
Sarum Road Hospital Mrs. Jenny Hadley
The London Clinic Mrs. Elizabeth Butterfield
The: Darum Lodge Clinic Jean Glover
Charter Clinic Chelsea Mr. Darshak Raja
Blackdown Clinic
IBH Rowley Hall Mrs. Betteiy
The Esperance Hospital
Mount Alvemia Hospital Mr. Philip Coming
AMI Grafton Manor Virginia Jones
The Ashdown Hospital
Plymouth Nuffield Hospital Ms. J. Henry
The Runnymede Hospital Diane Habat
Miss. Mary Farrar
The Dukes Priory Hospital Ms. Paula Wilkinson
All Hallows Hospital
Winifield Hospital Ms. Ann Seward
The Sussex Nuffield Hospital
Ridgeway Hospital Mrs. Rosemary Butler
BUPA Chalybeate Hospital Ms. Kathryn Lesley Mould
IBH Garrick Glen Hospital Ms. Ellice Pender
Mr. David Houghton
IBH Fulwood Hall Hospital
Tadworth Court Childem’s Hospital
St. Mathew’s Private Hospital Mr. David Lindsny
Liverpool Marie Curie Centre Mr. Eric Goodwin
BUPA Hospital Hull and East Riding Ms. Angela Frearson
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PUBA Parkway Hospital Ms. Anne Hughes
Cromwell Clinic
Fairfield Independent Hospital Mrs. J. Watkinson
The Portland Hospital for Women and Children Ms. Wendy Thompson
The Cleveland Nuffield Hospital Mrs. S. Hunter
The Princess Grace Hospital Ms. Kasia Vine
Cromwell Hospital Saran Dennison
British Home and Hospital for Incurables
Droitwich Private Hospital Angus Thompson
Ms. Judith Bryant
Ulster Independent Clinic
BUPA Hospital Bushey Ms. Angela Wood
Fitzwilliam Hospital
The Somerfield Hospital Ms. J. Laskow-Pooley
Ms. Barbara Furness
Rivers Hospital
BUPA Hospital harpenden Frances Leonard
Benerden Hospital
Mr. John Glinn
Wamdale Private Hospital Mr. Philip Malphant
Parkside Hospital Ms. Jill Burton
The Newcastle Nuffield Hospital
Altrincham Priory Hospital
Ticehurst House Hospital








Huddersfield Nuffield Hospital Ms. Anne Me Connell
Grosvenor Nuffield Hospital
EBH Renacres Hall Hospital
Foscote Private Hospital
The Chesterfield Hospital
Ashtead Hospital T. Sturge




The Priory Hospital Ms. Virginia Jervis




LIST OF THE SENIOR PHARMACISTS WHO WISHED TO BE 
ACKNOWLEDGED.
Mr. M. Pilling North West Regional Health Authority
Mr. Neil Spencer South Thames Regional Health Authority
Ms. Angela Pell North West Regional Health Authority
Mr. J. D. Harris Trent Regional Health Authority
Mr. Alan Milligan Northern and Yorkshire Regional Health Authority
Mr. Surinder S. Bassan West Midland Regional Health Authority
Mr. Miall James North Thames Regional Health Authority
Mr. L. W. May North West Regional Health Authority
R. I. Bell Trent Regional Health Authority
Mr. Peter Fletchaer North West Regional Health Authority
Mr. L. S. R. Baker Northern and Yorkshire Regional Health Authority
Mr. Mike Beaman North Thames Regional health Authority
Mr. P. M. Matthews West Midlands Regional Health Authority




COPY OF THE FINAL VERSION OF THE INTERVIEW QUESTIONNAIRE 
AND THE INTRODUCTORY LETTER SENT TO THE SENIOR 
PHARMACISTS.
Dear
As you may recall I am a postgraduate research student at the School of 
Pharmacy and Pharmacology, University of Bath, working under the supervision of 
Professor John E. Rees.
You may remember in 1994 completing a questionnaire on the subject of : 
"Pharmaceutical Services in Independent Hospitals as perceived by Pharmacists 
involved in Statutory Inspections
I have obtained a number of interesting results which may of interest to you, so 
I would welcome very much an opportunity to come and discuss some of these 
findings with you.
I am keen to talk with those Senior Pharmacists who have been involved in the 
inspection of 3 or more independent hospitals because their broader experience of 
inspection should reflect different types of hospitals, for example those with a 
pharmacist and others without.
Even if you are not currently involved in inspection, your opinion is still 
invaluable to our study, since your experience relates to the period that we collected 
our data.
I know that time is valuable for a person in your position but I assure you that 
our discussion would not last more than 30 minutes.
So, within a few days of sending you this letter, I will telephone to set up a 
convenient date and time to visit you.






2} Health Authority:-----------------------------------  Job Title:
3} Are you still involved in inspection of independent hospitals?
Yes CJ No C3
If FES:
Are you still using CSP or NAHAT guidelines during inspection?
If NO:
Who is currently involved in the inspection of pharmaceutical services 
in independent hospitals in your Health Authority? (Pharmacist expertise 
available to inspection team).
4} How many IHs are there in your HA.:-
5} A] How many of those IHs have a pharmacist either employed or contracted
for the provision of pharmaceutical services?
Pharmacists: --------
B] How many of those IHs do not have a pharmacist?
No pharmacists:---------------
6} A] Do you find you have different requirements when you set out to inspect
different independent hospitals?
Yes □  No □
B] Are your requirements different when you set out to inspect independent 
hospitals with and without a pharmacist?




1} On average, how would you say that the provision of pharmaceutical services 
compares in independent hospitals with and without a pharmacist?
(i.e. the quality of the service in the hospitals without a pharmacist generally is: 
WORSE Yes O  than in hospitals with a pharmacist?
or about the SAME Yes O  in hospitals with a pharmacist?
or BETTER Yes □  than in hospitals with a pharmacist?)
8} A] Our analysis of the responses obtained from the Senior Pharmacists 
involved in inspection shows that, on average, the quality of pharmaceutical service 
provision in hospitals with a pharmacist is better than in hospitals without. There 
were significant differences in service quality for 9 out of the 13 services we specified. 
But for the other four service criteria there were no significant differences in service 
quality between hospitals with and without a pharmacist; that was for:
• environmental storage of medicines
• IV-additives procedures 
•cytotoxics reconstitution, and 
•procedures involved in TPN.
Would you have expected this? Why?
Comments:------------------------------------------------------------------------------
B] For
• secure storage of medicines
• drug information, and
• antibiotic/cross infection policy,
the MODAL (the most occuring number) quality assessment for pharmacist and non­
pharmacist are the SAME in each case. That is also true for IV-additives.




{OBVIOUSLYSOME OF THESE WERE PHARMACISTS AND OTHERS NON-PHARMACISTS).
9 } In general, do you find that service providers over-estimate the quality of services 
they provide; that is, compared with your own estimate of the quality?
Yes C3 No d  Don’t Know O
(jlf this is the case for some services which services?).
1 0} Would you say that, in general, non-pharmacists are more likely than pharmacists 
to over-estimate the quality of the services they provide?
Yes O  No O  Don’t Know O
(If this is the case for some services which services?).
Comments:-----------------------------------------------------------------------------------
11} The MODAL assessments given by the pharmacists and the non-pharmacists was 
the same — that is to say — “very good” for 9 of the 12 pharmaceutical services 
criteria. For the other 3 services, the non-pharmacists again gave themselves a modal 
assessment of “very good”. However, the MODE for the pharmacists in those three 
cases — drug information, expiry date checks, and IV-additives — was less than “very 
good”.
So, the non-pharmacists ’ assessment of the quality of those three services suggested 
that their service quality was better than that provided by the pharmacists.
Ln contrast, there were none of the 13 services for which the inspectors’ modal 
assessment ranked hospitals without a pharmacist as better than hospitals with a 




12} In the early stages of our study, we faced some difficulties in obtaining 
information about which Senior Pharmacists were involved in the statutory inspection 
of independent hospitals in many Health Districts. That seemed to us to reflect 
deteriorating communication among pharmacists within the NHS, possibly as a result 
of the latest NHS reorganisations. Our experiences were published in an abstract and a 
poster at the 1995 British Pharmaceutical Conference held in Warwick.
A] To your knowledge, are you aware of increased problems of 
communication or sharing of information between Senior Pharmacists within NHS 
over the past 5 years. (If he say that this is a big issue, Refer to inspection).
Yes □  No □
Pleaise comment:---------------------------------------------------------------------------------
B] Do you think that it was reasonable for us to draw the conclusions we did 
from our experiences?
Yes □  No □
Please comment:---------------------------------------------------------------------------------
13} Am I correct in assuming that you are/were responsible for an NHS hospital 
pharmacy?
Yes □  No □
14} Are/Were you or your staff involved in providing a pharmaceutical service in any 
independent hospital which has/had a contract with the NHS for the provision of the 
pharmaceutical service?
Yes □  No □
If KEY:
Are/were you involved in the inspection of the relevant IHs at the same time as 
providing the service?




Would you say that you inspected that hospital in as much detail as other 
hospitals which have no contract with the NHS or hospitals with their own employed 
pharmacist?
Yes □  No □
Please comment:---------------------------------------------------------------------------------
If NO:
Would you say that a pharmacist in that position would inspect that hospital in 
as much detail as other hospitals which have no contract with the NHS or hospitals 
with their own employed pharmacist?
Yes □  No □
Please comment:---------------------------------------------------------------------------------
15} Some Health Authorities and some individual pharmacists consider that in such 
circumstances it should be obligatory for a senior pharmacist not involved in service 
provision to carry out the inspection procedures.
Do you consider that an independent inspection should be obligatory?
Yes O  N o O
16} In your opinion, how do the pharmaceutical services in IHs compare with those in 
NHS hospitals? (i.e. worse/same/better).
17} Finally, may I ask you how would you rate/assess level of pharmacist professional 
co-operation between the IHs and the NHS hospitals in your area?
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